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ABSTRACT 
The liver plays a central role in the metabolism of cholesterol 
being the major site at which lipoproteins are both assembled and 
degraded and the only organ where cholesterol can be degraded to 
bile salts. The synthesis of bile salts by the liver provides the 
major pathway for the removal of cholesterol from the body. 
The results in this thesis describe the characterisation of a 
rat hepatocyte monolayer system, suitable for studying the synthesis 
of bile salts. The utilization of the cholesterol derived from a 
high density lipoprotein subfraction (HDL2) for the synthesis of 
bile salts was also investigated. 
Following the isolation of a viable cell preparation, 
hepatocytes were maintained in monolayers for up to 24h. During 
this period hepatocytes were shown to maintain their viability and 
to synthesise and secrete bile salts, as determined by radio - 
immunoassay of conjugated cholic, chenodeoxycholic and ß- muricholic 
acids. The rate of synthesis of these bile salts by hepatocytes 
was increased by feeding rats cholestyramine for at least 5 days 
prior to the preparation of hepatocyte monolayers. 
Incubation of hepatocyte monolayers with rat HDL2 had no effect 
on the synthesis of the three bile acid conjugates measured when the 
cells were obtained from rats fed the pellet diet. However, when 
the experiment was repeated using hepatocytes obtained from rats 
fed cholestyramine, HDL2 was found to increase the synthesis of the 
bile salts measured. This is the first report that a defined 
lipoprotein fraction can increase the synthesis of bile salts. 
In an attempt to ascertain the reason for the increase in the 
synthesis of bile salts, hepatocytes isolated from cholestyramine- 
vi 
fed rats were incubated in the presence of HDL2 radiolabelled with 
either [4- 14Clcholesterol or [4- 14C]cholesteryl oleate. The 
degradation of the radiolabelled HDL2- cholesterol to bile salts 
was subsequently determined. The results indicated that the 
increase in the synthesis of bile salts was due to the utilization 
of HDL2 -cholesteryl ester. 
Finally, the effect of HDL2 on the synthesis of cholesterol 
and the utilization of newly synthesised cholesterol for the 
synthesis of bile salts in hepatocyte monolayers was determined. 
The results showed that HDL2 had no effect on either cholesterol 
synthesis or the utilization of newly synthesised cholesterol for 
the synthesis of bile salts. 
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1.1 General Introduction 
Cholesterol is an essential component of all mammalian systems 
being a component of cell membranes and the precursor of bile acids, 
steroid hormones and some vitamins. The cholesterol that contributes 
to the total body pool is derived from two sources. Cholesterol can 
be synthesised de novo, primarily by the liver and small intestine, or 
it can be absorbed from the diet. It has long been established that 
high plasma cholesterol levels show a positive correlation with the 
incidence of ischaemic heart disease (Kannel et al., 1971; Carlson and 
Bottiger, 1972). It is therefore important that efficient regulatory 
mechanisms exist to prevent the accumulation of total body cholesterol. 
These findings prompted extensive research into possible mechanisms 
for the removal of cholesterol from the body. In particular there 
have been intensive investigations into the synthesis of bile acids 
and also the removal of plasma lipoproteins from the circulation. 
The liver plays a particularly important role in both of these 
processes being a major site for the uptake and degradation of plasma 
lipoproteins and also the only organ where cholesterol is degraded to 
bile salts. The synthesis of bile salts provides the major route by 
which cholesterol is degraded and eventually eliminated from the 
body. 
The following account discusses the current knowledge of the 
complex metabolism of cholesterol whilst referring the reader to 
recent reviews that provide more detailed accounts of specialised 
areas. 
2 
1.2 The Plasma Lipoproteins 
The plasma lipoproteins serve to transport lipid in a water 
soluble form from their sites of assembly to specific target sites. 
The plasma lipoproteins consist of a hydrophobic core of triglyceride 
and cholesteryl ester, surrounded by a hydrophilic coat of protein, 
phospholipid and free cholesterol. The binding of the inner lipid 
to the outer solubilising coat is non -covalent (primarily through 
hydrogen bonds and van der Waal's forces) and allows ready exchange 
of components between plasma lipoprotein classes and also between 
plasma and tissue lipoproteins. 
There are four main classes of lipoproteins (Table 1.1) each 
floats within a different density range in the ultracentrifuge 
(Havel et al., 1955). These classes are chylomicrons, very low 
density lipoprotein (VLDL), low density lipoprotein (LDL) and 
high density lipoprotein (HDL). As well as their different 
physical characteristics the chemical composition of each of the 
lipoproteins is also quite distinct (Table 1.1). The conventional 
salt densities chosen for the isolation of the plasma lipoproteins 
are based on the density ranges of the human plasma lipoproteins. 
This does not necessarily apply to all species. In the rat the 
isolation of LDL in the conventional density range of 1.006 - 
1.063 g ml -1 results in the contamination of LDL with apoprotein E 
(apo E). This has subsequently been shown to be due to the 
contamination of the LDL fraction with a subfraction of HDL rich 
in apo E (Innerarity et al., 1980). It is therefore important 
not only to characterise lipoproteins by their density but also by 
their apoprotein content. This is particularly important as the 
















































































































































































































































































































































































































































































































































































































































moiety but also act as recognition sites for cell surface receptors 
and as co- factors for the enzymes involved in lipoprotein metabolism 
(Table 1.2). The site of catabolism of the lipid component in 
each lipoprotein class is therefore dependent on the apoprotein 
content. 
The ratio of the plasma lipoprotein classes varies according 
to diet (Callandra et al., 1977; Dolphin, 1981) and also from 
species to species (Mills and Taylaur, 1971; Johansson and Karlsson, 
1976; Chapman, 1980; Oschry and Eisenberg, 1982). The differences 
between the plasma lipoprotein profiles in the rat and human are 
shown in Table 1.3. 
The metabolism of the lipoproteins is extremely complex and 
each species have their own characteristics. The review that 
follows describes the metabolism of lipoproteins in the rat with 
occasional reference to the human system. 
1.2.1 The origin and metabolism of the plasma lipoproteins 
There is substantial evidence that plasma lipoproteins are 
synthesised only by the liver and small intestine and are secreted 
into the plasma as nascent particles (Havel, 1980). These 
particles on entry into the plasma compartment are subject to 
modification by enzymes, together with the physical transfer of 
components to yield the typical plasma lipoproteins. 
(a) Chylomicrons 
Chylomicrons are triglyceride -rich particles formed in 
the small intestine during the absorption of dietary lipids. 
The lipid and protein moieties are packaged into particles 
and secreted into the lymph where they are transported to 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































into the plasma the chylomicrons are subsequently catabolised 
(Green and Glickman, 1981). The major apoproteins of plasma 
chylomicrons are apoproteins A -I (apo A -I), A -IV (apo A -IV), 
B (apo B), C (apo C) and E (apo E). The apo C family serves 
two major functions. Firstly, large amounts of apo C -III 
relative to apo E result in an inhibition of the uptake of the 
chylomicron particle by the liver allowing catabolism of 
dietary triglyceride (Redgrave, 1970). Secondly, apo C -II 
activates the enzyme lipoprotein lipase (LPL). LPL is bound 
to the capilliary endothelium and has been detected in most 
extrahepatic tissues. Hydrolysis of the core triglyceride by 
LPL results in the release of monoacylglycerol, diacylglycerol 
and fatty acids. The mono- and diacylglycerol are then either 
delivered to adipose tissue and muscle or further hydrolysed to 
fatty acids in the plasma. The fatty acids released by 
hydrolysis of triglycerides are scavenged by plasma albumin and 
are thence transported to the liver. As the core triglyceride 
is depleted the surface components of the chylomicron particle 
'bud off' and form vesicles consisting of free cholesterol, 
phospholipid and the apoproteins A -I, A -IV and C. These 
components are then transferred to nascent HDL ( Redgrave and 
Small, 1979; Tall et al., 1979; Tall and Small, 1980). 
Transfer of these components to HDL results in the formation of 
a chylomicron remnant particle which is relatively rich in 
cholesterol esters compared to the nascent chylomicron particle 
whilst the protein component mainly consists of apo B and apo E. 
The transfer of apo C to HDL no longer inhibits the uptake of 
the chylomicron remnant by the hepatic apo E receptor (Sherrill 
and Dietschy, 1978; Cooper et al., 1982; Kita et al., 1982). 
5 
This leads to an appreciable uptake of dietary cholesterol 
by the liver. It has further been shown that uptake of the 
chylomicron remnant particle results in the entry of the 
protein and cholesteryl ester moieties into the lysosomes 
where they are subsequently hydrolysed (Stein et al., 1969; 
Sherrill and Dietschy, 1978). 
(b) Very low density lipoprotein (VLDL) 
Very low density lipoproteins are synthesised by both 
the small intestine and the liver. The intestinal VLDL 
functions to transport dietary lipid into the plasma in a 
similar way to the chylomicrons. However, the chylomicrons 
are quantitatively more important than VLDL in the absorption 
of dietary lipid. On entry into the plasma apo A -I and apo 
A -IV are transferred from VLDL to HDL and apo E and apo C are 
transferred from HDL to VLDL(Green et al., 1979; Green and 
Glickman, 1981). This results in the VLDL assuming its 
normal apoprotein profile (Table 1.2). However, the major 
source of VLDL is the liver (Risser et al., 1978). The 
subsequent metabolism of the VLDL is quite similar to that 
of the chylomicrons. Uptake of VLDL is inhibited by apo 
C -III and LPL is activated by apo C -II. These apoproteins 
are situated on the surface of the VLDL particle. Hydrolysis 
of the core triglycerides results in the delivery of mono - 
and diacylgycerol to the peripheral tissues. Surface 
components are then transferred from VLDL to HDL in much the 
same way as occurs during the metabolism of chylomicrons 
(Tall and Small, 1980). The transfer of free cholesterol, 
phospholipid and apoproteins A -I, A -IV and C from VLDL to 
HDL results in the formation of VLDL remnants. In the rat, 
6 
VLDL remnants are rapidly removed from the circulation resulting 
in only 3% of the remnants being converted to LDL (Faergeman and 
Havel, 1975). In humans, VLDL remnants are not so efficiently 
removed resulting in the further metabolism of VLDL to yield LDL 
Cholesteryl esters are transferred from HDL to VLDL by means of 
a cholesteryl ester transfer protein (Barter and Lally, 1978, 
Barter et al., 1982). Further transfer of VLDL apoproteins to 
HDL results in the formation of a cholesterol -rich lipoprotein 
particle containing only apo B i.e. LDL. In rats the activity 
of the cholesteryl ester transfer protein is very weak. This 
results in rat VLDL having a lower cholesteryl ester content 
than human VLDL. Rat HDL has a correspondingly higher content 
of cholesteryl ester compared to human HDL (Table 1.3). 
(c) Low density lipoprotein (LDL) 
In chapter 1.2.lbthe catabolism of VLDL to LDL in plasma 
was described. LDL functions primarily to transport cholesterol 
to the extrahepatic tissues although the liver also provides a 
significant contribution to the catabolism of LDL (Pittman et al., 
1979). Uptake of LDL by extrahepatic tissues is known to 
result in the inhibition of 3- hydroxy - 3 methylglutaryl coenzyme 
A reductase (HMG -Co A reductase) causing a reduction in the 
synthesis of cholesterol whilst also stimulating acyl Co A : 
cholesterol acyltransferase (ACAT) thereby stimulating 
esterification of the cholesterol taken up by the tissue 
(Goldstein et al., 1974; Brown et al., 1975). The uptake of 
LDL has been well characterised and can take place by both 
receptor and non -receptor pathways (see chapter 1.3). 
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(d) High density lipoprotein (HDL) 
High density lipoprotein is synthesised by the liver and 
small intestine and enters the plasma compartment as a 
discoidal nascent particle. The metabolism of nascent HDL 
in the plasma results in the production of subfractions of 
HDL (Fig. 1.1). In the rat these subfractions are termed 
HDL2 and HDL1 (Oschry and Eisenberg, 1980) whilst in humans 
the subfractions are HDL3 and HDL2 (Patsch et al., 1974). 
The physical and chemical characteristics of rat and human 
HDL2 are similar. The densities of the HDL subfractions 
decrease from HDL3 -- HDL2 - HDL1 as does their size. The 
chemical composition also varies, most importantly the 
relative content of cholesteryl ester and apo E increase from 
HDL3 - HDL2 - HDL1 
The nascent HDL particle secreted into the plasma consists 
of a bilamellar disc of free cholesterol, phospholipid and apo E 
(Hamilton et al., 1976). Compared to normal plasma HDL the 
nascent particle is deficient in cholesteryl esters and apo A -I. 
However on entry into the plasma, cholesterol, phospholipid and 
apo A -I, apo A -IV and apo C are transferred from the surface of 
the chylomicrons and VLDL to HDL giving rise to the production 
of HDL2 (HDL3 in humans). The major apoprotein associated 
with the HDL2 fraction is apo A -I and is the main activator of 
the enzyme lecithin cholesterol acyl transferase or LCAT 
(Fielding et al., 1972). The surface free cholesterol of the 
HDL2 particle is esterified by the action of LCAT and involves 
the transfer of the fatty acid from the sn -2 carbon of lecithin 
Rat 
HDL 
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Fig. 1.1 Fractionation of HDL by rate zonal ultracentrifugation. 
Rat and human plasma lipoproteins were subjected to rate zonal 
ultracentrifugation as described by Oschry and Eisenberg (1982). 
Rat HDL was fractionated into HDL1 and HDL2 whilst human HDL was 
separated into HDL2 and HDL3. 
to cholesterol. The lysolecithin so formed is scavenged by 
albumin. Esterification of the cholesterol is followed by 
movement of the non -polar ester into the core of the HDL2 
particle. Further esterification of the surface cholesterol 
would eventually lead to a depletion in the surface components 
of the HDL. However, transfer of cholesterol and phospholipid 
from chylomicrons and very low density lipoprotein replenishes 
the surface lipids of the HDL particle. Further esterification 
of cholesterol results in the formation of HDL1 which is then 
thought to be rapidly removed from the circulation (Chapter 1.3). 
Whilst the function of the other lipoprotein classes 
appears to involve the transport of lipid from the intestine 
and /or the liver to extrahepatic tissues the function of HDL is 
not so well defined. It has been suggested that HDL may 
function to transport cholesterol from peripheral tissues to the 
liver and adrenal gland for degradation (Glomset, 1968; Tall and 
Small, 1980). Furthermore current evidence suggests that plasma 
HDL concentrations show a positive correlation with a decrease 
in the risk of ischaemic heart disease (Miller and Miller, 1975). 
As was described earlier catabolism of HDL results in a depletion 
of surface free cholesterol and this cholesterol can be replaced 
by the transfer of surface components from chylomicrons and VLDL. 
However transfer of cholesterol from peripheral tissues to HDL 
may also occur (Glomset , 1968; Stein et al., 1977; Henriksson, 
1979; Stoudemine, 1980). This may provide a mechanism by 
which cholesterol can be accepted from the peripheral tissues 
and transported to the liver for its subsequent catabolism 
(Fig. 1.2). In humans, the existence of the cholesteryl ester 
1 
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Fig. 1.2 Possible function of HDL in transporting cholesterol 
from extrahepatic tissue to the liver for its degradation. 
1. Secretion of nascent HDL into the plasma by the liver. 
2. Transfer of cholesterol from extrahepatic tissue to HDL. 
3. Action of plasma lecithin : cholesterol acyl transferase 
(LCAT) on HDL3 to give HDL2. 
4. Uptake of cholesterol ester rich, apo E rich HDL2. 
PL- phospholipid; C- cholesterol; CE- cholesteryl ester 
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transfer protein may lead to HDL cholesteryl esters being taken 
up by the liver after transfer to lipoproteins of lower density. 
The complex interrelationships between the plasma 
lipoproteins during their metabolism is summarised in Fig. 1.3. 
1.2.2 The role of hepatic lipase in lipoprotein metabolism 
Hepatic lipase was first identified in the perfusate of livers 
following the administration of heparin (Jansen and Hulsmann, 1974) 
and is immunologically distinct from LPL (Jansen and Hulsmann, 1975). 
The function of hepatic lipase in vivo is not clearly understood. 
However, high hepatic lipase levels are known to decrease plasma 
HDL -cholesterol whilst relatively low- hepatic lipase activity 
corresponds to an increase in the rate at which tissues acquire 
cholesterol. The physiological role of hepatic lipase has recently 
been reviewed (Jansen, 1984). 
1.2.3 The uptake and degradation of the plasma lipoproteins 
Lipoprotein uptake occurs by both receptor and non -receptor 
pathways (Shepherd et al., 1979, Pittman et al., 1982b)and results 
in the degradation of the lipoprotein particle with the cholesterol 
portion remaining intact. In extrahepatic tissues the cholesterol 
is utilised for the synthesis of membrane whereas in the adrenal 
gland and gonads cholesterol also provides substrate for the 
synthesis of steroid hormones. In the liver cholesterol can be 
utilized for the assembly of lipoproteins, secreted into bile, or 
degraded to bile salts as well as providing cholesterol for cell 
membranes. 
Fig. 1.3 Metabolic interrelationships of the plasma lipoproteins. 
The pathways shown are a general outline of the physical and 
chemical modifications of the plasma lipoproteins. Some of the 
important differences between human and rat plasma lipoproteins are 
as follows:- a) HDL is fractionated into HDL3 and HDL2 in humans 
and HDL2 and HDL1 in rats b) the cholesteryl ester transfer 
activity in rat plasma is not significant c) VLDL remnants are 
rapidly removed from rat plasma with only a small proportion being 
further metabolised to LDL. In humans appreciable quantities of 
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(a) Receptor mediated uptake 
The formation of remnant particles during the metabolism of the 
triglyceride -rich lipoproteins and their subsequent uptake by a high 
affinity receptor pathway was described in Chapter 1.2.1 (a). 
However the most well defined pathway for the uptake of lipoproteins 
is the LDL receptor pathway (Goldstein and Brown, 1977). The 
historical developments of the uptake of LDL from plasma have been 
reviewed recently (Brown et al., 1981; Attie et al., 1982). 
The LDL receptor was first discovered in cultured human skin 
fibroblasts and recent evidence suggests that this receptor would be 
more correctly called the apo B/E receptor. The receptor has the 
following properties: - 
(i) apo E containing particles have a 10 to 25 fold higher 
affinity for the receptor than apo B containing 
lipoproteins (Pitas et al., 1980). 
(ii) chemical modification of lysine or arginine residues 
completely abolishes apo B or apo E binding (Basu et al., 
1976; Weisgraber et al., 1978). 
(iii) divalent cations are required for binding; EDTA abolishes 
binding of lipoproteins to the receptor (Goldstein and 
Brown, 1974). 
(iv) pronase treatment destroys binding (Goldstein and Brown 
1974). 
(v) binding of LDL is abolished by treatment of cells with an 
antibody raised against the bovine LDL receptor 
(Beisiegel et al., 1981). 
(vi) binding of an apo E rich HDL fraction isolated from the 
plasma of cholesterol fed dogs (apo E HDLc) to the 
receptor, at saturation, was about a quarter of LDL 
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binding. This was explained by apo E binding to four LDL 
receptors whereas each LDL particle only binds to one 
receptor site (Pitas et al., 1980). Lipoproteins 
containing apo E have a high affinity for the receptor but 
the receptor has a low capacity for apo E containing 
lipoproteins. 
Studies in vivo have enabled the quantitation of the uptake of 
LDL by the various tissues in the rat (Pittman et al., 1979; 
Carew et al., 1982; Pittman et al., 1982a). 
Although the catabolism of LDL by the receptor mediated pathway 
is now well characterised, catabolism of HDL is not so well defined. 
However, the contribution of the liver to the uptake of HDL has been 
studied by a number of research groups. In vivo studies have shown 
that the liver is a major site for the catabolism of HDL but other 
tissues also play a significant role (Roheim et al., 1971; Stein 
et al., 1983). Furthermore, partial hepatectomy in rats, whilst 
not affecting the half -life of HDL- protein, increases the half -life 
of HDL -cholesteryl esters (Van Tol et al., 1978). However in 
studies using a recirculating system for perfusion of the liver it 
has been reported that the hepatic contribution to HDL catabolism 
was only 7% after 4h and it was therefore concluded that only a 
small fraction of HDL was degraded directly by the liver 
(Sigurdsson et al., 1979). In those studies using isolated 
hepatocytes it has been concluded that the liver does in fact 
play a major part in the catabolism of HDL (Nakai et ai., 1976; 
Drevon et al., 1977; Ose et al., 1980; Ghiselli et al., 1981). 
If HDL does function to transport cholesterol from peripheral 
tissues for its ultimate degradation it would be expected that 
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the liver plays a significant role in the catabolism of HDL as the 
liver is the major organ which degrades cholesterol. 
Further studies on the hepatic degradation of HDL are 
required. Most studies so far reported have used HDL isolated in 
a broad density range. The study by Ghiselli et al., (1981) 
indicated that uptake of HDL subfractions by hepatocyte monolayers 
could occur at different rates. The use of a defined HDL 
subfraction may lead to more conclusive evidence for the 
importance of the liver in the degradation of HDL. It is likely 
that hepatic uptake of the HDL subfractions would occur at rates 
which reflect their relative apo E content. Uptake of HDL1 would 
therefore be expected to be greater than uptake of HDL2. It is 
possible that the acceptance of cholesterol from the peripheral 
tissues by the HDL2 subfraction followed by its catabolism to HDL1 
in the plasma, provides a mechanism whereby HDL could specifically 
deliver cholesterol to the liver. 
At the present time the effect of HDL on hepatic cholesterol 
metabolism is not clear. Incubation of HDL with hepatocyte 
monolayers has been reported to stimulate the synthesis of 
cholesterol (Breslow et al., 1977). This was attributed to the 
ability of HDL to accept cholesterol from plasma membranes. 
However, it has since been reported that incubation of hepatocytes 
with LCAT- treated HDL inhibits the synthesis of cholesterol (Ray 
et al., 1980). The use of defined HDL subfractions may help to 
improve our understanding of the metabolic consequences of HDL 
uptake by cells. 
Whilst receptor mediated uptake of LDL (and possibly HDL) 
occurs through recognition by the apo B/E receptor the uptake of 
chylomicron remnants occurs by a separate quite distinct receptor 
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called the apo E receptor. Although the existence of a saturable 
high affinity pathway for the uptake of chylomicron remnants was 
well established (Sherrill and Dietschy, 1978), the possibility of 
an alternative receptor site had only been suggested (Sherrill 
et al., 1980; Hui et al., 1981). Conclusive evidence was provided 
when uptake of chylomicron remnants was found to be unaffected in 
patients with familial hypercholesterolemia (FH) and in a Watanabe 
heritable hyperlipidemic (WHHL) rabbits (Brown et al., 1981; Kita 
et al., 1982). In FH patients and WHHL rabbits the number of 
apo B/E receptors expressed is either halved - heterozygous FH - 
or completely abolished - homozygous FH (Goldstein et al., 1983). 
In patients with homozygous FH the catabolism of LDL occurs 
entirely by the non -receptor pathway whilst uptake of chylomicron 
remnants is unaffected. This is due to expression of the apo E 
receptor being unaffected in these patients (Goldstein et al., 1983). 
(b) Non -receptor mediated uptake 
Although the receptor mediated pathway is important in the 
regulation of plasma cholesterol levels the non -receptor pathway also 
plays a significant role in lipoprotein catabolism. It has been 
suggested that approximately 33% of LDL catabolism normally occurs 
by means of the non -receptor pathway (Bilheimer et al., 1982) but in 
the WHHL rabbit the uptake of LDL by this pathway is significantly 
increased (Bilheimer et al., 1982; Pittman et al°, 1982b). It has 
been suggested by Shepherd et al., (1979) that as much as 66% of 
LDL catabolism occurs by non -receptor mediated uptake. The 
mechanism involved in the non -receptor pathway is not fully 
understood and its importance in the catabolism of LDL has recently 
been reviewed (Attie et al., 1982). 
14 
1.3 The Synthesis of Cholesterol 
The other major source of cholesterol to the total body pool is 
derived from de novo synthesis. In the rat the rate of sterol 
synthesis by the major organs has been investigated and it has been 
shown that the liver accounts for most of the total body sterol synthesis 
(Turley et al., 1981). The regulation of cholesterol synthesis in 
the rat is highly complex (Andersen and Dietschy, 1979a). Most 
importantly it has been shown that uptake of cholesterol in the 
form of lipoproteins influences the rate of hepatic cholesterol 
synthesis. Uptake of either chylomicron remnants or LDL was shown 
to suppress hepatic cholesterol synthesis whilst HDL had no effect 
(Andersen and Dietschy, 1977b). Furthermore, in the rat the rate 
of cholesterol synthesis is subject to wide variation depending on 
the stimuli (Andersen and Dietschy, 1977a, 1977b; Koelz et al., 
1981). 
The rates of cholesterol synthesis by the liver and its 
contribution to whole body cholesterol in a number of species has 
recently been reviewed (Turley and Dietschy, 1982). 
1.4 The Bile Acids 
Bile acids are formed from cholesterol in the liver via a 
series of reactions initiated by 7a- hydroxylation of cholesterol 
(Lindstedt, 1957; Bergstrom et al., 1958). 
On leaving the biliary tract bile acids are almost entirely 
present in their conjugated form; conjugation occuring with either 
glycine or taurine, through amide linkage with the carboxyl 
group of the side chain. Within the intestinal lumen the bile 
acids facilitate formation of the micellar phase which appears to be 
obligatory for the absorption of cholesterol and plays an essential 
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role in the absorption of fat -soluble vitamins and the products of 
triglyceride hydrolysis during fat digestion. A decrease in bile 
salt concentration below the critical micellar concentration 
prevents the formation of the micellar phase, resulting in lipid 
malabsorption. The synthesis of bile acids also provides the 
major route for the degradation of cholesterol. 
The synthesis of bile acids has been investigated in a number 
of mammalian species (Elliot and Hyde, 1971) but here particular 
attention will be paid to the rat. 
1.4.1 The synthesis of bile acids 
Although the pathway of bile acid synthesis in mammalian 
species is essentially the same (Fig. 1.4) there are considerable 
variations in the end products produced (Elliot and Hyde, 1971). 
In most species the major bile acids produced are cholic and 
chenodeoxycholic acids but in rats chenodeoxycholic acid can be 
further metabolised to a- and ß- muricholic acids (Mahawold et al., 
1957; Matschiner et al., 1957; Voight et al., 1968). 
The first step in the synthesis of all bile salts is the 
7a- hydroxylation of cholesterol. The enzyme that catalyses this 
reaction, cholesterol 7a- hydroxylase, is located in the 
endoplasmic reticulum and requires a thermostable co- factor, 
oxygen and NADPH (Scholan and Boyd, 1968; Boyd et al., 1969). 
The reaction is known to be dependent on cytochrome P -450, the 
cytochrome P -450 species being a minor form (Danielsson and 
Wikrall, 1981). Considerable evidence has also been provided to 
show that this first step is also the rate limiting step in the 
overall conversion of cholesterol to bile salts (Danielsson et al., 
1967, Boyd and Percy -Robb, 1971; Botham et al., 1980). The most 
Fig. 1.4 The biosynthetic pathway of bile acids. 
I - cholesterol; II - 7a- hydroxycholesterol; III - 7a- hydroxycholest- 
4en -3one; IV - 7a, 12a- dihydroxycholest- 4en -3one; V - 5ß- cholestane- 
3a, 7a, 12a, 26 tetrol; VI - cholic acid; VII -5- cholestane- 
3a, 7a -diol; VIII - chenodeoxycholic acid; IX - a- muricholic acid; 














































































































































































conclusive evidence was that presented by Botham et al., (1980) where 
addition of 7a- hydroxycholesterol to isolated rat hepatocytes was 
found to increase the synthesis of bile acids. 
Following 7a- hydroxylation of cholesterol the diol formed is 
dehydrogenated to a conjugated ketone. This ketone can be 12a- 
hydroxylated to produce an intermediate which eventually yields 
cholic acid or by reduction of the carbon 4, carbon 5 double bond 
and formation of 5ß- cholestane - 3a, 7a diol can be converted to 
chenodeoxycholic acid. In the rat chenodeoxycholic acid is further 
metabolised by 6ß- hydroxylation to yield a- and ß- muricholic acids 
(Fig. 1.4). 
This account briefly outlines the synthesis of bile acids in 
the rat. The reader is referred to two reviews for a more 
detailed discussion of the biosynthetic pathway of bile acids 
(Elliot and Hyde, 1971; Danielsson and Sjovall, 1975). 
After synthesis and secretion into the alimentary canal bile 
acids are highly conserved. This occurs through the enterohepatic 
circulation and approximately 95% of the bile salts that enter the 
duodenum, in the normal state, are recycled. To facilitate 
conservation a specific transport system is present in the terminal 
portion of the small intestine (Dietschy, 1968). The cholesterol 
7a- hydroxylase enzyme system is very sensitive to factors which 
modify the enterohepatic circulation and studies on biliary 
drained rats have shown that enzyme activity correlates well with 
bile acid synthesis rates (Boyd et al., 1967; Boyd et al., 1969). 
The increase in the catabolism of cholesterol to bile acids is 
also accompanied by an increase in the synthesis of cholesterol. 
(Danielsson and Sjovall, 1975). The control of cholesterol 7a- 
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hydroxylase and hence bile acid production is not clearly understood. 
However, cholesterol 7a- hydroxylase activity exhibits diurnal rhythm 
in both fed a fasted animals, as do a number of other enzymes. 
It has been suggested that the fall and rise in the enzyme activity 
is due to alterations in the rates of enzyme synthesis and 
degradation (Schinike et al., 1965; Higgins et al., 1971, Mitropoulos 
et al., 1972). The effects of various drugs and hormones have also 
been studied (Boyd and Lawson, 1970; Abrams and Grundy, 1981; Cole 
et al., 1982). Removal of the gonads or thyroid gland has no 
effect on the stimulation of cholesterol 7a- hydroxylase by dietary 
cholestyramine, whereas removal of the adrenal glands were found to 
lower the response to cholestyramine. Further studies on the 
effect of the thyroid hormone, thyroxine have shown that the 
synthesis of chenodeoxycholic acid was stimulated so that equal 
amounts of chenodeoxycholic and cholic acids are formed (Abrams and 
Grundy, 1981). This is thought to be caused by low rates of 12a- 
hydroxylation (Mitropoulos et al., 1968). Recent evidence has also 
indicated that the synthesis of bile salts is stimulated by 
of cholesterol 7a -hydroxylase 
phosphorylation %(Sanghvi et al., 1981). It was therefore suggested 
that the synthesis of bile acids may be under the control of cyclic 
AMP. It has since been shown in isolated hepatocytes that glucagon 
stimulates the synthesis of bile salts and that this effect is 
mediated through an increase in the intracellular cyclic AMP levels 
(Botham et al., 1983a, 1984). 
The regulation of the synthesis of bile acids is complex and 
involves many factors. The possible mechanisms for the regulation 
of bile acid synthesis have recently been reviewed (Salen and 
Shefer, 1983; Botham, 1984). 
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1.4.2 The sources of substrate for the synthesis of bile acids 
Bile acids can be synthesised from cholesterol obtained from 
either de novo synthesis or from uptake of the sterol from plasma 
in the form of lipoproteins. The contribution of each of these 
sources in providing substrate for the synthesis of bile acids is 
of great interest in determining the mechanisms of body cholesterol 
removal. 
There are a number of reports which show that newly synthesised 
cholesterol can be degraded to bile acids and that this cholesterol 
is the preferred substrate for the synthesis of bile acids (Staple 
and Gurin, 1954; Mitropoulos et al., 1974; Norman and Norum, 1976; 
Bjorkhem and Lewenhaupt, 1979). Evidence for the compartmentation 
of cholesterol in rat liver microsomes has been presented by 
Balasubramaniam et al., (1973). It has also been shown that the 
preferred substrate for the synthesis of 7a- hydroxycholesterol is 
newly synthesised cholesterol (Bjorkhem and Danielsson, 1975). 
These findings have led to the suggestion that different pools 
exist within the hepatocyte which contribute different amounts of 
substrate to the synthesis of bile acids. However it is important 
to note that the term 'preferred substrate' actually means that 
newly synthesised cholesterol is converted to bile acids in 
preference to equilibrating with other cellular cholesterol and 
does not necessarily mean that most of the bile acids are 
synthesised from this source. In rats it has been reported that 
only 25% of the bile acids synthesised are derived from newly 
synthesised cholesterol (Long et al., 1979). The remaining 75% 
is synthesised from pre -eq uilibrated cholesterol. 
However, under certain conditions the contribution 
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of these two sources of substrate to the synthesis of bile acids 
can change. Introduction of a bile fistula was shown to increase 
the contribution of the newly synthesised sterol to the synthesis 
of bile acids, whilst the mass of the alternative substrate pool 
that was degraded to bile salts was unchanged (Long et al., 1979; 
Stange et al., 1984). In effect, introduction of a bile fistula 
interrupts the enterohepatic circulation and therefore results in 
the stimulation of bile acid synthesis. These results by Long 
et al., (1979) reflect the ability of the rat to alter the rate of 
cholesterol synthesis to meet the increase in the demand of 
substrate for the synthesis of bile acids (Koelz et al., 1982) 
without requiring an increase in the mass of plasma cholesterol 
degraded to bile salts. This data also supports the results by 
Koelz et al., (1982) that dietary cholestyramine does not increase 
the uptake of lipoproteins by the rat liver. (Cholestyramine 
interrupts the enterohepatic circulation by preventing reabsorbtion 
of bile acids from the small intestine). However, in rabbits and 
humans the administration of cholestyramine results in an increase 
in the uptake of plasma lipoproteins as well as an increase in the 
synthesis of cholesterol (Shepherd et al., 1980; Slater et al., 1980). 
More recently a similar effect on the contribution of newly 
synthesised cholesterol to the synthesis of bile acids was observed 
in isolated hepatocytes. The contribution of newly synthesised 
cholesterol to the synthesis of bile acids was found to increase 
with increasing incubation time (Kempen et al., 1983). Isolation 
and subsequent incubation of hepatocytes results in these hepatocytes 
being deprived of a supply of cholesterol from a lipoprotein source. 
This would therefore lead to the hepatocyte cholesterol pool that is 
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derived from plasma sources becoming depleted. As a result the 
contribution of newly synthesised cholesterol to the synthesis of 
bile acids will increase. Further evidence for this conclusion 
has been presented by Edwards (1975) who reported that cholesterol 
synthesis in isolated hepatocytes increases with increasing 
incubation time. These observations support the concept that rates 
cholesterol synthesis and bile acid synthesis are closely coupled 
(Danielsson and Sjovall, 1975). 
A second approach in research to investigate the sources of 
substrate for the synthesis of bile acids has centred on the 
possibility of the preferential utilization of cholesterol from a 
particular lipoprotein fraction. There is now considerable 
evidence to suggest that HDL- cholesterol is used in preference to 
LDL- cholesterol for the synthesis of bile acids. This has been 
reported in humans (Halloran et al., 1978), squirrel monkeys (Portman 
et al., 1980) and rats (Miller et al., 1982). However, these 
studies have been beset with the problems of rapid exchange of 
sterol between lipoprotein classes. These studies have also 
indicated that the major source of substrate is HDL -free 
cholesterol as opposed to HDL -cholesteryl esters. In humans, 
only 10% of total biliary steroids were derived from lipoprotein 
cholesteryl ester (Schwartz et al., 1981). It was therefore 
concluded that cholesterol liberated from hydrolyzed esters 
undergoes recirculation into the free cholesterol pool rather 
than excretion into the bile. The preferential utilization of 
HDL -cholesterol for biliary steroids is consistent with the 
proposed greater metabolic activity of this sterol compared to 
the other lipoprotein classes. 
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Further studies into the investigation of the substrate pools 
for the synthesis of bile salts have also suggested that the 
individual bile acids themselves are derived from distinct substrate 
pools. A number of investigators have reported that cholic acid 
and chenodeoxycholic acid (Mitropoulos et al., 1974, Norman and 
Norum, 1976, Bjorkhem and Lewenhaupt, 1979; Long et al., 1979) or 
cholic acid and ß- muricholic acid (Ayaki et al., 1981; Kempen et al., 
1983; Stange et al., 1984) were derived from separate substrate 
pools. 
In summary, it is recognised that although newly synthesised 
cholesterol is the preferred substrate for the synthesis of bile 
acids, the major contribution of substrate is derived from a pre- equilibrated 
source. However, under certain conditions e.g. interruption of the 
enterohepatic circulation, the role of each of these sources of 
substrate can be reversed. The concept of separate substrate 
pools for the synthesis of the individual bile acids now appears 
to be well established. Further studies are required in this 
area as alteration in the contribution of these substrate pools to 
the synthesis of the individual bile acids may affect the 
lithogenicity of the bile and may therefore be important in 
gallstone disease. 
1.5 Summary 
Total body cholesterol is derived from either absorption from 
the diet or from de novo synthesis. The major organs that 
contribute to the source of newly synthesised cholesterol are the 
liver and small intestine. The cholesterol is transported between 
tissues as plasma lipoproteins. Each of the plasma lipoprotein 
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classes delivers lipid to a specific target site. It has been 
suggested that the function of one of the plasma lipoprotein 
classes is to transport cholesterol to the liver for subsequent 
degradation. 
The major route for the degradation of cholesterol is via 
the synthesis of bile acids. Both newly synthesised cholesterol 
and plasma cholesterol serve as substrate for this pathway. It 
is likely that the contribution of each of these sources to the 
synthesis of bile acids varies from species to species. In the 
rat, an increase in the demand of cholesterol for the synthesis 
of bile acids as occurs during interruption of the enterohepatic 
circulation is entirely met by an increase in the synthesis of 
cholesterol. However, in the human and rabbit uptake of 
cholesterol from the plasma is also increased. The uptake and 
degradation of plasma cholesterol to bile acids is of great 
importance in the regulation of total body cholesterol. 
HDL- cholesterol has been shown to be the preferred source 
of substrate for the synthesis of bile salts, from the plasma. 
This may explain why a high HDL /LDL ratio is beneficial to 
decreasing the risk of ischaemic heart disease. A summary of 
hepatocyte cholesterol metabolism is shown in Fig. 1.5. 
1.6 Aims of this study 
The study of the synthesis of bile acids and the source of 
substrate for this pathway has been confined to studies in vivo 
or shorter term studies in vitro (i.e. isolated hepatocytes in 
suspension and the perfused liver). 
Fig. 1.5 Summary of cholesterol metabolism in the hepatocyte 
(1) uptake of lipoproteins from the plasma (2) esterification 
of cholesterol by ACAT (3) hydrolysis of cholesteryl esters by 
cytosolic cholesterol esterase (4) utilization of cholesterol 
and cholesteryl esters for the synthesis of lipoproteins 
(5) de novo synthesis of cholesterol (6) 7a- hydroxylation of 
cholesterol (7) synthesis of bile salts from 7a- hydroxycholesterol 
(8) conjugation and secretion of bile acids into the bile 
(9) secretion of biliary cholesterol (10) uptake of bile salts 





























CONJUGATED BILE ACIDS 
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The major aims of this thesis are to develop a hepatocyte 
monolayer system which will enable longer term investigation into 
the synthesis of bile salts under more defined conditions than is 
allowed in vivo. In particular, the effect of plasma lipoproteins 
on the synthesis of bile salts will be investigated. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Materials 
Collagenase, gentamycin sulphate, insulin, bovine 
serum albumin (BSA) fraction V powder, ornithine hydrochloride, 
galactose, activated charcoal, reduced nicotinamide adenine 
dinucleotide, cholesterol, dipalmitoyl phosphatidylcholine, oleic 
acid, taurocholic acid, taurochenodeoxycholic acid, horseradish 
peroxidase, Coomassie brilliant blue G and PAGE Blue 83, were 
obtained from Sigma Chemical Company, Poole, Dorset, U.K. Bile 
acids were removed from BSA fraction V powder as described by 
Botham et al. (1980). 
Trypan blue, Nonidet P.42, polyethylene glycol 10 000, 
glycerol trioleate, molecular sieve type 5A (calcium alumino- 
silicate), 2- mercaptoethanol, polyacrylamide, sodium lauryl 
sulphate (SDS) and dodeca - molybdophosphoric acid were from BDH 
Chemicals Ltd., Poole, Dorset, U.K. 
Non- essential amino acids, foetal calf serum, newborn bovine 
serum and 50 mm plastic petri dishes were from Flow Laboratories 
Ltd., Irvine, Scotland, U.K. Foetal calf serum was heat 
inactivated by incubating for 30 min at 56 °C. Bile acids were 
removed from newborn bovine serum using activated charcoal as 
described by Botham et al. (1980). 
Dulbecco's modified Eagle's medium and streptomycin/ 
penicillin were from GIBCO (Europe) Ltd., Paisley, Scotland, U.K. 
Dri Film SC87 was obtained from Pierce Chemical Company, 
Rockford, Illinois, U.S.A. 
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2,5- diphenyl -oxazole (PPO) and 1,4 -bis 5- phenyl oxazyl -2- 
benzene (POPOP), p- phenylhydroxyacetic acid, Triton -X -100, 
acrylamide, N N' methylene bis acrylamide, N, N, N', N' - 
tetramethylethylene diamine were obtained from Koch -Light 
Laboratories Ltd., Colnbrook, Bucks, U.K. 
Cholestyramine (Cuemid) was a product of Merck, Sharp and 
Dohme, West Point, Philadelphia, U.S.A. 
Kieselgel 60H (silica gel)was from Merck, Darmstadt, 
Germany. 
'Percoll' was obtained from Pharmacia (Great Britain) Ltd., 
Milton Keynes, Bucks, U.K. 
Sodium pyruvate, cholesterol oxidase and cholesterol esterase 
were from Boehringer Corporation (London) Ltd., Lewes, East 
Sussex, U.K. 
Nystatin was from E.R. Squibb and Sons Ltd., Hounslow, 
Middlesex, U.K. 
Nylon Mesh (200 pm) was from Henry Simon Ltd., Stockport, 
Cheshire, U.K. 
[1 -14Clacetic acid (57 mCi /mmol), L44,5- 3H]leucine 
(54 Ci /mmol), [4 -14C]cholesterol (> 50 mCi /mmol), 
[11,12(n)- 3H]chenodeoxycholic acid (104 Ci /mmol) and sodium 
[125l]iodide 
(> 1375 Ci /mmol) were obtained from Amersham 
International p.l.c., Amersham, Bucks, U.K. 
All other chemicals and reagents were of analytical grade. 
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2.2 Animals 
Female Wistar rats (200 - 250g) were used throughout. 
Animals were fed either a standard laboratory chow, a soft diet, 
consisting of 70% wholemeal flour, 25% skimmed milk powder and 
5% yeast or the soft diet supplemented with 4% cholestyramine. 
Animals were allowed access to both food and water ad libitum. 
2.3 Treatment of glassware used for preparation of hepatocytes 
To prevent adhesion of hepatocytes to glassware all glass 
that came into contact with hepatocyte suspensions was treated as 
described below. 
Glassware was washed with chromic acid (80 - 85ml saturated 
sodium chromate in 2.21 concentrated sulphuric acid) then 
thoroughly rinsed with double distilled water and allowed to dry. 
This was followed by treatment with Dri Film SC 87 (10% v/v in 
petroleum ether). After allowing glassware to drain it was 
washed with hot water and dried in an oven at 60 °C for 2h. 
2.4 Preparation and maintenance of isolated rat hepatocytes 
Isolation of rat hepatocytes was carried out under sterile 
conditions. The perfusion apparatus and dissecting instruments 
were sterilised by exposure to ultra violet light for at least 
12h. All other equipment was sterilised using a steam autoclave. 
Culture media and perfusates were sterilised by filtration through 
a 0.4 um Millipore filter. 
2.4.1 Solutions required for isolation of hepatocytes 
Glucose- and calcium -free Locke's solution: sodium chloride 
(9g 1 -1) and potassium chloride (0.24g 1 -1) in double distilled 
water. 
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Glucose- and calcium -free Hank's solution: sodium chloride 
(8g 1-1), potassium chloride (0.4g 1 -1), magnesium sulphate 
.7 H2O (0.2g 1-1), potassium dihydrogen phosphate (0.06g 1-1) and 
phenol red (0.02% w /v) in 0.O1M sodium phosphate buffer, pH 7.4. 
The phenol red was present to monitor the pH of the perfusate 
during the perfusion. 
2.4.2 Preparation of isolated hepatocytes 
Isolated hepatocytes were prepared by a method based on that 
described by Quirstorff et al. (1973) and Botham and Boyd (1979). 
Female Wistar rats ('200 -250gß) were anaesthetized with 
diethyl ether. A longitudinal incision in the abdomen was made 
and the alimentary canal displaced. The hepatic portal vein was 
canulated and the liver washed free of blood with calcium- and 
glucose -free Locke's solution. After blanching of the liver was 
complete, the perfusion was stopped and the liver excised. After 
placing the liver in the perfusion apparatus (Fig. 2.1) it was 
washed for a further two minutes prior to perfusion with glucose - 
and calcium -free Hank's solution supplemented with 0.5 mM calcium 
chloride and containing 0.5 - 1% (w /v) collagenase for 15 - 20 min. 
The amount of collagenase used depended on the commercial 
preparation obtained. The liver was finally perfused with 
calcium- and glucose -free Locke's solution containing 
2 mM EDTA 
for 5 min. 
All perfusates were oxygenated during the perfusion 
and were 
supplemented with 2% (w /v) bovine serum albumin and 
38 mM sodium 
bicarbonate. The pH of the perfusates was adjusted 
to pH 7.4 
with sodium bicarbonate if necessary. Perfusion 
of the liver was 








Following perfusion of the liver, cells were dispersed in 
calcium- and glucose -free Hank's solution by gentle teasing with 
forceps in a glass petri dish and immediately poured through 
200 um nylon mesh into a glass beaker. The isolated hepatocytes 
were then sedimented by centrifugation and resuspended in 10m1 of 
culture medium consisting of Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 0.4 mM ornithine hydrochloride, non- 
essential amino acids, gentamycin sulphate (100mg 1 -1), 
penicillin /streptomycin (10 000 IU 1 -1; 10 000pg 1 -1), nystatin 
(2011 ml -1) and galactose (1 gl -1) containing 2% (w /v) charcoal 
treated bovine serum albumin. The resuspended hepatocytes were 
then applied to two 35m1 'Percoll' density gradients (0 - 70% v/v 
'Percoll' in supplemented DMEM, containing 2% bovine serum 
albumin). Continuous gradients were prepared using a gradient 
mixer. Viable cells were separated from non -viable cells by 
centrifugation at 50 x g for 15 min. The viable cells formed a 
pellet (Fig. 2.2) and were washed with 2 x 15ml supplemented DMEM, 
without bovine serum albumin. Hepatocytes were finally 
resuspended in 15ml of supplemented DMEM, containing 15% (v /v) 
foetal calf serum and insulin (100U 1 -1). The viability of this 
final suspension of hepatocytes, as determined by trypan blue 
exclusion, was routinely greater than 95 %. 
2.4.3 Maintenance of isolated hepatocytes 
Hepatocytes were diluted with supplemented DMEM containing 
15% (v /v) foetal calf serum and insulin (1000 1 -1), to give a 
final cell density of approximately 1 x 106 cells m1 -1. 
Hepatocytes were then incubated for 2 - 3h in 50 mm plastic 
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Fig. 2.2 Separation of non -viable hepatocytes from viable 
hepatocytes. The freshly isolated hepatocytes were applied to 
the top of a 0 -70% (v /v) Percoll gradient and centrifuged at 5Oxg 
for 15 min. The viable cells formed a pellet at the bottom of 
the gradient. 
29 
time cell adhesion took place. The medium was then aspirated 
and replaced with 2m1 of supplemented DMEM. This medium was 
designated the control medium. Additions to the control medium 
were made as indicated. Hepatocyte monolayers were incubated 
in an atmosphere of 5% carbon dioxide, 95% air at 37 °C for the 
indicated time periods. 
2.5 The viability of hepatocytes maintained as monolayers 
Viability of hepatocytes was determined by examination of 
their morphology, trypan blue exclusion, leakage of lactate 
dehydrogenase, determination of cellular content of cytochrome 
P -450 and protein synthesis. 
2.5.1 Examination of hepatocyte morphology 
Cell morphology was determined by microscopical examination. 
Viability and normal functioning of hepatocytes was dependent on 
cell adhesion and cell spreading. 
Photomicrography of cells was performed with an Olympus 
35mm camera back model PM -6 attached to an Olympus IMT model 213 
light microscope. Exposure time was determined using an Olympus 
photomicrographic exposure meter model EMM -7. 
2.5.2 Exclusion of trypan blue 
Percentage viability of hepatocyte monolayers was determined 
by addition of 0.2ml 0.4% (w /v) trypan blue in 5m1 of culture 
medium. Monolayers were incubated for 5 min at room temperature 
after which time the trypan blue was removed and percentage 
viability assessed. Viability was expressed as the percentage 
of cells excluding the dye. 
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2.5.3 Leakage of lactate dehydrogenase 
Lactate dehydrogenase was determined spectrophotometrically 
with pyruvate and reduced nicotinamide adenine dinucleotide (NADH) 
according to Bergmeyer and Bernt (1974). 
The equilibrium of reaction (1) lies far to the side of 
lactate and NAD 
Lactate 
Pyruvate + NADH + H+ ' Lactate + NAD+ .... (1) 
dehydrogenase 
The activity of lactate dehydrogenase was therefore determined from 
the rate of oxidation of NADH, by measuring the decrease in 
absorbance at 340nm. 
To determine the leakage of lactate dehydrogenase, the enzyme 
was assayed in both culture medium and the disrupted cells. Cells 
were disrupted by sonication of approximately 5mg of cellular 
protein in 2.5ml phosphate buffered saline, pH 7.4. An aliquot 
was assayed for lactate dehydrogenase activity. The culture 
medium was assayed directly. Percentage viability was expressed 
as the total units of lactate dehydrogenase in the medium divided 
by the total units in cells and medium x 100 %. 
2.5.4 Determination of cytochrome P -450 in rat hepatocyte 
monolayers 
The intracellular content of cytochrome P -450 in hepatocyte 
monolayers was determined according to the method of Omura and 
Sato (1964) with the modifications described by Paine et al. 
(1979). 
Hepatocytes were washed with 10m1 of 0.15M sodium chloride 
and then scraped into 5 ml of ice cold 0.15M potassium chloride 
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in 50 mM tris buffer, pH 7.4. Samples were diluted to a 
concentration of 3 - 5mg cultured cell protein ml -1 and homogenised 
in 20% (v /v) glycerol in 0.1M sodium phosphate buffer, pH 7.4, 
containing 1 mM EDTA and 0.2% (v /v) Nonidet P.42. Cytochrome 
P -450 was then determined by measuring the carbon monoxide 
difference spectra at 420nm using a Pye- Unicam SP8 -200 UV /VIS 
spectrophotometer. 
2.5.5 Determination of protein synthesis by rat hepatocyte 
monolayers 
Protein synthesis was determined by incubation of hepatocytes 
in culture medium containing [3H]leucine (ca. 2.5 uCi /ml). 
Incorporation of [3H]leucine into cellular protein was determined 
according to the method of Dazord et al. (1977). 
After the indicated time periods the medium was aspirated 
and lml of 0.4% (w /v) sodium deoxycholate in 0.1M sodium 
hydroxide added. Cells were removed from the petri dish by 
scraping with a rubber policeman and transferred to a 75 x 13mm 
test tube. The cells were sonicated for 5 sec at 4 °C, lml of 
ice -cold 20% (w /v) trichloracetic acid was added and the mixture 
centrifuged at 500 x g for 1 min to sediment precipitated 
protein. The precipitate was washed with 2 x lml of ice cold 
10% (w /v) trichloroacetic acid, followed by lml of ethanol. 
The pellet obtained, was solubilized in lml of 0.4% (w /v) 
sodium deoxycholate in 0.1M sodium hydroxide and incubated for 
lh at 37 °C to hydrolyse amino -acyl transfer ribonucleic acids. 
An equal volume of ice cold 20% (w /v) trichloroacetic acid was 
then added to precipitate the protein. After washing the 
precipitate with 2 x lml 10% (w /v) trichloroacetic acid the 
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precipitate was solubilised by the addition of lml 0.4% (w /v) 
sodium deoxycholate in 0.1M sodium hydroxide. An aliquot was 
assayed for protein content and an aliquot used to determine 
radioactivity. 
2.6 Determination of conjugated bile acids 
Conjugated cholic, chenodeoxycholic and ß- muricholic acids 
were determined by radioimmunoassay (Beckett et al. 1978; 
Beckett et al. 1979; Botham et al. 1983). Bile salt content of 
the medium was measured directly. Cellular bile salt content 
was determined after overnight extraction with 1M sodium 
hydroxide. This treatment has been shown to extract 100% of 
conjugated bile acids from tissue samples (Strange, et al. 1979). 
2.6.1 Preparation of immunogens 
Immunogens in the following bile salt: BSA molar ratios, 
cholic acid (17:1), chenodeoxycholic acid (18:1) and ß- muricholic 
acid (10:1), were prepared by the mixed anhydride method of 
Erlanger et al. (1957) as modified by Murphy et al. (1974). 
2.6.2 Preparation of antiserum 
lmg of each bile acid - BSA immunogen in lml of a 1:1 (v /v) 
emulsion of Freund's complete adjuvant in saline was injected 
subcutaneously into individual New Zealand white rabbits. A 
booster injection was given six weeks later using lmg of each 
conjugate in Freund's incomplete adjuvant emulsion. Blood was 
obtained from the ear vein and the serum separated from blood 
cells by centrifugation. The antiserum was used from these 
animals without further treatment. 
The total amount of the individual bile salts synthesised was 
determined by addition of the amount present iri the medium to that in 
the cells. 
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2.6.3 Determination of the optimum dilution of the antiserum 
The dilution of antiserum used in the assay of each bile acid 
was determined by incubation of 
125I- 
labelled bile acid- histamine 
with serial dilutions of the homologous antiserum, in the presence 
and absence of the highest concentration of standard used in each 
assay (Table 2.1). Binding of the 
125I- 
labelled ligand to the 
antiserum was determined as described in section 2.6.6. The 
antiserum dilutions which produced the largest differences in 
binding (Fig. 2.3) were subsequently used in each assay (section 
2.6.6). This gave the most sensitive assay conditions (Beckett 
et al., 1978). 
2.6.4 Preparation of bile acid -histamine conjugates 
Bile acid -histamine conjugates were prepared as described by 
Beckett et al. (1979). 
2.6.5 Iodination of bile acid -histamine conjugates 
Iodination of conjugates was carried out by a method based on 
that described by Hunter et al. (1975). 
50 nmol of each bile acid -histamine conjugate was mixed with 
1 mCi of sodium 
[125I1iodide 
and 20 ul of 20 mM chloramine T in 
0.5M phosphate buffer, pH 7.9. The mixture was vortexed for 20 
sec and the reaction stopped by the addition of 10 pl 0.15M sodium 
metabisulphite, in 0.5M phosphate buffer, pH 7.9. The radio - 
labelled bile acid -histamine conjugate was then extracted by the 
addition of 0.1m1 water followed by 0.3ml ethyl acetate. The 
ethyl acetate layer was subsequently collected and water removed 
by the addition of anhydrous sodium sulphate. The ethyl acetate 
fraction was transferred to a silica gel thin layer chromatography 
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Fig. 2.3 Antibody dilution curves for the radioimmunoassay of 
bile salts. (A) conjugated cholic acid, (B) conjugated 
chenodeoxycholic acid, (C) conjugated ß- muricholic acid. 
The dilution of antisera chosen was based on the largest 
difference between the highest concentration of standard and the 
control i.e. no standard. 
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(t.l.c.) plate and developed in ethyl acetate /toluene /ethanol/ 
triethylamine (50:25 : 25:10, v /v). This separated the unreacted 
sodium [125I] iodide from the radiolabelled conjugate. After 
scanning the plate with a Panax thin layer scanner the area 
corresponding to the radiolabelled conjugate was extracted with 
methanol. 
2.6.6 Assay procedure 
Bile salts were determined by using a specific antiserum in 
conjunction with a homologous bile acid -histamine ligand. The 
assay was performed by incubating 10 pl of the sample with 200 pl 
of radioimmunoassay buffer (100 mM sodium phosphate buffer, 15 mM 
sodium azide, 15 mM sodium chloride, pH 7.4) containing newborn 
bovine serum albumin, 
125I- 
labelled bile acid -histamine and 
antiserum. Antiserum was diluted to give optimum assay conditions 
(section 2.6.3). Samples were incubated at room temperature for 
at least 2h. The bound ligand was separated from the free ligand 
by addition of 3m1 2.5% (w /v) ammonium sulphate, followed by 
centrifugation at 3,000 r.p.m. (2560 x g) for 15 min at 4 °C in a 
Beckman J -6B centrifuge using a JS -3.0 rotor. The precipitate 
was counted using a New England Enterprises NE 1600 Gamma counter. 
The bile salt content of samples was determined from standard 
curves. The concentration of standards used and the minimum 
detection limits are shown in Table 2.1. 
2.7 Isolation of a rat plasma high density lipoprotein 
subfraction (HDL2) 
Rat HDL2 was isolated essentially as described by Oschry and 
Eisenberg (1982). 
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Blood was obtained from female Wistar rats under ether 
anaesthesia by cardiac puncture, and collected in 10m1 polypropylene 
tubes containing 40mg ethylenediaminetetraacetic acid (EDTA) to 
prevent clotting. Blood cells were separated from plasma by 
centrifugation at 2,000 r.p.m. (1140 x g) in a Beckman J -6 -B 
centrifuge using a JS -3.0 rotor, at 4 °C. 
The rat plasma obtained was adjusted to a density of 1.23g ml -1 
with solid sodium bromide and total plasma lipoproteins isolated by 
centrifugation at 35,000 r.p.m. (100000 x g) in a Beckman L8 -5B 
ultracentrifuge using a 50.2 Ti rotor for 48h at 7 °C. Using an 
MSE B X1V zonal rotor in an MSE Superspeed 75 ultracentrifuge the 
whole lipoprotein fraction obtained was subjected to rate zonal 
ultracentrifugation as described by Patsch et al. (1974) with the 
modifications of Shepherd et al. (1984). 
The zonal rotor consists of a large cylindrical bowl, with the 
cavity divided into compartments by vanes attached to a central 
core. A removable rotating seal assembly was attached to the 
rotor at a speed of 3,500 r.p.m. Using a LKB Ultragrad gradient 
mixer and pump, a discontinuous gradient (Fig. 2.4) of density 
1.00g ml -1 to 1.4g m1 -1 was pumped in from the periphery, at a rate 
of 50m1 min -1. The solution of density 1.0g m1 -1 consisted of 10 mM 
Tris -HC1 2 mM disodium EDTA, pH 7.6. The density of this solution 
was raised by the addition of solid sodium bromide to give a 
solution of density 1.49 m1 -1. The density of these solutions was 
checked with a hydrometer at 20 °C. 
After completion of the gradient the lightest density solution 
was present at the core and the heaviest density solution at the 
periphery of the rotor cavity. The whole lipoprotein fraction was 
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Fig. 2.4 Salt gradient for the isolation of HDL2 by rate 
zonal ultracentrifugation. 
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and loaded at the periphery of the rotor. This was followed by 
a cushion of solution of density 1.4g ml 
-1 
to ensure that all the 
sample was transferred to the rotor. The seal assembly was then 
removed and the rotor capped. The rotor chamber was sealed and 
brought down to vacuum. Lipoprotein subfractions were separated 
by centrifugation at 45,000 r.p.m. for 18h. The rotor was then 
decelerated to 3,500 r.p.m. The rotor cap was removed and the 
seal assembly attached to the rotor as before. The contents of 
the rotor were collected from the centre by pumping solution of 
density 1.4g m1 -1 into the periphery. Fractions were collected 
in 12ml aliquots and the absorbance at 280 nm monitored using a 
model UA -5 absorbance monitor with a quartz flow cell (ISCO Ltd.). 
The fractions obtained were dialysed and concentrated by reverse 
phase dialysis using polyethylene glycol. The concentrated 
lipoprotein fraction was dialysed overnight against two changes 
of 41 water prior to addition to culture medium 
2.8 Radiolabelling of rat HDL2 
Rat HDL2 was labelled in either the free cholesterol or the 
cholesteryl ester moiety. 
2.8.1 Labelling of HDL2 with [4- 14C]cholesterol 
25 iCi of [4 -14C]cholesterol was impregnated into Whatman 
in saline, 
No. 1 filter paper discs and incubated with isolated rat HDL2,for 
4h at 37 °C. The filter paper discs were removed and the 
labelled rat HDL2 added to culture medium prior to incubation with 
rat hepatocyte monolayers. 
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2.8.2 Labelling of HDL2 with [4- 14C]cholesteryl oleate 
Radiolabelling of HDL2 cholesteryl ester was performed using a 
modification of the method described by Craig et al. (1982). 
[4- 
14C]cholesteryl 
oleate was transferred from a lipid micro - 
emulsion to the lipoprotein fraction indicated by means of a 
cholesteryl ester transfer protein present in human plasma. 
Lipoproteins were first removed from human plasma by centrifugation 
at 35,000 r.p.m. (100,000 x g) in a Beckman L8 -5B ultracentrifuge 
using a 50.2 Ti rotor for 48h after adjusting the density to 
1.23g ml -1 by addition of solid potassium bromide. The 
lipoprotein -free plasma obtained was exhaustively dialysed against 
O.1M sodium chloride and stored at 4 °C until required. 
Method 1: A lipid microemulsion was prepared by injecting 0.21mg 
glycerol trioleate, 0.16mg cholesterol, 0.42mg dipalmitoyl 
phosphatidylcholine and approximately 10 pCi of [4- 14C]cholesteryl 
oleate in dry propan -2 -ol, into a rapidly vortexing solution of 
0.15M sodium chloride, containing 10 mM Tris -HC1, pH 7.4 and 
0.3 mM EDTA. To this was added lipoprotein -free human plasma 
(final concentration, 35mg protein m1-1) and total rat plasma 
lipoproteins (approximately 30mg lipoprotein protein). 
[4- 14C]cholesteryl oleate was transferred to lipoproteins by 
incubating for 24h at 37 °C. The incubation mixture was then 
centrifuged at 35,000 r.p.m. (100,000 x g) in a Beckman L8 -58 
ultracentrifuge using a 50.2 Ti rotor for 90 min to remove the 
microemulsion. The microemulsion was aspirated from the tube 
and the infranatant adjusted to a density of 1.4g m1-1 with 
solid sodium bromide prior to isolation of HDL2 by rate zonal 
ultracentrifugation. 
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Method 2: Plasma was obtained from rats, as described previously 
and a crude HDL fraction was prepared. The VLDL and LDL fractions 
were first removed by adjusting the density of the plasma to 
1.06g ml -1 by addition of solid sodium bromide, followed by 
centrifugation at 35,000 r.p.m. (100,000 x g) for 18h, using a 
Beckman L8 -5B ultracentrifuge and a 50.2 Ti rotor. HDL was then 
isolated after adjusting the density of the infranatant to 
1.23g m1 -1 with solid sodium bromide, followed by centrifugation 
for 48h using the same conditions as indicated above. The HDL 
fraction was then labelled with [4- 
14C]cholesteryl 
ester. This 
was followed by isolation of HDL2 from the incubation mixture 
using the procedure outlined in Method 1. 
2.9 Synthesis of [4-'cjcholesteryl oleate 
30m1 of toluene, dried by the addition of 2g molecular sieve 
5A (calcium alumino- silicate), was added to 40mg oleic acid in a 
dry round bottomed flask. This was followed by the addition of 
5 drops of thionyl chloride. The mixture was refluxed for 8h, 
allowed to cool and the solvent evaporated using a rotary 
evaporator. 25 uCi of [4- 14C]cholesterol was added to the 
resulting oleoyl chloride, followed by the addition of 10m1 of 
dry toluene. The mixture was refluxed for 2h and allowed to 
cool prior to evaporation of the solvent. The residue was taken 
up in toluene and cholesterol and cholesteryl oleate separated by 
thin layer chromatography (t.l.c.) on silica gel t.l.c. plates. 
The chromatogram was developed in a solvent system consisting of 
petroleum ether /diethyl ether /acetic acid (95 : 5 : 1 v /v). After 
scanning of the t.l.c. plate with a thin -layer radioactive 
scanner(Panax equipment Ltd., Redhill, Surrey), the areas 
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corresponding to [4- 14CJcholesterol and [4- 14C]cholesteryl oleate 
were scraped into separate tubes. The radioisotopes were eluted 
from the silica gel by a two step procedure. Immediately after 
scraping the silica gel into tubes 15ml chloroform was added and 
allowed to stand for 30 min at 4 °C. The supernatant was 
collected and the silica gel extracted further with 2 x 10m1 
ethyl acetate. Following separation of the gel from the solvent 
by centrifugation the supernatants were pooled and the solvent 
evaporated. The residue was taken up in 2m1 acetone. The 
percentage conversion of [4- 1Cjcholesterol to 4- 14Cjcholesteryl 
oleate was 86% and the total recovery of the radiolabel was 
greater than 90 %. The purity of the cholesteryl oleate was 
determined by t.l.c. using petroleum ether /diethyl ether /acetic 
acid (95 : 5 : 1 v /v) and petroleum ether /diisopropyl ether/ 
acetic acid (30 : 70 : 2 v /v). 
No obvious contaminant was observed. 
2.10 Separation of cholesterol, cholesteryl ester and bile salts 
after incubation of hepatocyte monolayers with radioactive 
precursors 
Following extraction of samples, cholesterol, cholesteryl 
ester and bile salts were separated by t.l.c. prior to the 
determination of radioactivity (section 2.11). 
2.10.1 Preparation of samples for thin layer chromatography 
Lipids and bile salts were extracted from samples after the 
addition of sodium hydroxide (final concentration, 1M) using 
chloroform /methanol (2:1 v /v) according to the procedure of 










Fig. 2.5 Thin layer chromatogram of [4- 
14C]cholesteryl 
oleate obtained by a thin -layer chromatogram scanner. 
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Cholesterol and cholesteryl ester partitioned in the non - 
aqueous phase. This was taken to dryness and the residue taken 
up in a known volume of chloroform. 
The bile salts were extracted in the aqueous phase. 
Addition of sodium hydroxide prior to the extraction of samples 
improved the recovery of the bile salts. The protein precipitate 
present in the bile salt extract was removed by centrifugation and 
washed with 2 x 2m1 methanol. The washes were pooled with the 
original supernatant, the solvent evaporated and the residue taken 
up in a known volume of methanol. 
Recoveries were determined as indicated in Chapter 2,16. 
2.10.2 Thin layer chromatography of non -aqueous and aqueous 
extracts 
A known volume of extract was applied to t.l.c. plates using 
a microsyringe. The sample of the non -aqueous extract 
(containing cholesterol and cholesteryl ester) was developed in a 
solvent system consisting of 60 - 80% (v /v) petroleum ether/ 
diisopropyl ether /acetic acid (30 : 70 : 2, v /v). Samples of the 
aqueous extract (containing bile salts) were developed in ethyl 
acetate /methanol /acetic acid /water (35 : 12 : 2 : 2, v /v). 
Recovery of radioactivity from t.l.c. plates was improved by 
application of non -radioactive standards onto plates after 
application of samples. Identification of cholesterol, cholesteryl 
ester and bile salts was determined using non -radioactive standards 
adjacent to the samples being developed. The standards were 
visualised by spraying with 1% (w /v) phosphomolybdic acid in 
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Fig. 2.6 Thin -layer chromatography of sample extracts (A) t.l.c. 
for determination of the radioactivity associated with bile salts. 
(1) standards, TC- taurocholate TCDCA - taurochenodeoxycholic 
(2) sample (B) t.l.c. for determination of the radioactivity 
associated with cholesterol and cholesteryl ester (1) standards 
FC- cholesterol; CE - cholesteryl ester (2) sample. 
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Cholesterol, cholesteryl ester and bile salts in the samples were 
visualised by iodine vapour (Fig. 2.6) and bands corresponding to 
the standards were scraped into phials and counted. 
2.11 Assay of radioactivity in samples 
Radioactivity present in bands scraped from t.l.c. plates 
were assayed by addition of 10m1 scintillation cocktail consisting 
of 4g 2,5 diphenyl -oxazole (PPO) and 30mg 1,4 -bis 5- phenyl oxazyl- 
2- benzene (POPOP) in 1 litre of toluene, and counted in a Packard 
Tri -Carb scintillation spectrophotometer. 
Aqueous samples from the protein synthesis experiment 
(section 2.5.5) were counted in 10m1 scintillation cocktail 
consisting of 4g PPO and 30mg POPOP in 1 litre 66% (v /v) toluene, 
33 %(v /v)Triton -X -100. 
2.12 Determination of cholesterol 
Cholesterol was determined in the non -aqueous extracts of 
samples using cholesterol oxidase (Nocardia sp.) by the 
fluorimetric method of Gamble et al. (1978). Cholesterol is 
oxidised to 4- cholesten -3 -one with the concomitant formation of 
hydrogen peroxide by the action of cholesterol oxidase. The 
hydrogen peroxide produced is a measure of the amount of 
cholesterol present and is estimated with p- hydroxyphenylacetic 
acid. Oxidation of p- hydroxyphenylacetic acid yields a 
fluorescent quinone. Fluorescence was detected using a Perkin - 
Elmer 3000 fluorescence spectrophotometer. 
For determination of total cholesterol, cholesteryl esters 
were hydrolyzed using cholesterol esterase from Pseudomonas 
fluorescens (Gamble et al. 1978). 
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2.13 Determination of protein 
Protein was determined by the method of Bradford (1976) using 
bovine serum albumin as standard. 
2.14 Sodium dodecyl sulphate polyacrylamide gel electrophoresis of 
HDL2 apoproteins 
Slab gel electrophoresis was performed according to the 
method of Laemmli (1970) with the modifications described by 
Douglas and Butow (1976). 
2.14.1 Solutions required 
A. Separating gel buffer: 1.5M Tris HC1, 8 mM EDTA, 0.4% (w /v) 
SDS, pH 8.8. 
B. Stock acrylamide: 30% (w /v) acrylamide, 0.8% (w /v) 
N, N'- methylene bisacrylamide dissolved in water, filtered through 
glass wool and stored in the dark ay 4 °C. 
C. Stacking gel buffer: 0.5M Tris HC1, 8 mM EDTA, 0.4% (w /v) 
SDS, pH 6.8. 
D. Polyacrylamide: 1.5% (w /v) polyacrylamide dissolved slowly in 
water containing 1 mM sodium azide and 1 mM sodium fluoride. 
E. Concentrated sample buffer: 0.2M tris HC1 buffer, pH 6.8, 
8 mM EDTA, 8% (w /v) SDS, 40% (v /v) glycerol, 4% (v /v) 2- 
mercaptoethanol, 0.0025% (w /v) bromophenol blue. Samples were 
solubilised in the sample buffer and then diluted 4 times. 
F. Electrode buffer: 50 mM Tris- glycine buffer, pH 8.6, 2 mM 
EDTA, 0.1% (w /v) SDS. 
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2.14.2 Preparation of separating gel 
A gel cassette was assembled, which consisted of two 18 x 18 cm 
glass plates separated by two spacers smeared with high vacuum grease 
placed at the sides of the glass plates. The cassette was placed in 
a 'foil boat' and the bottom sealed by pouring 12ml of a solution 
consisting of 8.75m1 B, 2.38 ml 2M Tris HC1, pH 8.8, 0.25 ml 10% (w /v) 
SDS & 1.2ml water to which was added 250 ul 10% (w /v) ammonium 
persulphate and 10 pl TEMED. TEMED was added to initiate 
polymerisation. After approximately 30 min the gel had set and the 
foil boat and excess gel was removed from the bottom of the cassette. 
A 15% polyacrylamide gel was then prepared by pouring 30m1 of a 
separating gel mixture consisting of 7.5ml A, 15.0m1 B, 5.0m1 D, 2.2ml 
water and 0.3ml 10% (w /v) ammonium persulphate to which 15 ul of 
TEMED had been added, into the cassette. Secondary butanol, 
saturated with water, was carefully layered onto the separating gel 
which was then left to set. After approximately lh (during which 
time the gel had set) the secondary butanol was removed and a 
stacking gel prepared. The stacking gel mixture consisted of 
1.2ml B, 2.0m1 C, 1.3ml D, 3.4ml water, 15 pl 10% (w /v) ammonium 
persulphate and 5 ul TEMED. A toothed comb was inserted into the 
top of the cassette and the stacking gel allowed to set. When 
polymerisation was complete the toothed comb was carefully 
removed and samples placed into the sample holders. 
2.14.3 Preparation of HDL2 apoproteins prior to SDS -PAGE 
HDL2 apoproteins were delipidated essentially as described by 
Tocher and Boyd (1983). 
10 volumes of ethanol /diethyl ether (1:4 v /v) were added to 
the HDL2 sample and left for 2h at -20 °C. After addition of 
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0.2 volumes of water the non -aqueous layer was removed. Lipid was 
further extracted by the addition of 5 ml cold ethanol /diethyl ether 
(1:4 v /v). The aqueous extract was freeze dried and protein 
solubilised in 6M urea containing 1 mM EDTA. Proteins were then 
precipitated by the addition of an equal volume of 20% (w /v) 
trichloroacetic acid. The precipitate obtained was washed with 
10% (w /v) trichloroacetic acid, followed by ice cold acetone, 
before drying by vacuum desication. The apoproteins were finally 
solubilised in solution E and diluted 4 fold before being subjected 
to SDS - polyacrylamide slab electrophoresis. Approximately 100 ug 
of protein was applied to the gel. 
Protein bands were visualised by staining with Coomassie PAGE Blue 83. 
2.15 Statistical analysis 
Results are expressed as ± standard deviation of the data 
presented. Statistical evaluation is by means of Student's t test 
for paired data. 
2.16 Recoveries 
Recovery of bile salts and of cholesterol in these experiments 
following extraction of samples was determined by the following 
method. After extraction of cells and medium the total radio- 
activity attributable to free cholesterol, cholesteryl ester and 
bile salts was determined. This enabled the determination of the 
total radioactivity recovered. Recovery of radioactivity was 
always greater than 95%. However as the bile salts only 
represented a small fraction of the total radioactivity recovery of 
bile salts was determined by radioimmunoassay of the extracts. The 
total bile salts detected were compared with the bile salts detected 
in the untreated sample. The total recovery of bile salts was always 
greater than 95 %. 
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2.17 Counting efficiency 
14 
The efficiency of counting for C disintegrations was 75% 
and for 3H was 32 %. 
The efficiency of counting was determined using radioactive standards. 
No quenching effects were observed with silica gel scraped from t.l.c. 
plates. However it is important to note that no quench curves were 
obtained for addition of samples to the 'aqueous' scintillant (Chapter 
2.11). This must be noted in the interpretation of those results 
obtained with the aqueous scintillant, namely those experiments 
where the incorporation of [3H]leucine into protein was determined 
(Chapter 2.5.5.). 
It is noted that results should be quoted in disintegrations 
per minute rather than counts per minute. 
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CHAPTER 3 
THE VIABILITY OF RAT HEPATOCYTE MONOLAYERS 
3.1 Introduction 
In recent years isolated hepatocytes have been used to investigate 
an increasing number of problems in biochemical research. 
Investigations over short time periods of a few hours are facilitated 
by maintaining hepatocytes in suspension whilst longer term studies 
over 24h to a few days are achieved by maintenance of hepatocytes as 
monolayers. The use of isolated hepatocytes has proved to be 
particularly useful in studying certain aspects of cholesterol 
metabolism and has been the subject of a recent review (Forte, 1983). 
In vitro techniques have distinct advantages over studies using 
the whole animal. A number of experiments on cells from the same 
animal can be performed whilst the use of a defined culture medium 
allows strict control of the cell's environment. Furthermore, when 
investigating the metabolism of lipoproteins, the use of isolated 
hepatocytes avoids the problem of in vivo exchange of the lipid and 
protein moieties between the different lipoprotein classes. This 
facilitates the investigation of the role of the liver in the 
catabolism of a defined lipoprotein class. However, there are 
some disadvantages in using in vitro techniques: - 
a) some circulating hormones present in the plasma are known to 
influence the metabolism of cholesterol (Chapter 1). The 
culture medium used to maintain hepatocytes does not contain 
any of these hormones. 
b) whilst the use of isolated hepatocytes enables the 
investigation of the catabolism of a defined lipoprotein 
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class, it is possible that transfer and exchange of lipids 
between lipoprotein classes provides a mechanism whereby 
these lipids are removed from the plasma (Chapter 1.2.1). 
c) In vivo, hepatocytes are in contact with three compartments, 
(i) the perisinusoidal space or space of Disse 
(ii) the intercellular space 
(iii) the bile canaliculi 
The functional differentation of the hepatocyte plasma membrane 
has been demonstrated by studies on isolated plasma membrane 
fractions (Wisher and Evans, 1975). Bile acids are normally taken 
up on the sinusoidal surface and secreted on the bile canalicular 
side (Chapter 1.4). During isolation of hepatocytes this membrane 
polarity is lost. This may give rise to certain problems e.g. 
isolated hepatocytes synthesise and secrete bile salts into the 
medium from where they can be taken up (Iga and Klaassen, 1982). 
This could have an effect on the control mechanisms under study. 
It is important to be aware of these disadvantages, but providing 
they are taken into account much information can be obtained using 
viable isolated hepatocytes as an experimental system. 
Before undertaking any detailed biochemical studies using 
rat hepatocytes a number of difficulties have to be considered. 
The liver is essentially a heterogeneous tissue.* In normal rats 
hepatocytes account for 78% of the total liver volume with 
approximately 6% non -hepatocytes and 16% being intercellular 
spaces (Millward- Sadler and Jezequel, 1979). The procedure 
chosen for isolating hepatocytes is designed to obtain a 
homogeneous viable cell preparation. Many methods of hepatocyte 
isolation currently used involve perfusion of the liver with 
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collagenase followed by varying degrees of mechanical disruption. 
This procedure was first described in 1969 by Berry and Friend. 
However, modifications of this method vary widely (Quirstorff 
et al., 1973; Seglen, 1973; Berg and Inversen, 1976). This is 
partly due to the variation in the preparations of crude 
collagenase used in the cell isolation procedure. These enzyme 
preparations have varying powers of tissue dispersion and as a 
result the initial viability of hepatocytes obtained can vary 
from 40 - 95 %. 
The method of hepatocyte isolation used for this study 
(Chapter 2.4.2), included the use of a density gradient 
centrifugation step using 'Percoll'. (' Percoll' consists of 
colloidal silica particles of different size coated with 
polyvinylpyrrolidone which renders the particles non -toxic). 
This procedure facilitates the separation of non -viable cells 
from viable cells. Contamination from other cell types can 
also be avoided. 
Following isolation of a viable preparation of hepatocytes 
it is essential that suitable methods for the maintenance of 
hepatocytes in monolayer culture are available. Just as the 
techniques for isolation of hepatocytes vary, so do the methods 
of hepatocyte maintenance. A variety of culture media 
ranging from basal salt solutions (Johansson et al., 1981; 
Paine et al., 1982) to more complex media (Williams et al., 1977; 
Davis et al., 1979; Horiuti et al., 1982; Paine et al., 1982) have 
been used. 
The success of maintaining the viability of hepatocytes in 
monolayer culture is dependent on the adhesion of cells to a 
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suitable culture surface. Once adhesion has taken place the medium 
is removed and replaced with fresh medium prior to undertaking the 
desired experiments. 
The experiments described in this thesis were all performed 
on hepatocytes maintained in monolayer culture. The results 
presented in this chapter illustrates the complexity of maintaining 
hepatocytes in monolayers and provide evidence of their biochemical 
integrity over the experimental periods used. The methods chosen 
for determination of hepatocyte viability are only a selection of 
the many criteria available (Crisp and Pogson, 1972; Baur et al. 
1975). 
3.2 Viability of freshly isolated hepatocytes 
Initially rat hepatocytes were obtained in excellent yield 
(1.2 - 3.4 x 108 cells per liver) and on average had a viability 
of 70% as assessed by exclusion of trypan blue. If viability was 
less than 65% the preparation was discarded. Following 'Percoll' 
density gradient centrifugation the viability of hepatocytes was 
routinely greater than 95 %. The yield of hepatocytes decreased 
to 0.8 - 1.9 x 108 cells per liver. 
3.3 Adhesion of hepatocytes to culture surfaces 
Hepatocytes were maintained in monolayers as described in 
Chapter 2.4.3. Adhesion of hepatocytes to culture surfaces was 
achieved by incubating cells in culture medium supplemented with 
foetal calf serum and insulin. Donor calf serum, adult rat 
serum and foetal calf serum can all be used to promote cell 
adhesion. However, the efficiency of attachment of the 
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hepatocytes varies with the different sera used. Adhesion of cells 
to Petri dishes was found to be most efficient in DMEM supplemented 
with 15% foetal calf serum and insulin (results not shown). 
Incubation of cells for 2 - 3h was sufficient to allow adhesion of 
cells to occur. Following the attachment of the hepatocytes to the 
culture surface, the medium containing foetal calf serum and insulin 
was removed and hepatocytes were maintained in DMEM containing 
additions when required. 
The viability of hepatocyte monolayers was then assessed prior 
to investigation of the major aims of the project (Chapters 4 - 6). 
3.4 The viability of hepatocytes maintained in monolayers 
Viability of hepatocytes was assessed by:- 
a) examination of their morphology by light microscopy, 
b) exclusion of trypan blue, 
c) leakage of lactate dehydrogenase, 
d) the ability to synthesise proteins, 
e) the cellular content of cytochrome P -450. 
3.4.1 Morphology of hepatocytes 
Hepatocyte morphology was examined immediately after suspension 
in culture medium containing foetal calf serum and insulin. 
Initially hepatocytes were spherical and occured as either single 
cells or in aggregates of 4 or 5 (Fig. 3.1a). Following the 
adhesion of hepatocytes to the culture surfaces their morphology 
was again examined at 3h and 24h. After 3h cells had begun to 
flatten and reassociate (Fig. 3.1b). By 24h, hepatocytes had 
formed a nearly continuous monolayer (Fig. 3.1 c -f). Close 
Fig. 3.1 Morphology of rat hepatocytes. Morphology was 
assessed as described in the text. Photographs were taken 
as described in Chapter 2.5.1. (a) freshly isolated 
hepatocytes; magnification x 100. (b) hepatocytes 3h 
after cell adhesion had taken place (approximately 5h after 
Fig. 3.1a); magnification x 200. (c -f) hepatocytes 24h 
after adhesion had taken place; (c) magnification x 10, 
(d) magnification x 100, (e) magnification x 200, 
(f) magnification x 400. Figs. 3.1 a -c and e were taken 





















- 00 ry-i 
r") Q (7-'0 C. 
-1-)Ca 
(T, 








examination of Figs. 3.1 c -f reveals a number of spherical hepatocytes 
of granular appearance on the surface of the monolayer. These cells 
are dead. When cells adhere to culture plates in aggregates those 
cells not in contact with other cells die. The reason for this is 
unclear but it appears that cells are dependent on adhesion to the 
culture surface for their survival. This phenomenon has previously 
been observed by Bissel et al. (1973). 
The sequence of events observed following the adhesion of 
hepatocytes to culture surfaces are consistent with the findings of 
others (Bissel et al., 1973; Boney, 1974; Seglen and Fossa, 1978). 
3.4.2 Exclusion of trypan blue by rat hepatocyte monolayers 
Exclusion of trypan blue provides a useful and rapid method for 
assessing cell viability. Viability was determined at 0, 3, 19 and 
24h after the adhesion of hepatocytes to the Petri dishes and was 
greater than 85% over 24h (Fig. 3.2). 
3.4.3 Leakage of lactate dehydrogenase by rat hepatocyte monolayers 
Determination of viability by leakage of lactate dehydrogenase 
from the cells indicated that the viability fell to 60% after 24h 
(Fig. 3.2). However the addition of lmg m1 -1 galactose to the 
culture medium improved the survival of hepatocytes (Fig. 3.2). 
Subsequently in all experiments performed, galactose was added to 
the culture medium (Chapter 2.4.3). This increase in viability 
by the addition of galactose is in agreement with the findings of 
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Fig. 3.2 Viability of rat hepatocyte monolayers as determined 
by trypan blue exclusion (01-111) and leakage of lactate 
dehydrogenase in the absence (O-O) and presence (41--* of 
lmg ml -1 galactose in the culture medium. Viability of 
hepatocytes was determined as described in Chapter 2. Results 
shown are representative of a typical hepatocyte preparation. 
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3.4.4 Protein synthesis by rat hepatocyte monolayers 
Synthesis of protein by rat hepatocytes was determined by 
incubating cells with [3H]leucine. Incorporation of [3H]leucine 
into cellular protein and protein secreted into the medium was 
constant over 24h (Fig. 3.3). 
3.4.5 The cellular content of cytochrome P -450 
The specific content of cytochrome P -450 falls quite rapidly 
during incubation of hepatocytes over 24h (Fig. 3.4). The loss 
of cytochrome P -450 by hepatocytes has previously been reported 
by others (Bissel and Guzelian, 1979; Maslansky and Williams, 1982; 
Paine and Legg, 1978). The reason for this decline in cytochrome 
P -450 content has been shown to be partly due to a decrease in the 
synthesis of haem with a simultaneous increase in haem degradation 
(Bissel and Guzelian, 1979; Paine et al., 1982). Paine and Hockin 
(1980) have also shown that components present in the culture medium 
used for hepatocyte maintenance affect the loss of cytochrome P -450. 
By formulating a medium lacking in the sulphur containing amino 
acids, cystine and cysteine, they maintained cytochrome P -450 levels 
at 70% of the physiological concentration. Further, by the addition 
of 5- aminolaevulinic acid to culture medium and therefore bypassing 
the rate -limiting step in haem synthesis, cytochrome P -450 content 
was maintained at physiological concentrations. 
3.5 Discussion 
The procedure used for the isolation of rat hepatocytes has 
facilitated the preparation of a homogeneous cell type of generally 
excellent viability. The adhesion of hepatocytes to Petri dishes 
by preincubation in medium containing serum is consistent with the 
3 6 9 12 15 18 21 24 
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Fig. 3.3 Synthesis of protein by rat hepatocyte monolayers. 
Protein synthesis by rat hepatocyte monolavers was determined 
(Specific activity - 3.2yCi 4 
by measuring the incorporation of [3H]leucine,into cellular 
protein (®--a) and protein secreted into the medium !e ). 
The results are the mean of duplicate determinations from 
hepatocytes obtained from 2 rats. Error bars show the 
range of the values obtained. 
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reports of others (Horiuti et al., 1982; Laishes and Williams, 1976; 
Seglen and Fossa, 1978). The efficiency of attachment was also 
found to be largely dependent on the initial viability of the 
hepatocyte suspension obtained and was greatly improved by the 
addition of insulin. This is in agreement with the findings of 
Laishes and Williams (1976). Further studies have indicated that 
attachment of cells to the culture surface is also dependent on 
divalent cations and that the cell adhesion factor present in 
serum is fibronectin (Hook et al., 1977; Seglen and Fossa, 1978). 
The identification of a specific cell attachment protein has 
allowed cell adhesion to proceed without using serum and insulin. 
Durrington et al. (1982) have shown that the synthesis and 
secretion of VLDL by rat hepatocyte monolayers maintained on 
fibronectin- treated Petri dishes is increased by insulin. The 
effect of serum on the survival of hepatocytes has also been 
investigated. Serum was not required for hepatocyte survival up 
to 2 days after isolation. However, for maintenance of hepatocytes 
for periods in excess of 2 days viability was greatly improved by 
the addition of serum to the culture medium ( Horiuti et al., 1982). 
The maintenance of hepatocytes on dishes coated with fibronectin 
and the effect on the synthesis of bile salts is discussed in 
Chapter 4. 
The routine methods used for assessing hepatocyte viability 
were examination of morphology and the exclusion of trypan blue. 
The morphology of hepatocytes provides a quick and efficient means 
of assessing viability. The reaggregation and formation of 
flattened monolayers provides an excellent indication of hepatocyte 
function. Preparations in which such a change in morphology 
(Chapter 3.4.1) did not occur were discarded as were those 
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preparations in which viability as assessed by trypan blue exclusion 
fell to less than 85 %. 
A further possibly more sensitive method of assessing the 
integrity of cell membranes was provided by determination of the 
leakage of the cytoplasmic enzyme, lactate dehydrogenase. Non- 
viable cells have a tendency to detach from monolayers during 
incubation. Determination of lactate dehydrogenase activity in 
the medium not only assesses the leakage of this enzyme by 
hepatocytes adhered to culture dishes but also enzyme activity due 
to detached hepatocytes. The method for determination of viability 
by exclusion of trypan blue does not include detached cells in the 
viability count. 
Many studies using isolated hepatocytes have confined tests of 
viability to the exclusion of vital dyes or leakage of cytoplasmic 
enzymes. These tests, whilst useful, only provide an indication 
of the permeability of the plasma membrane. In determining the 
biochemical integrity of an isolated cell preparation it is 
preferable to show not only the extent of damage to the plasma 
membrane but also that complex metabolic processes can take place. 
The method chosen for demonstrating that complex reactions can 
take place was incorporation of [3H]leucine into protein. This 
provided an indication of the rate of protein synthesis. This is 
a useful method for assessing the biochemical integrity of 
hepatocytes as it is an indication of the interaction between 
different cell organelles. The incorporation of [3H]leucine into 
protein was linear throughout the 24h incubation. The final 
criteria chosen for assessing the integrity of hepatocyte 
monolayers was determination of the cellular cytochrome P -450 
content. This is particularly relevant to the work presented in 
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this thesis as synthesis of bile salts involves cytochrome P -450- 
dependent hydroxylations (Chapter 1.4). The results confirm 
previous reports that hepatocytes maintained in monolayers lose 
cytochrome P -450. The loss of cytochrome P -450 content would 
seem to indicate a loss in hepatocyte viability. However, it is 
clear from the results presented that the plasma membrane is 
intact and that hepatocytes synthesise protein at a constant rate 
over 24h. Other workers have also reported that isolated 
hepatocytes lose components such as glutamate (Cronell et al., 
1974), methionine (Krebs et al., 1976) and glutathione (Vina et al., 
1978). The current evidence would therefore seem to indicate that 
isolated hepatocytes, whilst useful, are only an approximation to 
the true in vivo state. It is therefore important to demonstrate 
that the metabolic pathway under investigation functions normally 
in isolated hepatocytes. The synthesis of bile salts by rat 
hepatocyte monolayers is discussed in detail in Chapter 4. 
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CHAPTER 4 
THE SYNTHESIS OF BILE SALTS BY RAT HEPATOCYTE MONOLAYERS 
4.1 Introduction 
The synthesis of bile acids occurs only in the liver via a 
series of reactions initiated by 7a-hydroxylation of cholesterol. 
(Lindstredt, 1957; Bergstrom et al. 1958). The biosynthesis of 
bile acids is discussed in detail in Chapter 1.4. 
The use of isolated hepatocytes to investigate the synthesis 
of bile acids has been reported by a number of research groups 
(Anwer et al., 1975; Botham et al., 1980; Gardner and Chenouda, 
1978; Kempen et al., 1982; Yousef et al., 1978). These studies have 
all involved maintenance of hepatocytes in suspension. In this 
laboratory, the investigation of bile salt synthesis by hepatocytes 
has been facilitated by the use of radioimmunoassays for conjugated 
cholic, chenodeoxycholic and -muricholic acids. This has allowed 
measurement of pmol quantities of these bile salts. Current 
evidence suggests that the measurement of these three bile salts 
should provide a reliable index of the total synthesis of bile acids 
by isolated hepatocyte preparations. Yousef et al. (1978) reported 
that 95% of the total bile salts secreted by isolated hepatocytes 
Y 
maintained in suspension consisted of trihydrox \lated bile salts 
and chenodeoxycholic acid. More recently, however, Kempen 
et al. (1982) provided evidence that greater than 95% of the 
bile salts synthesised by hepatocytes in suspension, consisted 
of conjugated cholic, ß- muricholic and chenodeoxycholic acids. 
Conjugated chenodeoxycholic acid was synthesised in relatively 
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low quantities and this was attributed to its further metabolism 
to ß- muricholic acid. For clarity, 'total bile salt synthesis' 
is used to describe the sum of the three major bile salts 
determined. 
The results in this chapter presents evidence for the 
synthesis of bile salts by rat hepatocytes maintained in 
monolayers. The most suitable conditions for maintenance of 
hepatocytes for studying synthesis of bile salts are also 
investigated. Whilst this work was in progress Davis et al. 
(1983a; 1983b), reported that rat hepatocytes in monolayer 
culture synthesise and secrete cholic and ß- muricholic acids. 
They did not detect synthesis of chenodeoxycholic acid. 
4.2 The effect of diet on the synthesis of bile salts by rat 
hepatocyte monolayers 
Rat hepatocytes in monolayers were found to synthesise and 
secrete conjugated cholic, chenodeoxycholic and ß- muricholic acids 
during 24h of incubation (Fig. 4.1). Conjugated cholic and 
conjugated ß- muricholic acids were the major bile salts 
synthesised, conjugated chenodeoxycholic acid being synthesised 
in low quantities. 
Alteration of the diets given to rats, resulted in alteration 
of the rates of synthesis of the three bile salts measured 
(Fig. 4.1). Hepatocytes isolated from rats fed the soft diet 
synthesised the lowest quantity of bile salts (Fig. 4.2). In 
the first 5h of incubation total bile salts were synthesised at 
a rate of 60 pmol mg cell protein -1 h 
-1 
which fell to 8 pmol 
mg cell protein -1 h -1 between 5 - 24h. When rats were fed 
the pellet diet there was a significant increase in the synthesis 
Fig. 4.1 The effect of diet on the synthesis of bile salts by 
rat hepatocyte monolayers. Hepatocyte monolayers were prepared 
as described in Materials and Methods. The effect of feeding 
the 'soft diet' (F --m), pellet diet (o--m) or the 'soft diet' 
+ 4% cholestyramine (s-s) on the synthesis of (A) conjugated 
cholic acid (B) conjugated ß- muricholic acid and (C) conjugated 
chenodeoxycholic acid, by isolated hepatocytes were determined. 
For the 'soft diet' and 'soft diet' + 4% cholestyramine each 
point represents duplicate determinations from hepatocytes 
obtained from four rats. For the pellet diet each point 
represents the mean of duplicate determinations from hepatocytes 
obtained from two rats. Statistical analysis is (a) a comparison 
of the 'soft diet' + 4% cholestyramine with the pellet diet and 
the 'soft diet' and (b) a comparison between the pellet diet and 
the 'soft diet'. Bile salts detected at Oh represent cell 
associated levels after adhesion of hepatocytes to the culture 
surface had taken place. Significance limits : a P < 0.05, 
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24 
Fig. 4.2 The effect of diet on total bile salt synthesis. 
Legend as for Fig. 4.1. 
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of total bile salts by hepatocytes. In the first 5h of incubation, 
synthesis was increased to a rate of 90 pmol mg cell protein -1 
- h 
-1 
and was 30 pmol mg cell protein h between 5 - 24h. 
When rats were fed the bile salt sequestrant cholestyramine, 
synthesis of all the bile salts was significantly increased 
(Fig. 4.1). The rate of synthesis of total bile salts was 
increased to 780 pmol mg cell protein -1 h 
-1 
in the first 5h and 
was 210 pmol mg cell protein -1 h -1 between 5 - 24h. Although 
the synthesis of bile salts decreased after the first 5h of 
incubation, the rates of synthesis by hepatocytes prepared from 
rats fed any of the diets, were constant between 5 - 24h. 
In rats fed the pellet diet the ratio of conjugated cholic 
acid : conjugated chenodeoxycholic acid + conjugated -muricholic 
acid indicated that equal amounts of conjugated cholic acid and 
conjugated chenodeoxycholic acid + conjugated a- muricholic acid 
were synthesised (Table 4.1). The ratio of these values provides 
an indication of whether 7a- hydroxycholest- 5en -3one is first 
12a- hydroxylated and therefore gives rise to cholic acid or is 
26- hydroxylated and therefore produces chenodeoxycholic acid and 
its metabolite ß- muricholic acid (Chapter 1.4). In hepatocytes 
isolated from rats fed the soft diet there was slightly more 
conjugated chenodeoxycholic acid + conjugated ß- muricholic acid 
synthesised than conjugated cholic acid. Feeding cholestyramine 
resulted in a significant increase in the synthesis of all three 
bile salts; synthesis of conjugated chenodeoxycholic + conjugated 
ß- muricholic acids was stimulated to a greater extent than 
conjugated cholic acid (Table 4.1). There was no change in the 
ratio cf conjugated chenodeoxycholic acid : conjugated ß- muricholic 
Ratio of conjugated cholic acid : conjugated chenodeoxycholic + 
conjugated ß- muricholic acids 
Diet Pellet 
Time (h) 
Soft Soft + 4% cholestyramine 
0 1.28 ± 0.39 0.66 ± 0.24* 0.42 ± 0.18* 
5 1.10 ± 0.37 0.73 ± 0.30 0.56 ± 0.20* 
19 1.10 ± 0.45 0.71 ± 0.28* 0.41 ± 0.20 
24 0.92 ± 0.37 0.61 ± 0.25* 0.37 ± 0.10 
Ratio of conjugated chenodeoxycholic acid : conjugated 
ß- muricholic acid 
Diet Pellet Soft Soft + 4% cholestyramine 
diet 
Time (h) 
0 0.36 ± 0.10 0.63 ± 0.23 0.38 ± 0.10 
5 0.09 ± 0.03 0.18 ± 0.10 0.11 ± M3 
19 0.04 ± 0.02 0.20 ± 0.10* 0.04 ± 0.01 
24 0.05 ± 0.03 0.17 ± 0.09* 0.03 ± 0.01 
Table 4.1 The effect of diet on the ratio of conjugated cholic 
acid : conjugated chenodeoxycholic + conjugated ß- muricholic acids 
and the ratio of conjugated chenodeoxycholic acid : conjugated 
- muricholic acid, as a measure of 12- hydroxylation and 
6- hydroxylation respectively. Results are the mean ± standard 
deviation of duplicate determinations from hepatocytes obtained 
from 'soft diet' (4 rats), pellet diet (2 rats) & 'soft diet' + 
4% cholestyramine (4 rats). Statistical analysis is a comparison 
with the pellet diet. Significance limits: * P < 0.05 
59 
acid in hepatocytes obtained from rats fed either of the diets 
indicating that 6- hydroxylation of chenodeoxycholic acid to 
ß- muricholic acid was not affected. 
During the incubation of hepatocytes over 24h the ratio of 
conjugated chenodeoxycholic : ß- muricholic 
acid fell significantly (Table 4,1). This was due to conversion 
of chenodeoxycholic acid to -muricholic acid via 6ß- hydroxylation 
by the hepatocytes. 
The more efficient rates of synthesis of bile salts observed 
in hepatocytes isolated from rats fed the diet containing 
cholestyramine should facilitate the investigation of the major 
aims of this project (Chapter 1.6). As a result the following 
experiments to characterise the catabolism of cholesterol to bile 
salts by isolated hepatocytes, were performed using hepatocytes 
prepared from rats in which cholestyramine was included in the 
diet. 
4.3 The effect of maintaining the cellular cytochrome P -450 
content on the synthesis of bile salts by hepatocytes 
As has been indicated in Chapter 3.4.4 the cellular content 
of cytochrome P -450 decreases during incubation of hepatocytes. 
However, Paine and Hockin (1980) have shown that the rate at which 
cytochrome P -450 content falls can be decreased by addition of 
100 pM 5- aminolaevulinic acid to the culture medium. The 
addition of 100 pM 5- aminolaevulinic acid to the culture medium 
used in this study was also found to decrease the rate at which 
hepatocytes lost cytochrome P -450 (Fig. 4.3). However, it was 
not as effective in maintaining cellular cytochrome P -450 content 
as in the media used by Paine, et al. (1982). This may beddue 
100 - 
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24 
Fig. 4.3 The effect of 5- aminolaevulinic acid on the cellular 
cytochrome P -450 content of hepatocyte monolayers. Following 
adhesion of hepatocytes to plastic Petri dishes they were 
incubated in medium containing 100 uM aminolaevulinic acid 
(41--41) or in control medium (0-0). Cells were pooled from 
5 - 8 plates and cytochrome P -450 content determined. Results 
are the mean of duplicate determinations from hepatocytes 
obtained from 2 rats. Error bars show the range of the values 
obtained. 
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to the higher cystine and cysteine content in DMEM compared to 
these media (see Chapter 3.4.4). 
The effect of maintaining cytochrome P -450 content on the 
synthesis of bile salts by hepatocytes was subsequently 
determined. The results show that there was no difference in 
the synthesis of the individual bile salts measured, the total 
bile salts or in the ratios of conjugated cholic acid : 
conjugated chenodeoxycholic + conjugated -muricholic acids or 
conjugated chenodeoxycholic acid : conjugated ß- muricholic acid 
(Fig. 4.4, Table 4.2). 
4.4 The effect of bovine serum albumin on bile salt synthesis 
by rat hepatocyte monolayers 
The synthesis of conjugated cholic, chenodeoxycholic and 
g- muricholic acids were determined in hepatocyte monolayers 
incubated in DMEM containing 0% (w /v), 2% (w /v) and 4% (w /v) 
charcoal- treated bovine serum albumin fraction V powder (BSA). 
The synthesis of conjugated cholic acid and conjugated 
ß- muricholic acid were decreased in the presence of BSA, whilst 
synthesis of conjugated chenodeoxycholic acid was significantly 
increased (Fig. 4.5). To a certain degree the effect of BSA 
was dependent on the concentration used. Whilst synthesis of 
conjugated cholic acid was decreased in the presence of albumin 
this decrease was not significant. However, the decrease in 
the synthesis of conjugated ß- muricholic acid although not 
significant in the presence of 2% (w /v) BSA was significant 
when hepatocytes were incubated in the presence of 4% (w /v) BSA. 
The increase in the synthesis of conjugated chenodeoxycholic 
acid was significant at both the concentrations of BSA used. 
Fig. 4.4 The effect of 5- aminolaevulinic acid on the synthesis 
of bile salts by rat hepatocyte monolayers. Hepatocytes were 
incubated in the presence (o--o) or absence (o-o) of 100 uM 
5- aminolaevulinic acid and the synthesis of (A) conjugated cholic 
acid (B) conjugated ß- muricholic acid and (C) conjugated 
chenodeoxycholic acid were determined. Values shown represent 
the mean ± standard deviation of duplicate determinations in 
hepatocytes obtained from three rats. Bile salts detected at Oh 
represent cell associated levels following adhesion of hepatocytes 



































Ratio of conjugated cholic acid : conjugated chenodeoxycholic 
+ ß- muricholic acids 
Time (h) 
Control + 100 pM 5- aminolaevulinic acid 
0 0.38 ± 0.2 0.38 ± 0.2 
6 0.54 ± 0.10 0.67 ± 0.2 
18 0.39 ± 0.10 0.38 ± 0.08 
24 0.34 ± 0.09 0.42 ± 0.02 
Ratio of conjugated chenodeoxycholic acid : conjugated 
-muricholic acid 
Time (h) 
Control + 100 pM 5- aminolaevulinic acid 
0 0.29 ± 0.10 0.29 ± 0.10 
6 0.10 ± 0.00 0.28 ± 0.04 
18 0.03 ± 0.00 0.06 ± 0.02 
24 0.02 ± 0.00 0.03 ± 0.01 
Table 4.2 The effect of 5- aminolaevulinic acid on the ratio of 
conjugated cholic acid : conjugated chenodeoxycholic + conjugated 
ß- muricholic acids and the ratio of conjugated chenodeoxycholic 
acid : conjugated ß- muricholic acid as an indication of 
12- hydroxylation and 6- hydroxylation respectively. Results are 
the mean ± standard deviation of duplicate determinations from 
hepatocytes obtained from three rats. 
Fig. 4.5 The effect of bovine serum albumin on the synthesis 
of bile salts by hepatocyte monolayers. The effect of 2% albumin 
(.-a) and 4% albumin (i--i) on (A) the synthesis of conjugated 
cholic acid (B) the synthesis of conjugated ß- muricholic acid 
(C) the synthesis of conjugated chenodeoxycholic acid as compared 
to a control without albumin (o--o) were determined. Each point 
represents the mean of duplicate determinations from hepatocytes 
obtained from four rats. Bile salts detected at Oh represent 
cell- associated levels after adhesion of the hepatocytes to the 
culture surface had taken place. Statistical analysis is a 
comparison with the control. Significance limits : *P < 0.05. 








































The increase observed in the presence of 2% (w /v) BSA was not further 
increased by hepatocytes when incubated with medium containing 4% (w /v) 
BSA. Total synthesis of bile salts was decreased in the presence of 
albumin but was only significant in the presence of 4% (w /v) BSA 
(Fig. 4,6A). Incubation of hepatocytes in the presence of BSA did 
not change the ratio of conjugated cholic acid : conjugated 
chenodeoxycholic acid + conjugated ß- muricholic acid indicating that 
there was no effect on the rate of 12a- hydroxylation (Table 4.3). 
However, 66- hydroxylation as measured by calculation of the ratio 
of conjugated chenodeoxycholic acid : conjugated ß- muricholic acid 
was significantly decreased in the presence of BSA (Table 4.3), thus 
indicating a decrease in the conversion of chenodeoxycholic acid to 
its metabolite ß- muricholic acid. 
The effect of BSA on the intracellular bile salt content was 
also examined. During incubation of hepatocytes the intracellular 
bile salt content decreased as the bile salts were secreted into 
the medium. Incubating hepatocytes in the presence of BSA resulted 
in an increase in the rate at which the intracellular bile salt 
content decreased. (Fig. 4,6B). 
4.5 The effect of antiserum to conjugated chenodeoxycholic acid on 
the synthesis of bile salts by rat hepatocyte monolayers 
To investigate further the observed effects of BSA on the 
synthesis of bile salts, hepatocytes were incubated in DMEM 
containing antiserum to conjugated chenodeoxycholic acid. The 
antiserum used in these experiments was raised in a different 
rabbit to the antiserum used in the radioimmunoassay. This 
latter antiserum had a significantly higher binding capacity for 
conjugated chenodeoxycholic acid. However, at the concentrations 
Fig. 4.6 The effect of bovine serum albumin on the synthesis 
of bile salts by rat hepatocyte monolayers. The effect of 2% 
albumin (.--a) and 4% albumin (u ---s) on (A) total synthesis of 
conjugated bile salts and (B) intracellular content of total 
bile salts as compared to a control without albumin (o-o) 
were determined. Bile salts detected at Oh represent cell - 
associated levels after adhesion of hepatocytes to the culture 
surface had taken place. Each point represents the mean of 
duplicate determinations from hepatocytes obtained from four 
rats. Statistical analysis is a comparison with the control. 







Fig. 4.7 The effect of a specific antiserum to conjugated 
chenodeoxycholic acid on the synthesis of conjugated 
chenodeoxycholic acid by rat hepatocyte monolayers. 
Hepatocytes were incubated in the absence (gyp) or presence 
of 0.25% (v /v) antiserum *AI) and 0.5% (v /v) antiserum 
(H). The effect of the antiserum on the apparent 
synthesis of conjugated chenodeoxycholic acid was determined. 
Bile salts detected at Oh represent cell associated levels 
after adhesion of hepatocytes to Petri dishes had taken place. 
Each point represents the mean of duplicate determinations 
from hepatocytes obtained from four rats. Error bars show 
± standard deviation. Significance limits : *P < 0.05. 
0.4 
5 19 
Incubation time (h) 
24 
Ratio of conjugated cholic acid : conjugated chenodeoxycholic 
+ conjugated ß- muricholic acids 
Control 2% 4% 
Time (h) 
0 0.55 ± 0.20 0.55 ± 0.20 0.55 ± 0.20 
6 0.54 ± 0.20 0.54 ± 0.20 0.61 ± 0.10 
18 0.38 ± 0.09 0.41 ± 0.04 0.46 ± 0.08 
24 0.36 ± 0.08 0.36 ± 0.01 0.39 ± 0.04 
Ratio of conjugated chenodeoxycholic acid : conjugated 
6- muricholic acid 
Time (h) 
Control 2% 4% 
0 0.63 ± 0.30 0.63 ± 0.30 0.63 ± 0.30 
6 0.10 ± 0.03 0.24 ± 0.03a 0.40 ± 0.10a 
18 0.04 ± 0.01 0.15 ± 0.09a 0.21 ± 0.10a 
24 0.03 ± 0.01 0.11 ± 0.06a 0.16 - 0.08a 
Table 4.3 The effect of bovine serum albumin on the ratios of 
conjugated cholic acid : conjugated chenodeoxycholic + conjugated 
ß- muricholic acids and the ratio of conjugated chenodeoxycholic 
acid : conjugated ß- muricholic acid as an indication of the rates 
of 12- hydroxylation and 6- hydroxylation respectively. Values 
shown are the mean ± standard deviation of duplicate determinations 
from hepatocytes obtained from four rats. Statistical analysis is 
a comparison with control values. Significance limits : a P < 0.05. 
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of the antiserum used in the incubation with hepatocytes slight 
interference with the assay of conjugated chenodeoxycholic acid 
occurred. As a result in those samples containing the 
antiserum of lower binding capacity conjugated chenodeoxycholic 
acid was measured using a standard curve obtained with both 
antisera present in the incubation buffer used in the 
radioimmunoassay. There was no cross reactivity between the 
antiserum used in the incubation of hepatocytes with either 
conjugated cholic acid or conjugated ß- muricholic acid. 
Total synthesis of bile salts was unaffected but a 
significant increase in conjugated chenodeoxycholic acid was 
observed (Fig. 4.7). There was no change in the ratio of 
conjugated cholic acid : conjugated chenodeoxycholic acid + 
conjugated ß- muricholic acid or the ratio of conjugated 
chenodeoxycholic acid : conjugated ß- muricholic acid (Table 4.4). 
4.6 The effect of different methods used to promote cell 
adhesion on the subsequent synthesis of bile salts by 
hepatocyte monolayers 
The effect of the procedure used to facilitate adhesion of 
hepatocytes to culture surfaces on the synthesis of bile salts 
by hepatocytes was investigated. Hepatocyte adhesion to 
culture surfaces was facilitated using either foetal calf serum 
and insulin as described in Chapter 2.4.3 or by incubation of 
hepatocytes in serum- and insulin -free medium, on Petri dishes 
pretreated with fibronectin. Petri dishes were coated with 
fibronectin by a procedure based on that used by Durrington 
et al. (1982), Culture medium (1ml) containing 20 pg fibronectin 
Ratio of conjugated cholic acid : conjugated chenodeoxycholic 
+ conjugated ß- muricholic acids 
Time (h) 
Control 0.25% 0.5% 
0 0.5 ± 0.2 0.5 ± 0.02 0.5 ± 0.2 
6 0.46 ± 0.07 0.47 ± 0.09 0.61 ± 0.22 
18 0.45 ± 0.03 0.44 ± 0.10 0.46 ± 0.12 
24 0.48 ± 0.04 0.44 ± 0.10 0.49 ± 0.2 
Ratio of conjugated chenodeoxycholic acid : conjugated 
ß- muricholic acid 
Time (h) 
Control 0.25% 0.5% 
0 0.36 ± 0.10 0.36 ± 0.10 0.36 ± 0.10 
6 0.07 ± 0.01 0.09 ± 0.01 0.09 ± 0.01 
18 0.03 ± 0.00 0.06 ± 0.01 0.04 ± 0.00 
24 0.03 ± 0.00 0.05 ± 0.01 0.04 ± 0.01 
Table 4.4 The effect of a specific antiserum to conjugated 
chenodeoxycholic acid on the ratio of conjugated cholic acid : 
conjugated chenodeoxycholic acid + ß- muricholic acid and the 
ratio of conjugated chenodeoxycholic acid : conjugated 
ß- muricholic acid. The results are the mean ± standard 
deviation of duplicate determinations from hepatocytes obtained 
from 4 rats. 
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(Speywood Laboratories, Nottingham, U.K.) was added to Petri dishes 
and incubated for 2h at 37 °C, after which time the medium was 
removed. After incubation of hepatocytes in treated dishes for 
lh, adhesion of hepatocytes to the culture surface was essentially 
complete. Following adhesion of hepatocytes to Petri dishes the 
medium was removed and replaced with serum- and insulin -free medium. 
Hepatocytes were incubated for 24h after which time the synthesis of 
conjugated cholic, chenodeoxycholic and ß- muricholic acids was 
determined (Table 4.5). No difference in the synthesis of 
conjugated cholic or chenodeoxycholic acid was observed. However, 
the synthesis of conjugated ß- muricholic acid appeared to be greater 
in those hepatocytes in which adhesion had been facilitated by foetal 
calf serum and insulin. As a result of this increase in synthesis 
of conjugated ß- muricholic acid, total synthesis was also increased 
in these hepatocytes. Viability as assessed by examination of 
hepatocyte morphology and exclusion of trypan blue was similar for 
hepatocytes maintained on fibronectin- coated dishes as for those 
preincubated in medium containing foetal calf serum and insulin. 
4.7 The effect of insulin on the synthesis of bile salts by rat 
hepatocyte monolayers 
In an attempt to establish the basis for the greater rates of 
bile salt synthesis by hepatocytes in which adhesion was facilitated 
by foetal calf serum and insulin, the effect of insulin on the 
synthesis of bile salts was investigated. 
Following adhesion of hepatocytes to Petri dishes coated with 
fibronectin, hepatocytes were incubated for 24h in the absence or 
presence of insulin. As well as investigating the effect of 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































were exposed to the same concentration of insulin as used in the 
promotion of cell adhesion, i.e. 1000 1 -1. Insulin was found to 
have no effect on the synthesis of any of the bile salts 
determined (results not shown). 
4.8 Discussion 
The results show that isolated hepatocytes maintained in 
monolayers synthesise conjugated cholic chenodeoxycholic and 
ß- murichoiic acids. Hepatocytes isolated from rats fed the 'soft 
diet' synthesised bile salts at the lowest rates, whilst feeding 
the pellet diet to rats resulted in higher rates of synthesis. 
Brydon et al. (1980) have reported that the activity of the 
enzyme cholesterol 7a- hydroxylase was lower in animals fed a low - 
fibre diet. It is possible that the higher rate of synthesis 
observed in hepatocytes isolated from rats fed the pellet diet is 
due to the higher fibre content of that diet. 
The rate of synthesis of total bile salts in these hepatocyte 
preparations are comparable with the rate reported by Davis et al. 
(1983a, 1983b). Feeding cholestyramine resulted in a 5 - 10 fold 
increase in the synthesis of bile salts by hepatocyte monolayers, 
a finding consistent with the known effects of cholestyramine 
(Huff et al., 1963; Botham et al. 1980; Kempen et al. 1982). The 
observation that synthesis of conjugated ß- muricholic acid is 
stimulated to a greater extent than conjugated cholic or 
chenodeoxycholic acids, confirms the results obtained with 
hepatocytes maintained in suspension (Botham et al., 1980; Botham 
and Boyd, 1983). It is likely that the synthesis of bile salts 
by rat hepatocytes in monolayer culture reflect the in vivo 
activity of cholesterol 7a- hydroxylase. 
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Maintenance of the total cytochrome P -450 content by 
supplementing the culture medium with 5- aminolaevulinic acid had 
no effect on the synthesis of bile salts by rat hepatocytes. 
The regulation of cholesterol 7a- hydroxylase, the enzyme 
catalyzing the rate limiting step in bile salt synthesis, is 
complex. Although cholesterol 7a- hydroxylase is a cytochrome 
P- 450 -dependent enzyme, current evidence suggests that the 
activity of cholesterol 7a- hydroxylase is not dependent on 
total cytochrome P -450 content. Administration of 
phenobarbitone results in an increase in cytochrome P -450 but 
does not affect cholesterol 7a- hydroxylase activity (Boyd et al., 
1969; Botham and Boyd, 1979). However, interruption of the 
enterohepatic circulation whilst increasing the activity cf 
cholesterol 7a- hydroxylase has no effect on total cytcc'hrcr:e 
P-450 (Boyd et al., 1969). Danielsson and Wikvall 8_'0 have 
reported that the cytochrome P -450 species associated with 
cholesterol 7a- hydroxylase is a minor constituent of total 
cellular cytochrome P -450. It is therefore possible that when 
total cytochrome P -450 is induced by drugs such as phenobarbitone, 
no significant change in the cytochrome P -450 form specific for 
7a- hydroxylation occurs. Conversely the increase in cholesterol 
7a- hydroxylase observed on diversion of the enterohepatic 
circulation, could be due to an increase in the specific 
cytochrome P -450 form associated with this enzyme, which may only 
produce a negligible affect on total cytochrome P -450. In the 
experiments reported here total cytochrome P -450 content seems to 
be defective but there is no indication of the hepatocyte content 
of the cytochrome P -450 specific for 7a- hydroxylation. It is 
likely that incubation of hepatocytes with medium containing 
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5- aminolaevulinic acid whilst decreasing the rate at which cellular 
cytochrome P -450 content decreases does not have a significant 
effect on the cytochrome P -450 specific for cholesterol 
7a- hydroxylase. 
Incubating hepatocytes in culture medium containing BSA led to 
an overall decrease in the synthesis of total bile salts. However, 
a significant increase in the amount of chenodeoxycholic acid was 
observed. In rats, chenodeoxycholic acid is known to be 
metabolised to a- and ß- muricholic acids (Mahawold et al., 1957; 
Matschiner et al., 1957; Voight et al., 1968). In isolated 
hepatocytes maintained in suspension ß- muricholic acid has been 
shown to be a major product of bile salt synthesis (Kempen et al., 
1982; Botham and Boyd, 1983). More recently conversion of 
chenodeoxycholic acid to ß- muricholic acid has been demonstrated 
in both hepatocyte suspensions (Botham and Boyd, 1983) and 
hepatocyte monolayers (Davis et al., 1983b). The apparent 
increase in the synthesis of conjugated chenodeoxycholic acid may 
be due to the formation of a conjugated chenodeoxycholic acid - 
BSA complex. Binding of bile salts to serum albumin has been 
reported to inhibit their re- uptake by hepatocytes maintained in 
suspension (Anwer et al., 1976; Iga and Klaassen, 1982). 
Inhibition of the re- uptake of chenodeoxycholic acid would prevent 
its further metabolism to ß- muricholic acid. This would result 
in the observed apparent increase in the synthesis of conjugated 
chenodeoxycholic acid. 
The uptake of bile acids by hepatocytes has been shown to be 
inversely correlated with the affinity of the bile acid for 
albumin (Hoffman et al., 1975). The formation of bile salt - BSA 
complexes would also provide an explanation for the increase in the 
67/x8 
rate at which intracellular bile salt concentrations fall as 
re- uptake of secreted bile acids by hepatocytes would be inhibited. 
In an attempt to mimic the effect of BSA on the apparent 
increase in the synthesis of conjugated chenodeoxycholic acid, 
hepatocyte monolayers were incubated in the presence of an 
antiserum specific to conjugated chenodeoxycholic acid. The 
increase in conjugated chenodeoxycholic acid observed (Fig. 4.7) 
further supports the conclusion that the increase in the synthesis 
of conjugated chenodeoxycholic acid in the presence of BSA is 
caused by binding thereby preventing its re- uptake and further 
metabolism to ß- muricholic acid. No other effects on the 
synthesis of bile salts were observed. This also provides 
further evidence of the specificity of the antiserum used. 
The reason for the overall decrease in the synthesis of 
bile salts by hepatocytes in the presence of albumin is unclear. 
Studies on hepatocyte monolayers have shown that alteration of 
the viscosity of the culture medium causes a decrease in the 
synthesis and secretion of plasma proteins (Davis et al., 1980) 
and also VLDL (Yedgar et al., 1982). It is possible that slight 
changes in the viscosity of the medium, due to the addition of 
albumin, may cause the observed decrease in the total synthesis of 
bile acids. 
The results presented confirm that conjugated cholic acid and 
conjugated ß- muricholic acid are the major bile salts synthesised 
by isolated rat hepatocytes. The rat hepatocyte monolayers also 
synthesise and secrete conjugated chenodeoxycholic acid. In 
related work, it has been reported that cholic and ß- muricholic 
acids were synthesised by rat hepatocyte monolayers but the 
synthesis of chenodeoxycholic acid was not detected (Davis et al. 
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1983a, 1983b). However, a gas liquid chromatographic method was 
used for the detection of bile acid derivatives and the presence 
of an unidentified peak was reported (Davis et al., 1983a). 
The investigation of the effect of various additions to the 
culture medium has enabled the optimum conditions for hepatocyte 
maintenance to be chosen. These conditions are based firstly 
on maintaining rates of bile salt synthesis over 24h and secondly, 
on keeping additions to the culture medium to a minimum. Whilst 
addition of 5- aminolaevulinic acid decreased the rate at which 
cellular cytochrome P -450 content declined, no effect on the 
synthesis of bile salts was observed. Addition of BSA led to a 
decrease in the rate of synthesis of bile salts and inhibited the 
metabolism of chenodeoxycholic acid to ß- muricholic acid. The 
optimum conditions of hepatocyte maintenance were therefore 
provided by using serum- and insulin -free DMEM. 
The results of a preliminary investigation undertaken 
indicate that fibronectin- treated Petri dishes can be used to 
study the synthesis of bile salts by hepatocyte monolayers. The 
results also suggest that insulin has no effect on the synthesis 
of bile salts over a 24h incubation. However, before undertaking 
the routine use of fibronectin- coated Petri dishes, it is 
desirable to first investigate the metabolic integrity of 
hepatocytes maintained on these dishes in more detail. It is 
hoped that in the future the use of Petri dishes coated with 
fibronectin will allow more defined conditions of hepatocyte 
maintenance. 
In conclusion, all the experiments described in this thesis 
were performed using hepatocytes obtained from rats fed the soft 
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diet supplemented with 4% cholestyramine, unless otherwise 
indicated. Following the isolation of hepatocytes, adhesion to 
Petri dishes was facilitated by preincubation of cells in culture 
medium supplemented with foetal calf serum and insulin. After 
cell attachment was complete, hepatocytes were maintained in 
serum- and insulin -free DMEM, with additions as indicated e.g. 
lipoproteins, radioactive precursors. 
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CHAPTER 5 
THE EFFECT OF A RAT PLASMA HIGH -DENSITY LIPOPROTEIN 
SUBFRACTION ON THE SYNTHESIS OF BILE SALTS 
BY RAT HEPATOCYTE MONOLAYERS 
5.1 Introduction 
The catabolism of cholesterol to bile salts provides the major 
route for the degradation of cholesterol (Bergstrom and Norman, 1953). 
The cholesterol that is degraded to bile salts can be derived from 
either de novo synthesis or from the plasma lipoproteins 
(Chapter 1.4.2). Current evidence suggests that the preferred 
substrate for the synthesis of bile salts is newly synthesised 
cholesterol (Mitropoulos et al., 1974; Bjorkhem and Danielsson, 1975; 
Norman and Norum, 1976; Bjorkhem and Lewenhaupt, 1979). However, it 
has been suggested that of the plasma lipoproteins HDL may function 
to regulate the cholesterol content of extrahepatic tissues by 
transporting cholesterol from these tissues to the liver for its 
ultimate removal from the body (Glomset, 1968; Tall and Small, 1980). 
This can be achieved by either degradation of cholesterol to bile 
salts or by direct secretion of the unmodified sterol into bile. 
Although the liver has been shown to be a major site for the uptake 
of HDL (Stein et al., 1983) there has been no evidence to suggest 
that HDL stimulates the synthesis of bile acids. The experiments 
described in this chapter were designed to investigate the effect of 
HDL2 on the synthesis of bile salts by rat hepatocyte monolayers. 




5.2 Isolation and characterisation of rat HDL2 
Rat HDL2 was isolated by rate zonal ultracentrifugation as 
described in Chapter 2.7. The lipoprotein fraction obtained was 
characterised by its zonal elution profile and its apoprotein 
content. The protein : cholesterol ratio of the HDL2 obtained 
was also determined. 
5.2.1 Rate zonal ultracentrifugation 
Fig. 5.1 shows the zonal elution profile obtained from rat 
plasma lipoproteins. The absorbance at 280nm of the first 50m1 
of eluate is high. This is due to the presence of VLDL which is 
colloidal in nature. This fraction also contains LDL. The peak 
obtained at an elution volume of 140 - 250m1 represents the HDL2 
fraction. This fraction was taken and subsequently concentrated 
for use in the experiments to be undertaken. 
5.2.2 SDS-PAGE of HDL2 apoproteins 
Following delipidation, HDL2 apoproteins were subjected to 
SDS -PAGE as described in Chapter 2.14. The major protein 
identified was apo A -I whilst apo A -IV and apo E were also 
present (Fig. 5.2). These are the major apoproteins reported 
to be associated with HDL2 (Oschry and Eisenberg, 1982). Apo C 
was also found to be present. 
5.2.3 The protein and cholesterol content of the HDL2 fraction 
The HDL2 fraction obtained was diluted with culture 
medium to provide a physiological concentration of 500 u9 ml -1 
of HDL2 protein. Following dilution of the HDL2 the cholesterol 
0.2 
100 200 300 400 
Zonal rotor effluent (ml) 
Fig. 5.1 Rate zonal ultracentrifugation of rat plasma lipoproteins. 
Rat lipoproteins were subjected to rate zonal ultracentrifugation in 
a 1.0 - 1.4g m1 -1 sodium bromide gradient according to the method of 
Oschry and Eisenberg (1982). 
- apo A-1V 
- apo E 
apo A-I 
- apo C's 
Fig. 5.2 SDS -PAGE of the apoproteins of rat plasma HDL2. 
Following delipidation of the HDL2 -apoproteins approximately 
100 ug of HDL2- protein was loaded onto gels (15% acrylamide). 
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content due to HDL2 in the culture medium was determined (Table 5.1). 
The results show that for every 500 pg of HDL2 protein, there is 
360 pg of cholesterol, with 35.9 pg of this cholesterol being in the 
unesterified form. The ratios of cholesterol : protein and 
unesterified cholesterol : total cholesterol were also calculated so 
that the HDL2 used in these experiments could be compared with the 
HDL2 prepared by Oschry and Eisenberg (1982). (Table 5.1). 
5.3 The effect of HDL2 on the synthesis of bile salts by rat 
hepatocyte monolayers 
Hepatocytes prepared from rats fed a pellet diet were maintained 
in monolayers for up to 24h. Hepatocytes were incubated in the 
presence or absence of HDL2 (500 pg HDL2 protein m1 -1) and the effect 
on the synthesis of conjugated cholic, conjugated chenodeoxycholic 
and conjugated ß- muricholic acids was determined. The synthesis of 
these bile acid conjugates was not affected by incubating hepatocytes 
with HDL2 (Fig. 5.3). However the experiment was repeated using 
hepatocytes obtained from rats fed the bile salt sequestrant, 
cholestyramine. Incubation of these hepatocytes with HDL2 increased 
the synthesis of conjugated cholic and conjugated -muricholic acids 
but this increase was not significant at all of the time points 
(Fig. 5.4). Synthesis of conjugated chenodeoxycholic acid was 
significantly increased in the first 3h of incubation but no change 
was observed when compared to the control at 19h and 24h. Total 
synthesis of bile salts (i.e. conjugated cholic acid 
+ conjugated 
chenodeoxycholic acid + conjugated ß- muricholic acid) was 
significantly increased by hepatocytes incubated in the presence of 
HDL2 (Fig. 5.5). 
Protein Free Total FC TC 
cholesterol cholesterol - 
(FC) (TC) TC Protein 
This study 
pg /ml culture medium 
500 35.9 360 0.10 0.72 
Oschry and Eisenberg 40.5 3.6 25.5 0.12 0.73 
(1982) 
mg /100mg lipoprotein 
Table 5.1 Protein and cholesterol content of rat HDL2. The protein 
and cholesterol content of rat HDL2 prepared for use in this study was 
compared to the HDL2 prepared by Oschry and Eisenberg. 
Fig. 5.3 The effect of HDL2 on the synthesis of bile salts by 
rat hepatocytes prepared from rats fed the pellet diet. The 
effect of HDL2 (:- --a) on (A) the synthesis of conjugated cholic 
acid (B) the synthesis of conjugated -muricholic acid (C) the 
synthesis of conjugated chenodeoxycholic acid as compared to a 
control without HDL2 (o--0) were determined. Each point represents 
the mean of duplicate determinations from hepatocytes obtained from 
two rats. Bile salts detected at Oh represent cell- associated 
levels after adhesion of the hepatocytes to the culture surface had 






































Fig. 5.4 The effect of HDL2 on the synthesis of bile salts by 
rat hepatocytes obtained from rats fed the 'soft diet' + 4% 
cholestyramine. The effect of HDL2 (..a) on (A) the synthesis 
of conjugated cholic acid (B) the synthesis of conjugated 
ß- muricholic acid (C) the synthesis of conjugated chenodeoxycholic 
acid as compared to a control without HDL2 (o-o) were determined. 
Each point represents the mean of duplicate determinations from 
hepatocytes obtained from six rats. Bile salts detected at Oh 
represent cell associated levels after adhesion of the hepatocytes 
to the culture surface had taken place. Statistical analysis is 
a comparison with the control. Significance limits : *P < 0.05. 
































Fig. 5.5 The effect of HDL2 on the total synthesis of bile salts 
by rat hepatocyte monolayers prepared from rats fed a diet containing 
cholestyramine. Hepatocytes were maintained in monolayers in the 
absence (o-o) or presence (ts --s) of HDL2 (500 ug HDL2 protein m1-1) 
for the indicated time periods. Bile salts detected at Oh represent 
cell associated levels following adhesion of hepatocytes to Petri 
dishes. Each point represents the mean of duplicate determinations 
from hepatocytes obtained from 6 rats. Significance limits : 
*P < 0.05. Error bars show ± standard deviation. 
10- 
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The ratio of conjugated cholic acid : conjugated chenodeoxycholic 
acid + conjugated ß- muricholic acid and the ratio of conjugated 
chenodeoxycholic acid : conjugated ß- muricholic acid were also 
determined. These ratios provide good indications of the rates of 
12a- hydroxylation and 6ß- hydroxylation respectively (Chapter 4.2). 
HDL2 did not affect these ratios in hepatocytes isolated from rats 
fed the pellet diet or the diet supplemented with cholestyramine. 
5.4 The effect of HDL2 on the cellular cholesterol content of 
rat hepatocytes 
The free cholesterol content and the total cholesterol content 
of hepatocyte monolayers incubated in the presence or absence of 
HDL2 were determined. HDL2 was found to have no effect on the 
free cholesterol content or the total cholesterol content of 
hepatocytes isolated from rats fed the pellet diet (Fig. 5.6). In 
those hepatocytes isolated from rats fed cholestyramine HDL2 did 
not affect the free cholesterol content but produced a slight but 
not significant increase in the total cholesterol content (Fig. 5.7). 
There was no significant difference in the cholesterol content of 
hepatocytes isolated from rats fed the pellet diet compared to those 
hepatocytes prepared from rats fed cholestyramine. 
5.5 Discussion 
Following the isolation of HDL2 by rate zonal ultracentrifugation 
it was characterised prior to undertaking the desired experiments. 
Determination of the apoprotein content indicated that the major 
apoproteins reported to be associated with HDL2 were present. 
Apo A -I was the major apoprotein present and it is known to 
be 
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24 
Fig. 5.6 Effect of HDL2 on the cellular cholesterol content of 
rat hepatocytes. Hepatocytes isolated from rats fed the pellet 
diet were maintained in monolayers for the indicated time periods. 
The free cholesterol.(o- -o control ; 111-41+ HDL2) and the total 
cholesterol (0--0 control ; S--a + HDL2) content of hepatocytes 
were determined. Each point represents the mean of duplicate 
determinations from hepatocytes obtained from 2 rats. Error 
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Incubation time (h ) 
Fig. 5.7 Effect of HDL2 on the cellular cholesterol content of 
rat hepatocytes. Hepatocytes isolated from rats fed the soft 
diet + 4% cholestyramine were maintained in monolayers for the 
indicated time periods. The free cholesterol (o-0 control ; 
-- + HDL2) and the total cholesterol (o--- control ;. + 
HDL2) content of hepatocytes was determined. Each point 
represents the mean of duplicate determinations from hepatocytes 
obtained from six rats. 
Error bars show ± standard deviation. 
75 
confirmed. This apoprotein is essential for the uptake of HDL2 
by the receptor- mediated pathway of the hepatocyte. 
Determination of the ratio of protein : cholesterol and the 
ratio of unesterified cholesterol : total cholesterol indicated 
that the values obtained were in good agreement with those 
reported by Oschry and Eisenberg (1982). Following the 
characterisation of the HDL2 obtained it was concluded that it 
was suitable for use in the intended experiments. 
It has been reported by Davis et al. (1983a) that incubation 
of rat hepatocyte monolayers with a rat plasma lipoprotein 
fraction of density < 1.02g ml -1 increases the synthesis of bile 
acids. Incubation of LDL and HDL with hepatocyte monolayers was 
found to have no effect on the synthesis of bile salts. The 
results presented in this chapter on the effect of HDL2 on the 
synthesis of bile salts by rat hepatocytes obtained from rats 
fed a pellet diet, confirm one aspect of the report by Davis 
et al. (1983a). However, the results obtained with hepatocytes 
prepared from rats cholestyramine indicate for the first time 
that HDL can increase the synthesis of bile salts. These 
results appear to indicate that under certain conditions HDL can 
deliver cholesterol to the liver for degradation to bile salts. 
However, this does not necessarily mean that HDL functions in 
vivo to transport cholesterol from extrahepatic tissues to the 
liver for its degradation. It is important to note that 
cholestyramine has a number of effects on the metabolism of 
cholesterol in the liver. It has been shown in Chapter 4 that 
cholestyramine stimulates the synthesis of bile salts. The 
mechanism by which this occurs is not fully understood. 
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However, dietary cholestyramine also results in both an increase 
in the synthesis of cholesterol by the liver (Huff et al., 1963; 
Fears and Morgan, 1976) and an increase in the uptake of 
cholesterol from the plasma. In humans (Shepherd et al., 1980) 
and rabbits (Slater et al., 1980) feeding cholestyramine results 
in an increase in the clearance of LDL from plasma. Slater 
et al. (1980) showed that, whilst other tissues contribute, the 
major organ responsible for the increase in the catabolism of LDL 
was the liver. Further studies in dogs indicated that the 
increase in the catabolism of LDL was probably due to an increase 
in the expression of the apo B/E receptor on the hepatocyte 
plasma membrane (Hui et al., 1981; Chao et al., 1982). Uptake 
of LDL by the liver is mediated through recognition of apo B on 
the surface of the LDL particle, by the hepatocyte B/E receptor. 
Although these studies were performed in different species, 
feeding cholestyramine appears to involve an increase in the 
availability of cholesterol to the hepatocyte due to an increase 
in the uptake of plasma cholesterol and a stimulation in the 
synthesis of cholesterol. It is known that a proportion of the 
increase in the cholesterol delivered to the hepatocyte is 
utilized for the increased synthesis of bile salts. However, 
the contribution of cholesterol derived from de novo synthesis 
versus cholesterol from plasma, in supplying the substrate for 
the degradation to bile salts is unknown. 
The results indicate that HDL2 can increase the synthesis 
of bile salts by hepatocytes maintained in monolayers, but as 
yet there is no indication as to the mechanism by which this 
occurs. There are however two possibilities. As has been 
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suggested, HDL2 may function to deliver cholesterol to the liver 
for degradation. This may also involve an increase in the 
synthesis of bile salts by stimulation of cholesterol 
7a- hydroxylase activity. Alternatively the presence of HDL2 in 
the hepatocyte culture medium may serve to provide an additional 
source of substrate to satisfy the increase in the activity of 
cholesterol 7a- hydroxylase as a result of feeding cholestyramine. 
It is possible that in hepatocytes isolated from rats fed 
cholestyramine there is a deficiency in the cholesterol available 
for degradation to bile salts. 
In vivo, the increase in the supply of cholesterol required 
for the synthesis of bile salts as a result of feeding 
cholestyramine can be met by both an increase in de novo synthesis 
of cholesterol and an increase in the uptake of cholesterol from 
the plasma. However, in those hepatocytes maintained in 
lipoprotein -free medium all of the cholesterol utilized for the 
synthesis of bile salts has to be derived from newly synthesised 
cholesterol. (In the first few hours of incubation some of the 
cholesterol used by the hepatocyte for the synthesis of bile 
salts may be derived from a preformed pool within the cell. 
However, this is likely to be utilized within the first few 
hours of incubation (Kempen et al., 1982)). In those hepatocytes 
incubated in lipoprotein -free medium the newly synthesised 
cholesterol supplied to the substrate pool for the synthesis of 
bile salts may not be sufficient to meet the increase in the 
supply of substrate necessary as a result of feeding cholestyramine. 
The addition of HDL2 to the culture medium would therefore serve to 
provide the additional cholesterol required for the synthesis of 
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bile salts. The observation that the presence of HDL2 in the 
hepatocyte culture medium did not increase the synthesis of bile 
salts by hepatocytes prepared from rats fed the pellet diet 
further suggests that the availability of cholesterol for the 
synthesis of bile salts may be limiting in hepatocytes isolated 
from rats fed cholestyramine. If this were the case the 
increase in the synthesis of bile salts observed in the presence 
of HDL2 would not be due to the stimulation of cholesterol 
7a- hydroxylase by HDL2. This possibility will require further 
investigation. 
If the function of HDL2 is to deliver cholesterol to the 
liver for its degradation it might be expected that the 
incubation of HDL2 with hepatocytes obtained from rats fed the 
pellet diet would also result in an increase in the synthesis 
of bile salts. However, it is important to stress that this 
conclusion may not be valid. If incubation of hepatocytes with 
HDL2 results in the inhibition of the synthesis of cholesterol, 
the total amount of cholesterol available within the hepatocyte 
may not change. HDL2 could, by decreasing the contribution of 
newly synthesised cholesterol to the synthesis of bile salts, 
supply cholesterol for degradation without producing an increase 
in the total bile salts synthesised. It is clear that the 
effects of HDL2 observed on the synthesis of bile salts by 
hepatocytes require further investigation. 
Determination of the ratio of conjugated cholic acid : 
conjugated chenodeoxycholic acid + conjugated -muricholic acid 
and the ratio of conjugated chenodeoxycholic acid : conjugated 
8- muricholic acid in the presence of HDL2 showed that this 
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lipoprotein fraction did not affect these ratios when compared to 
(data not shown) 
the control /. As these ratios were unaffected it appears that the 
HDL2- cholesterol utilized for the synthesis of bile salts enters 
a common precursor pool for the synthesis of the major bile acid 
conjugates measured. 
In an attempt to establish whether the increase in the 
catabolism of cholesterol to bile salts by hepatocytes prepared 
from rats fed cholestyramine, was as a direct result on an increase 
in the availability of cholesterol, the free and total cholesterol 
content of hepatocytes was determined. HDL2 did not affect these 
parameters in hepatocytes isolated from rats fed the control diet 
or the diet supplemented with cholestyramine. It therefore 
appears likely that uptake of HDL2 by hepatocytes results in the 
cholesterol being utilized for either the assembly of lipoproteins, 
secretion as biliary cholesterol or the degradation to bile salts. 
Utilization of HDL2 -cholesterol in this way would result in the 
hepatocyte maintaining the intracellular cholesterol content at a 
constant level. 
In conclusion, interruption of the enterohepatic circulation 
by feeding dietary cholestyramine results in an increase in the 
catabolism of cholesterol to bile salts which is not evident 
in hepatocytes isolated from rats fed the control diet. The 
possible mechanisms involved in the increase in the synthesis of 
bile salts by hepatocytes are discussed in Chapter 6. 
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CHAPTER 6 
THE CATABOLISM OF HDL2- CHOLESTEROL BY RAT HEPATOCYTE MONOLAYERS 
6.1 Introduction 
The results in Chapter 5 have shown that under certain 
conditions HDL2 can stimulate the synthesis of bile salts by rat 
hepatocyte rnonolayers. This stimulation in the synthesis of bile 
salts may require an increase in the supply of cholesterol which 
can be obtained from either a stimulation in the synthesis of 
cholesterol or through uptake of HDL2- cholesterol. The 
contribution of each of these sources in providing substrate for 
the synthesis of bile salts by hepatocytes is unknown. However, 
in those hepatocytes incubated with control medium, the cholesterol 
used for the synthesis of bile salts has to be obtained entirely 
from newly- synthesised cholesterol. Addition of HDL2 to the 
culture medium provides an alternative source of cholesterol for 
degradation to bile salts. It would therefore seem likely that the 
increase in the synthesis of bile salts observed on addition of 
HDL2 to the culture medium was partly due to uptake and subsequent 
degradation of HDL2 -cholesterol. However, incubation of HDL with 
some cell types from extrahepatic tissues has been reported to 
facilitate the removal of cellular cholesterol and result in a 
stimulation of cholesterol synthesis (Stein et al., 1977; Henriksson 
et al., 1979; Stoudemire et al., 1980). It is therefore possible 
that a stimulation in cholesterol synthesis by hepatocytes incubated 
in the presence of HDL2 could result in newly synthesised cholesterol 
supplying the increase in the substrate required for the synthesis of 
bile salts. 
81 
To determine the source of cholesterol for synthesis of bile 
salts rat hepatocyte monolayers were incubated in medium containing 
HDL2 labelled with either [4- 14C]cholesterol or [4- 14C]cholesteryl 
oleate. This enabled the determination of the contribution of 
HDL2 -free cholesterol and HDL2 -cholesteryl oleate to the synthesis 
of bile salts. The effect of HDL2 on the synthesis of cholesterol 
and the utilization of newly- synthesised cholesterol for the 
synthesis of bile salts by rat hepatocytes was also determined. 
This was achieved by incubating hepatocyte monolayers in medium 
containing [14C]acetate in the presence and absence of HDL2. 
6.2 Radiolabelling of HDL2 
The HDL2 fraction of rat plasma was radiolabelled with either 
14 14 
or [4- [4- C]cholesteryl oleate as described in 
Chapter 2.8. 
6.2.1 HDL2 radiolabelled with [4- 14C]cholesterol 
Following the radiolabelling of HDL2 with [4 -14C] cholesterol 
the specific activity of the HDL2 -free cholesterol was determined. 
The specific activity of the free cholesterol was 68452 CPM nmol -1 
of free cholesterol. 
6.2.2 HDL2 radiolabelled with [4 -14C] cholesteryl oleate 
HDL2 was radiolabelled in the cholesteryl ester moiety by 
transfer of [4- 14C]cholesteryl oleate from a lipid microemulsion 
to the HDL2. Transfer of the [4- 14C]cholesteryl oleate was 
facilitated by a cholesteryl ester exchange protein present in 
human plasma (Barter and Lally, 1978). 
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Labelling of the whole lipoprotein fraction, followed by 
isolation of HDL2 by rate zonal ultracentrifugation gave poor 
results. The percentage transfer of [4- 
14C]cholesteryl 
oleate 
to HDL2 was approximately 5 %. However by radiolabelling the 
crude HDL fraction after removal of the VLDL and LDL fraction by 
density gradient ultracentrifugation (Chapter 2.8) 18% of the 
14 
[4- C]cholesteryl oleate was transferred to the HDL2 fraction. 
The specific activity of the esterified cholesterol was found to 
be 7.38 CPM nmol . If the labelling procedure was repeated 
using rat lipoprotein -free plasma the transfer of [14C]cholesteryl 
oleate was less than 1 %. This would appear to confirm a previous 
report that the activity of the cholesteryl ester transfer protein 
in rat plasma is very low (Oschry and Eisenberg, 1982). 
Following the isolation of HDL2 labelled in the cholesteryl 
ester moiety it was characterised by its apoprotein content. 
Following delipidation HDL2 apoproteins were subjected to SDS -PAGE 
(Fig. 6.1). The gels obtained indicated that the HDL2 fraction 
was contaminated with albumin and had proportionately less apo A -1V 
and apo E than was found in the untreated HDL2 (Chapter 5, Fig. 5.2). 
This serious loss of apoproteins may be due to the relatively harsh 
conditions of radiolabelling used. The abnormal protein content of 
this HDL2 fraction will be discussed in Chapter 6.8. 
6.3 The entry of HDL2- cholesterol into rat hepatocyte monolayers 
following incubation in culture medium containing 
HDL2- [4- 
14 
C]cholesterol or HDL2- [4- 14C]cholesteryl oleate 
Hepatocyte monolayers were incubated in the presence of HDL2 
labelled in either the free cholesterol or cholesteryl ester moiety. 
The entry of the radiolabelled cholesterol into hepatocytes was 
-albumin 
-apo A-IV 
_- a p o E 
- apo A-I 
Fig. 6.1 Apoprotein content of HDL2 radiolabelled with 
[4- 14C]cho1esteryl oleate. 
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subsequently determined. 
6.3.1 Entry of HDL2 -free cholesterol into hepatocytes 
Hepatocyte monolayers prepared from rats fed cholestyramine 
were incubated with HDL2 radiolabelled with [4- 14C]cholesterol 
for 3, 19 and 24h. After the indicated time periods the medium 
was aspirated and stored at -20 °C. The cells were washed with 
3 x lml of phosphate bufferxed saline, 1M sodium hydroxide was 
added and the cells were scraped from the Petri dishes. The 
radioactivity attributable to cholesterol and cholesteryl esters 
was determined as described in Chapter 2.10. Uptake of HDL2 -free 
cholesterol into the hepatocyte was rapid during the first 3h of 
incubation but increased at a slower rate between 3h and 24h. 
(Fig. 6.2). The results also showed that uptake of HDL2 -free 
cholesterol into hepatocytes resulted in a proportion of this 
cholesterol being esterified. 
Incubation of HDL2 with hepatocyte monolayers therefore 
results in the uptake and subsequent entry of HDL2- cholesterol 
into the hepatocyte cholesterol pool. However, these experiments 
do not indicate whether this cholesterol enters the hepatocyte via 
the non -receptor - or receptor -mediated pathway (Chapter 1.2.3). 
However it is likely that some of the HDL2 -free cholesterol enters 
the hepatocyte through exchange of cholesterol with the hepatocyte 
plasma membrane. 
6.3.2 The entry of HDL2- [4- 14C]cholesteryl oleate into hepatocytes 
Entry of HDL2 -cholesteryl ester into hepatocytes was 
determined in the same way as was described for determination of 







Incubation time (h) 
19 24 
Fig. 6.2 Entry of HDL2 -free cholesterol into hepatocytes. 
The entry of HDL2 -free cholesterol into rat hepatocytes was 
determined as described in the text. The radioactivity 
attributable to free cholesterol (0.--e) and cholesteryl ester 
(a a) was determined as described in Chapter 2.10 and 2.11. 
The results are the mean ± the range of duplicate 
determinations from hepatocytes obtained from 2 rats. 
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After the indicated time periods the radioactivity due to 
cellular free cholesterol and cellular cholesteryl ester was 
determined. The radioactive cholesteryl ester associated with 
the cells increased rapidly during the first 3h and then remained 
constant throughout the rest of the experimental period. 
(Fig. 6.3). It is important to note that the radioactive 
cholesteryl ester associated with the hepatocytes is not only a 
measure of the uptake and subsequent entry of the HDL2- cholesteryl 
ester into the hepatocytes but is also a measure of the HDL2 - 
cholesteryl ester that is bound to the outer surface of the 
hepatocytes. However hepatocytes were also found to contain 
radioactivity in the cell free cholesterol (Fig. 6.3). This is 
probably due to the hydrolysis of the HDL2 -cholesteryl ester on 
entering the hepatocyte. Hydrolysis is likely to occur in the 
lysosomes following receptor- mediated uptake by the action of the 
lysosomal cholesterol esterase (Chapter 1.2.1). The appearance 
of radioactive free cholesterol in the hepatocytes occurs very 
rapidly in the first 3h and remains fairly constant up to 19h. 
However, between 19 - 24h the radioactivity attributable to free 
cholesterol falls quite markedly (Fig. 6.3). The reason for this 
is unclear. However, it would seem reasonable to suggest that 
between 3 - 19h the supply of cholesterol to the hepatocyte free 
cholesterol pool from HDL2 -cholesteryl ester is equal to the 
utilization of that free cholesterol. During the 19h - 24h time 
points the output of the cholesterol from hepatocytes that is 
derived from HDL2 -cholesteryl ester exceeds the input resulting in 
a decrease in the intracellular free cholesterol derived from 
uptake of HDL2 -cholesteryl ester. 
3 19 
Incubation time (h) 
24 
Fig. 6.3 Entry of HDL2- cholesteryl ester into hepatocytes. 
The entry of HDL2 -cholesteryl ester into the hepatocyte was 
determined as described in the text. The results show the 
cellular radioactivity due to free cholesterol (.-s) and 
cholesteryl ester (o-o). The results are the mean 
± the 
range of duplicate determinations from, hepatocytes obtained 
from 2 rats. 
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6.4 The utilization of HDL2- cholesterol by hepatocyte monolayers 
The metabolism of cholesterol by hepatocytes is extremely 
complex (Chapter 1). The cholesterol within the hepatocyte can 
be used for secretion as biliary cholesterol, the assembly of 
plasma lipoproteins, the synthesis of bile salts and also membrane 
synthesis. In Chapter 6.3.1 the esterification of, 
HDL2- [4- 14C]cholesterol on entry into the hepatocyte was described. 
However, by analysis of the medium other pathways can also be 
studied. 
The results that follow describe in part, the utilization of 
HDL2- cholesterol by hepatocytes maintained in monolayers with 
particular attention to the utilization of HDL2 -cholesterol for the 
synthesis of bile salts. 
6.4.1 The contribution of HDL2 -free cholesterol to the synthesis 
of bile salts 
Following the incubation of hepatocyte monolayers for the 
indicated time periods the radioactivity due to bile salts was 
determined as described in Chapter 2.10. The results indicate 
that HDL2 can supply free cholesterol for degradation to bile 
salts (Fig. 6.4). The degradation of HDL2 -free cholesterol to 
bile salts is constant throughout the duration of the experiment 
(Fig. 6.4). 
A comparison of the specific activities of the cell free - 
cholesterol with the specific activity of the bile salts indicated 
that the cell free -cholesterol specific activity is significantly 
lower than the specific activity of the bile salts (Fig. 
6.5). 
It would seem unlikely that all of the free 
cholesterol within the 
hepatocyte is available for the synthesis 





a 35 4- o 









°-- 10 u 
5 
19 
Incubation time (h) 
24 
Fig. 6.4 The utilization of HDL2 -free cholesterol for the 
synthesis of bile salts by rat hepatocytes. The secretion of 
bile salts derived from HDL2 -free cholesterol into the 
hepatocyte culture medium was determined as described in the 
text. The results shown are the mean ± the range of duplicate 
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Fig. 6.5 Comparison of the specific activity of the cell free 
cholesterol with the specific activity of the bile salts. 
Following incubation of hepatocytes with HDL2- [4- 14C]free 
cholesterol the specific activity of the hepatocyte free 
cholesterol (i--o) and the specific activity of the bile salts 
secreted into the medium (o---o) was determined. The results are 
the mean ± the range of duplicate determinations from hepatocytes 
obtained from 2 rats. 
8E) 
particularly as a proportion of the free cholesterol within the cell 
serves a structural function. If after entry of HDL2 -free 
cholesterol into the hepatocyte it does not freely equilibrate with 
the pools of cholesterol within the cell (Chapter 1.6) then some 
pools will have a higher specific activity than others. Evidence 
for the possibility of the specific delivery of HDL2 -free cholesterol 
to specific pools of cholesterol appears to be provided by the 
results that show the high specific activity of bile salts compared 
to the specific activity of the cellular free cholesterol (Fig. 6.5). 
The measurement of the free cholesterol in the hepatocytes is limited 
to the total free cholesterol within the cell and does not measure the 
cholesterol content of the individual pools of cholesterol. The 
specific activity of the hepatocyte free cholesterol therefore shows 
the average distribution of HDL2- [4- 
la 
C]cholesterol within the cell 
and does not take into account the possible non -uniform distribution 
of this cholesterol on entry into the hepatocyte. 
Having shown that the HDL2 -free cholesterol could provide 
substrate for the synthesis of bile salts the proportion of bile 
salts synthesised from cholesterol derived from this source was 
determined. Calculations were performed by comparing the specific 
activity of the lipoprotein -free cholesterol with the specific 
activity of the bile salts. If the specific activity of the bile 
salts was found to be the same as the specific activity of the HDL2 - 
free cholesterol then all of the substrate for the synthesis of bile 
salts would be derived from HDL2 -free cholesterol. This, of course, 
would be an extreme situation: The results show that the 
contribution of HDL2 -free cholesterol to the synthesis of bile salts 
steadily increases throughout the incubation but does not exceed 1 %. 
(Table 6.1). It was therefore concluded that HDL2 -free cholesterol 
Incubation time (h) 3 19 24 
1. Specific activity of bile salts (CPM nmol -1) 210 ± 43 381 t 54 488 ± 85 
(Fig. 6.5). 
2. pmol of HDL2 -free cholesterol degraded to 3.06 ± 0.63 5.57 ± 0.69 7.12 t 1.25 
3. 
4. 
bile salts nmol -1 of bile salts in the medium 
(Specific activity of HDL2 -free cholesterol 
line 1) 
Bile salts secreted into the medium 
(nmol mg -1 cell protein) 





-free cholesterol degraded to bile 8.14 ± 2.83 27.07 ± 4.06 39.44 ± 2.98 
salts i.e. line 2 x line 3 (pmol mg-1 of 
cell protein). 
5. of bile salts synthesised from HDL2 -free 
cholesterol (4 - 3 x 100). 
0.31 0.56 0.71 
Table 6.1 The degradation of HDL2 -free cholesterol to bile salts by rat hepatocyte 
monolayers. The proportion of bile -salts synthesised from HDL2 -free cholesterol by 
hepatocytes was calculated by comparing the specific activity of the bile salts with 
the specific activity of HDL2 -free cholesterol. The specific activity of the HDL2- 
free cholesterol was calculated to be 68452 CPM nmol 
_, 
Results show the mean of 
duplicate determinations from hepatocytes obtained from two rats. 
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is not a major source of cholesterol for degradation to bile salts. 
It therefore appears that the major source of cholesterol for the 
synthesis of bile salts in these incubations is cholesterol derived 
from HDL2- cholesteryl esters or from newly synthesised cholesterol. 
6.4.2 The contribution of HDL2 -cholesteryl ester to the synthesis 
of bile salts 
The contribution of HDL2 -cholesteryl ester in providing 
substrate for the synthesis of bile salts was determined by analysis 
of the culture medium after 3, 19 and 24h. The radioactivity 
associated with the bile salt fraction and the specific activity of 
the bile salts was determined in the same way as was described in 
section 6.4.1. The radioactivity associated with the bile salts 
steadily increased throughout the incubation (Fig. 6.6). 
A comparison of the specific activity of the cellular free 
cholesterol pool in hepatocytes incubated with HDL2- [4- 14C]cholesteryl 
oleate with the specific activity of the bile salts indicated that the 
specific activity of the free cholesterol was higher than the specific 
activity of the bile salts (Fig. 6.7). This is the opposite to what 
was observed when cells were incubated with HDL2- [4- 14C]cholesterol. 
This probably indicates that whilst HDL2 -cholesteryl esters can supply 
cholesterol for the synthesis of bile salts the preferred fate for 
this esterified cholesterol is into pathways other than the synthesis 
of bile salts i.e. lipoprotein cholesterol and biliary cholesterol. 
Having established that HDL2 -cholesteryl esters supply cholesterol for 
degradation to bile salts the contribution of cholesterol from this 
source to the synthesis of bile salts was determined. 
The results 
are shown in Table 6.2. The results show that all of the 
increase 
in the cholesterol required for the synthesis of bile 
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24 
Fig. 6.6 The degradation of HDL2- cholesteryl esters to bile salts 
by rat hepatocyte monolayers. The secretion of bile salts derived 
from HDL2- cholesteryl ester into the hepatocyte culture medium was 
determined as described in the text. The results shown are the 
mean ± the range of duplicate determinations from hepatocytes 















Incubation time (h) 
19 24 
Fig. 6.7 Comparison of the specific activity of the cell free 
cholesterol with the specific activity of the bile salts. 
Following incubation of hepatocytes with HDL2- [4- 14C]cholesteryl 
ester the specific activity of the hepatocyte free cholesterol 
(*---s) and the specific activity of the bile salts secreted into 
medium (o-o) was determined. The results are the mean ± the 




1. Specific activity of bile salts (CPM nmol -1) 
(Fig. 6.7). 
2. nmol of HDL2- cholesteryl ester degraded to 
bile salts nmol -1 of bile salts secreted into 
the medium. 
(Specific activity of HDL2 -cholesteryl ester 
line 1). 
3. Bile salts secreted into the medium (nmol mg -1 
4. 
5. 
3 19 24 
1.22 ± 0.42 1.76 ± 0.48 1.42 ± 0.60 
0.17 ± 0.04 0.24 ± 0.09 0.19 ± 0.08 
4.92 ± 0.92 6.76 ± 0.75 7.44 ± 1.30 
cell protein). 
Total HDL2 -cholesteryl ester degraded to bile 
salts i.e. line 2 x line 3 (nmol mg -1 of cell 
protein). 
0.81 1.62 1.43 
% of bile salts synthesised from HDL2 -cholesteryl 
esters. 
16.5 23.9 19.2 
Table 6.2 The degradation of HDL2 -cholesteryl esters to bile salts by hepatocyte 
monolayers. The proportion of bile salts synthesised from HDL2 -cholesteryl esters 
was determined by comparing the specific activity of the HDL2 -cholesteryl ester with 
the specific activity of the bile salts. The specific activity of the HDL2 - 
cholesterol that was esterified was 7.38 CPM nmol -1. The results shown are the 
mean . the range of duplicate determinations from hepatocytes obtained from 2 rats. 
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accounted for by degradation of HDL2- cholesteryl esters (Table 6.2). 
6.4.3 The secretion of cholesteryl esters by hepatocytes derived 
from HDL2 -free cholesterol 
In Chapter 6.3.1 we saw that on entry of HDL2 -free cholesterol 
into the hepatocyte a proportion is esterified. The cholesteryl 
ester pool within the hepatocyte primarily functions as a precursor 
site for the secretion of cholesteryl ester as a component of 
lipoproteins (Drevon et al., 1980). Following the determination 
of radioactivity attributable to cholesteryl esters in the hepatocyte 
culture medium, it was found that cholesteryl ester derived from 
HDL2 -free cholesterol was secreted into the medium at a steady rate 
(Fig. 6.8). A comparison of the CPM mg -1 of cell protein in the 
secreted cholesteryl esters with the CPM due to the HDL2 -free 
cholesterol provided an indication of the amount of HDL2 -free 
cholesterol used for the cholesteryl esters secreted as newly 
synthesised lipoproteins (Table 6.3). The results indicate that 
between 7 - 15 pmol of HDL2 -free cholesterol is utilized for 
secretion as cholesteryl esters per mg of hepatocyte cell protein. 
Whilst the utilization of hepatocyte cholesteryl ester by other 
pathways is possible, the contribution of this source of cholesterol 
to these pathways is probably negligible. The use of 
stored 
esterified cholesterol by the hepatocyte for pathways other 
than for 
secretion in lipoproteins requires hydrolysis by 
the cytosolic 
cholesterol esterase. It has been reported that 
in rat liver the 
activity of cytosolic cholesterol esterase does not 
provide a 
significant contribution to the degradation of 
hepatocyte cholesteryl 











Fig. 6.8 The utilization of HDL2 -free cholesterol by hepatocyte 
monolayers for the secretion of cholesteryl esters. The 
secretion of cholesteryl esters into the hepatocyte culture medium 
that were derived from HDL2 -free cholesterol was determined as 
described in the text. The results show the mean ± the range of 
duplicate determinations from hepatocytes obtained from 2 rats. 
 
Incubation time (h) 
HDL2 -free cholesterol in 
(pmol mg -1 of cell protein) 
1. Cell free cholesterol 
(CPM of cell free cholesterol mg -1 of cell 
protein = specific activity of HDL2 -free 
cholesterol). 
2. Cell cholesteryl esters 
(CPM of cell cholesteryl ester mg 
-1 
of cell 
protein = specific activity of HDL2 -free 
cholesterol). 
3. Cholesteryl ester secreted into the medium 
(CPM of medium cholesteryl ester mg -1 of 
cell protein ' specific activity of HDL2 -free 
cholesterol). 
4. Bile salts secreted into the medium 
(CPM due to bile salts in the medium mg -1 of 
cell protein = specific activity of HDL2 -free 
cholesterol). 
3 




5. Total. 104 ± 14 
6. nmol mg -1 of cellular protein of HDL2 -free 
cholesterol present at Oh. 
7. uptake i.e. line 5 = line 6 x 100. 
19 24 
91 ± 15 112 ± 8 
23 ±4 30 ±7 
16 ±5 13 ±2 
27 ± 5 39 ± 8 
157 ± 16 194 ± 20 
1.06 0.95 0.97 
9.8 16.5 20 
Table 6.3 Estimation of the uptake of HDL2 -free cholesterol by hepatocytes. Uptake 
of HDL2 -free cholesterol was calculated by addition of the pmol of HDL2 -free cholesterol 
present in the cells as free and esterified cholesterol with the pmol of HDL2 -free 
cholesterol secreted into the medium as bile salts and cholesteryl ester. The results 
shown are the mean ± range of duplicate determinations from hepatocytes obtained from 
2 rats. 
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6.4.4 The contribution of HDL2- cholesteryl ester to the secretion 
of free cholesterol by hepatocytes 
The radioactivity attributable to free cholesterol that was 
present in the medium was determined as described previously 
(Chapter 2.10). The results indicate that between 2 - 4 times as 
much HDL2 -cholesteryl ester is utilized for secretion as free 
cholesterol into the medium than is utilized for the synthesis of 
bile salts (Fig. 6.9). The radioactive free cholesterol that is 
secreted into the medium represents the secretion of biliary 
cholesterol and lipoprotein -free cholesterol by hepatocyte 
monolayers. Calculation of the nmol of HDL2 -cholesteryl ester 
that provides cholesterol for secretion as free cholesterol 
indicates that between 4 - 6 nmol of HDL2 -cholesteryl ester per 
mg of hepatocyte cell protein was utilized for this pathway. 
This compares with approximately 1.5 nmol of HDL2 -cholesteryl 
ester being utilized for the synthesis of bile salts (Table 6.4). 
6.5 The estimation of the uptake of HDL2- cholesterol by 
hepatocyte monolayers 
In Chapter 6.4 the fate of HDL2 -cholesterol after entry into 
hepatocytes was described. These results can also provide some 
indication as to the uptake of HDL2- cholesterol throughout the 
period of study. This will indicate the significance of the 
degradation of HDL2 -cholesterol by these hepatocytes monolayers. 
6.5.1 Estimation of the uptake of HDL2 -free cholesterol 
The uptake of HDL2 -free cholesterol was determined by 
calculation of the mass of HDL2 -free cholesterol that entered 















Incubation time (h) 
19 24 
Fig. 6.9 Secretion of free cholesterol derived from HDL2- 
cholesteryl esters by hepatocyte monolayers. The utilization 
of HDL2- cholesteryl ester for secretion as free cholesterol by 
hepatocytes was determined as described in the text. The 
results show the mean ± the range of duplicate determinations 
from hepatocytes obtained from 2 rats. 
Incubation time (h) 
esters 
HDL2- cholesteryljin 
(nmol mg -1 of cell protein) 
1. Cell free cholesterol 
(CPM of cell free cholesterol mg -1 
of cell protein = specific activity 
of HDL2 -cholesteryl ester). 
2. Cell cholesteryl esters 
(CPM of cell cholesteryl esters mg -1 
of cell protein = specific activity of 
HDL2 -cholesteryl ester). 
3. Free cholesterol secreted into the medium 
(CPH of medium cholesteryl ester mg -1 of 
cell protein 4-specific activity of HDL2 - 
cholesteryl ester). 
4. Bile salts secreted into the medium 
(CPM due to bile salts in the medium mg -1 
3 
46.10 t 5.60 
37.30 t 6.20 
5.56 ± 2.40 
1.21 ± 0.63 
19 
44.30 ± 6.20 
35.20 ± 4.30 
5.69 t 3.2 
1.76 ± 0.73 
24 
24.90 ± 3.70 
34.60 ± 5.75 
3.39 ± 1.60 
1.44 ± 0.54 
of cell protein = specific activity of 
HDL2 -cholesteryl ester. 
5. Total. 90.17 86.95 64.33 
6. nmol mg -I of cellular protein of HDL2 - 
cholesteryl ester present at Oh. 512.1 480 442 
7. % uptake i.e. line 5 = line 6 x 100. 17.6 18.1 14.5 
Table 6.4 Estimation of the uptake of HDL2 -cholesteryl esters by hepatocytes. Uptake 
of HDL2 -cholesteryl esters was calculated by addition of the nmol of HDL2 = cholesteryl 
ester present in the cells as free and esterified cholesterol with the nmol of HOL2- 
cholesteryl ester secreted into the medium as bile salts and free cholesterol. The 
results shown are the mean ± range of duplicate determinations from hepatocytes obtained 
from 2 rats. 
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and bile salts. It is important to note that the radioactivity 
present within the hepatocyte at any given time is not 
representative of the uptake of HDL2 -free cholesterol. It has 
already been shown that uptake of HDL2 -free cholesterol results 
in its utilization and subsequent secretion into the medium. 
It is therefore important that in obtaining an estimate of the 
uptake of HDL2 -free cholesterol by hepatocytes the appearance of 
this lipoprotein free cholesterol into the medium is also taken 
into account. A comparison of the pmol of HDL2 -free cholesterol 
present in the hepatocyte culture medium at Oh with the pmol of 
HDL2 -free cholesterol utilized by the hepatocytes provides an 
indication of the uptake of HDL2 -free cholesterol (Table 6.3). 
After 3h approximately 10% of HDL2 -free cholesterol had been taken 
up by hepatocytes and this increased to 20% after 24h. However, 
this estimate of uptake is less than the actual uptake of HDL2 -free 
cholesterol. The experiments undertaken do not allow determination 
of that HDL2 -free cholesterol in the form of biliary cholesterol or 
newly synthesised lipoproteins. However the values obtained at the 
very least provide a minimum estimate of the uptake of HDL2 -free 
cholesterol by hepatocyte monolayers. 
6.5.2 Estimation of the uptake of HDL2 -cholesteryl ester 
In Chapter 6.5.1 the uptake of HDL2 -free cholesterol was 
estimated. Using the same reasoning as was used for estimating 
the uptake of HDL2 -free cholesterol, the uptake of HDL2 -cholesteryl 
ester can be determined. In this case the nmol of HDL2 -cholesteryl 
ester that enters the hepatocyte and is utilized by the hepatocytes 
was determined (Table 6.4). The results indicate that after 3h of 
incubation of hepatocytes with HDL2 -cholesteryl ester approximately 
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16% of the HDL2- cholesteryl ester had been taken up. However at 
later time points the apparent uptake of HDL2 -cholesteryl ester by 
hepatocytes fell (Table 6.4). This may have been due to the 
utilization of HDL2 -cholesteryl ester for resecretion by hepatocytes 
as cholesteryl esters as a component of newly synthesised 
lipoproteins. This may explain the apparent decrease in the uptake 
of HDL2 -cholesteryl esters by hepatocytes during the incubation. 
As was indicated in Chapter 6.5.1 these values only provide a 
minimum estimate of the uptake of HDL2- cholesterol by hepatocyte 
monolayers. 
6.6 The effect of HDL2 on the synthesis of cholesterol by hepatocyte 
monolayers 
The results presented in Chapter 6.4 indicated that the increase 
in the synthesis of bile salts in the presence of HDL2 was all due to 
the catabolism of HDL2 -cholesteryl esters. This would result in 
there being no alteration in the contribution of newly- synthesised 
cholesterol to the synthesis of bile salts. To confirm this 
conclusion the effect of HDL2 on the synthesis of cholesterol by 
hepatocytes was determined. Synthesis of cholesterol was assessed 
by determination of the incorporation of [1- 14C]acetate into 
cholesterol. Following the incubation of hepatocytes with 
[1- 14C]acetate in the presence and absence of HDL2 the cells and 
medium were extracted as described previously (Chapter 2.10). The 
radioactivity attributable to free cholesterol in both the cells and 
medium was subsequently determined by t.l.c. as described in Chapter 
2.10.2. The newly- synthesised cholesterol that had been esterified 
was estimated after first hydrolysing the cholesteryl esters with 
alcoholic potassium hydroxide (0.5M potassium hydroxide in 90% (v/v) 
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ethanol) at 70 °C for 30 min. The lipids were then extracted from 
the hydrolysate and the radioactivity attributable to total free 
cholesterol determined (Chapter 2.10). 
The hydrolysis of the cholesteryl esters prior to determination 
of the radioactivity due to cholesterol was necessary as acetate is 
also a substrate for the synthesis of fatty acids following its 
activation by acetyl thiokinase. Determination of the radioactivity 
attributable to cholesteryl esters without prior hydrolysis would 
therefore result in an overestimate of the synthesis of cholesterol 
from [1- 14C]acetate. 
The results indicated that whilst the incorporation of 
[1- 14C]acetate into cholesterol in the presence of HDL2 is slightly 
increased this increase is not significant (Fig. 6.10). 
Furthermore, HDL2 did not affect that proportion of newly 
synthesised cholesterol that was esterified (Fig. 6.11). 
6.7 The effect of HDL2 on the utilization of newly -synthesised 
cholesterol for the synthesis of bile salts 
The utilization of newly -synthesised cholesterol for the 
synthesis of bile salts was estimated by measuring the incorporation 
of [1- 14C]acetate into bile salts. The radioactivity attributable 
to bile salts was determined as described previously (Chapter 2.10). 
The results show that HDL2 has no significant effect on the 
utilization of newly -synthesised cholesterol for the synthesis of 
bile salts (Fig. 6.12). 
The use of [14C]acetate for determination of the synthesis of 
cholesterol has been criticised by a number of workers (Dietschy 
and Brown, 1974; Dietschy and McGarry, 1974, Gibbons and Pullinger, 
1977) and it has been shown that the use of this substrate resulted 
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Incubation time (h) 
19 24 
Fig. 6.10 The effect of HDL2 on the synthesis of cholesterol by 
hepatocyte monolayers was determined by incubating hepatocytes in 
medium containing [14C]acetate in the absence (0-0) or presence 
(1,--18) of HDL2. The results shown are the mean ± range of 
duplicate determinations from hepatocytes obtained from 2 rats. 








Fig. 6.11 The effect of HDL2 on the esterification of newly 
synthesised cholesterol by hepatocyte monolayers. The 
esterification of newly synthesised cholesterol was determined 
by the difference in the radioactivity due to free cholesterol 
before and after hydrolysis of the cholesteryl esters with 
alcholic potassium hydroxide. The esterification of newly 
synthesised cholesterol in the presence (s s) and absence 
(O-O) of HDL2 was thus determined. The results are 
the mean 
± range of duplicate determinations from hepatocytes obtained 
from 2 rats. 





Incubation time (h) 
19 24 
Fig. 6.12 The effect of HDL2 on the utilization of newly 
synthesised cholesterol for the synthesis of bile salts by rat 
hepatocyte monolayers. The utilization of newly synthesised 
cholesterol for the synthesis of bile salts by hepatocyte 
monolayers in the presence (s--s) and absence (o--0) of HDL2 
was determined as described in the text. Results are mean ± 
range of duplicate determinations from hepatocytes obtained 
from 2 rats. 
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in an underestimate of sterol synthesis. However, in comparative 
studies where the quantitative synthesis of cholesterol is not 
under investigation the use of this substrate should provide a 
useful method for assessing effects on cholesterol synthesis. 
6.8 Discussion 
The experiments described in this chapter were designed in an 
attempt to explain the observed increase in the synthesis of bile 
salts when hepatocytes isolated from rats fed cholestyramine were 
incubated with HDL2. 
The first objective was to prepare rat HDL2 radiolabelled in 
either the free cholesterol or cholesteryl ester moiety. 
Radiolabelling of HDL2 -free cholesterol with [4- 
14C]cholesterol 
was 
easily achieved as free cholesterol can readily exchange. 
Radiolabelling with [4- 14C]cholesterol was facilitated by incubating 
HDL2 with filter paper discs impregnated with [4- 14C]cholesterol. 
However radiolabelling of HDL2- cholesterol esters presents certain 
problems. HDL2 -cholesteryl ester can be labelled by:- 
1) injection of radioactive free cholesterol into rats followed 
by isolation of HDL from the plasma (Sigurdsson et al., 1979). 
2) incubation of plasma with radioactive free cholesterol 
followed by isolation of HDL (Drevon et al., 1977). In 
this method the radioactive free cholesterol is incorporated 
into the free cholesterol on the surface of the lipoprotein 
particles. The HDL -free cholesterol is then esterified by 
the action of LCAT. Following esterification the cholesteryl 
esters are internalised. 
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3) HDL2- cholesteryl esters can be labelled by transfer of 
radioactive cholesteryl ester from a lipid microemulsion 
to the HDL (Craig et al., 1983). The transfer of the 
cholesteryl ester is facilitated by a cholesteryl ester 
transfer protein that is present in the plasma of certain 
species (Chapter 1.2.4). 
Whilst methods 1 and 2 allow radiolabelling of the HDL2 - 
cholesteryl ester the HDL2 -free cholesterol is also radiolabelled. 
However it has been reported that most of the radioactive free 
cholesterol can be removed by exchange with hepatocytes (Drevon 
et al., 1977). However, for the experiments described in this 
chapter HDL2 was labelled in the cholesteryl ester moiety using 
method 3 (Chapter 2.8.2). This enabled only the cholesteryl 
ester moiety to be labelled. However there were some 
disadvantages. Firstly the specific activity of the HDL2 - 
cholesteryl ester is relatively low compared with the other 
methods and secondly the labelling procedure is harsh. This 
resulted in the loss of certain apoproteins (Fig. 6.1). It is 
possible that the loss of these apoproteins from the HDL2 may 
result in poorer uptake of the HDL2 particle by hepatocyte 
monolayers. The HDL2 radiolabelled with [4- 14C]cholesteryl 
oleate was also found to be contaminated with albumin. It is 
probable that the source of this contamination is the human 
plasma used as a source of the cholesteryl ester transfer protein. 
However, the anomalies in the protein content of this HDL2 did 
not affect the increase in the synthesis of bile salts by rat 
hepatocytes incubated in the presence of HDL2, that was previously 
described in Chapter 5. 
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The results have shown that HDL2- cholesterol enters the 
hepatocyte from which it can be utilized by numerous pathways. 
Estimation of the uptake of HDL2 -cholesteryl ester and HDL2 -free 
cholesterol by hepatocytes indicated that uptake of HDL2 after 
24h was 14% and 20% respectively. However, as was stated 
previously (Chapter 6.5) these values are the minimum estimates 
for the uptake of the HDL2- cholesterol fractions. In those 
hepatocytes incubated in the presence of HDL2 labelled with 
[4- 
14C]cholesterol, 
analysis of the medium enabled the 
determination of the role of HDL2 -free cholesterol in supplying 
cholesterol for degradation to bile salts and for secretion as 
cholesteryl esters. The secretion of cholesteryl esters into 
the medium by hepatocytes reflects the secretion of newly - 
synthesised lipoproteins by hepatocytes (Drevon et al., 1980). 
However, the presence of the HDL2 in the culture medium prevented 
the determination of mass measurements of cholesterol and 
cholesteryl esters secreted into the medium. The presence of 
HDL2- [4- 
14 
C]cholesterol also prevented the assessment of the 
utilization of HDL2 -free cholesterol for secretion as biliary 
cholesterol and lipoprotein -free cholesterol by hepatocytes. 
When hepatocytes were incubated with HDL2 labelled with 
[4- 14C]cholesteryl oleate, analysis of the medium enabled the 
contribution of HDL2 -cholesteryl ester in supplying cholesterol 
for the synthesis of bile salts to be determined. Whereas in 
those incubations of hepatocytes with HDL2 labelled with 
[4- 14C]cholesterol the secretion of radiolabelled cholesteryl 
esters could be detected, this pathway could not be assessed in 
those experiments where hepatocytes were incubated with HDL2 
labelled in the cholesteryl ester moiety. However, the 
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contribution of HDL2 -cholesteryl esters to the secretion of biliary 
cholesterol and lipoprotein -free cholesterol was determined. 
In these experiments differentiation between the biliary free 
cholesterol and lipoprotein -free cholesterol secreted into the 
medium by hepatocytes was not attempted. Although these 
experiments allowed estimation of the uptake of HDL2- cholesterol 
it is important to understand that the limitations of these 
experiments do not allow an absolute determination. 
The major objective of these studies was to determine the 
contribution of HDL2- cholesterol to the synthesis of bile salts 
and to explain the observed increase in the synthesis of bile salts 
by hepatocyte monolayers incubated with HDL2. The experiments 
using HDL2 labelled with either [4- 14C]free cholesterol or 
[4- 14C]cholesteryl oleate indicated that the increase in the 
synthesis of bile salts was due to the degradation of HDL2 - 
cholesteryl esters to bile salts (Table 6.2). The mass of HDL2 - 
cholesteryl esters degraded to bile salts also indicated that the 
contribution of newly synthesised cholesterol to the synthesis of 
bile salts might be decreased when hepatocytes were incubated in 
the presence of HDL2. However the experiments with [14C]acetate 
indicated that this was not the case. The apparent overestimate 
of the contribution of HDL2 -cholesteryl ester to the synthesis of 
bile salts is not significant (see Table 6.2). The results in 
this chapter,- together with the current evidence that is available, 
suggest that the increase in the synthesis of bile salts by 
hepatocytes in the presence of HDL2, reflects a deficiency in the 
cholesterol available for degradation to bile salts, 
in those 
hepatocyte incubations which do not have an exogenous 
source of 
cholesterol. In vivo, the supply of cholesterol 
for the synthesis 
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of bile salts is derived from both the plasma and from endogenous 
synthesis in the liver. Feeding cholestyramine results in an 
increase in the synthesis of bile salts (see Chapter 4) which 
therefore results in an increase in the demand for substrate i.e. 
cholesterol. In the rat it is likely that the increased 
cholesterol required as a result of stimulating bile salt 
synthesis is provided by an increase in hepatic cholesterol 
synthesis (Koelz et al., 1982). Interruption of the 
enterohepatic circulation therefore results in a greater 
percentage of the bile salts synthesised being derived from 
newly- synthesised cholesterol (Long et al., 1978). However, in 
vivo a proportion of the bile salts would still be synthesised 
from cholesterol derived from the plasma. In an isolated cell 
system such as the hepatocyte monolayers used in this study, the 
plasma cholesterol no longer provides a source of substrate for 
the synthesis of bile salts. If in these hepatocytes the 
synthesis of cholesterol was maximally stimulated due to feeding 
cholestyramine, removal of the source of exogenous cholesterol 
would result in the hepatocytes becoming deficient in 
metabolically active cholesterol i.e. that cholesterol used to 
supply substrate for the synthetic and degradative pathways 
within the hepatocyte and not that cholesterol performing a 
structural role. This deficiency of cholesterol in hepatocytes 
isolated from rats fed cholestyramine would result in the 
synthesis of bile salts being limited by the supply of cholesterol 
Addition of lipoprotein- cholesterol to the medium, in this case 
HDL2, restored the supply of cholesterol thereby resulting in 
an 
increase in the synthesis of bile salts. There 
are numerous 
reports which would seem to support this explanation. 
In 
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Chapter 5 it was suggested that one reason for the increase in 
the synthesis of bile salts, in the presence of HDL2 by 
hepatocytes obtained from animals fed cholestyramine, was an 
increase in the uptake of HDL2. However evidence by Koelz 
et al., (1982) has shown that cholestyramine -feeding does not 





synthesis of cholesterol by the liver in the rat has been shown 
to be quantitatively more important than in other species 
(Koelz et al., 1982; Turley et al., 1981; Spady and Dietschy, 
1983). In particular synthesis of cholesterol in the rat is 
subject to greater fluctuations under the influence of external 
stimuli than is known to occur in other species. Koelz et al., 
(1982) therefore suggested that the increase in the synthesis of 
cholesterol on feeding cholestyramine is sufficient to meet the 
requirements for cholesterol by the liver and it is therefore 
unecessary for an increase in the uptake of plasma cholesterol 
by the liver in rats. In other species such as the rabbit and 
human where cholesterol synthesis cannot be induced to the same 
extent as in the rat, feeding cholestyramine will result in an 
increase in the uptake of plasma lipoproteins by the liver 
(Slater et al., 1980; Shepherd et al., 1980). 
In Chapter 5, it was also reported, that HDL2 did not 
affect the synthesis of bile salts by hepatocytes obtained 
from 
animals fed a pellet diet. This observation may 
also reflect 
the efficient regulation of cholesterol synthesis 
by the rat. 
In isolated hepatocytes in suspension the synthesis 
of 
cholesterol increases with incubation time (Edwards, 
1975), as 
does the contribution of newly- synthesised 
cholesterol to the 
synthesis of bile salts (Kempen et al., 1983). 
The addition of 
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HDL2 to the culture medium may result in HDL2- cholesterol being 
utilized for the synthesis of bile salts and an inhibition of the 
stimulation of cholesterol synthesis that is observed in the 
absence of exogenous cholesterol. This may then result in no 
alteration in the synthesis of bile salts but produce a decrease 
in the contribution of newly- synthesised cholesterol to the 
synthesis of bile salts. At the present time the effect of 
HDL2 on cholesterol metabolism by hepatocytes prepared from rats 
fed a standard pellet diet is not well defined and will require 
further investigation (Chapter 7). 
In conclusion, the effect of HDL2 on the synthesis of bile 
salts by hepatocyte monolayers appears to reflect the 
nutritional status of the rats used for the preparation of 
hepatocytes. Although hepatocytes obtained from rats fed 
cholestyramine appear to be deficient in cholesterol, this 
system should still prove useful in further experiments 
(Chapter 7). 
Footnote. 
It must be pointed out that the large amount of cholesteryl ester 
transferred to the hepatocytes from HDL2 (Table 6.4), is inconsistent 
with the effect of HDL2 on the total cellular cholesterol content of 
hepatocytes described earlier (Chapter 5.4, Fig. 5.7). This 
inconsistency is most likely due to the errors involved in calculating 
the specific activity of HDL2 cholesteryl ester. However, it is also 
possible that uptake of large amounts of HDL2 -cholesteryl ester by 
hepatocytes results in the secretion of cholesteryl esters in the form 
of lipoproteins. This would result in no nett change in the cellular 
cholesterol content of hepatocytes. 
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CHAPTER 7 
FINAL CONCLUSIONS AND FURTHER EXPERIMENTS 
7.1 Overall Summary 
The major aims of this project were to characterise an in vitro 
system suitable for the long term study of bile salt synthesis and 
then to use this system to investigate the utilization of plasma 
cholesterol for the synthesis of bile salts. 
The system used was isolated rat hepatocytes maintained in 
monolayers. The integrity of this system was assessed by the 
viability of the hepatocytes, together with their ability to 
synthesise bile salts (Chapters 3 and 4). After the determination 
of suitable conditions for the maintenance of hepatocytes the effect 
of a HDL subfraction (HDL2) on the synthesis of bile salts by 
hepatocyte monolayers was investigated. The results in this thesis 
are summarised below:- 
(1) rat hepatocytes of excellent viability were isolated using 
a recirculating perfusion system. Many of the problems 
associated with obtaining a viable cell preparation were 
overcome by centrifugation of the freshly isolated 
cells 
on a 'Percoll' density gradient, 
(2) hepatocytes were maintained in monolayers 
for up to 24h 
during which time their metabolic integrity remained 
intact (Chapter 3). 
hepatocyte monolayers were shown to synthesise 
and secrete 
the major bile acid conjugates synthesised 
by the rat i.e. 
conjugated cholic, chenodeoxycholic 
and -muricholic acids, 
(3) 
101 
(4) alteration of the rates of bile salt synthesis in vivo by 
dietary manipulation was reflected in the rate of bile 
salt synthesis by the hepancyte monolayers prepared from 
these rats. 
(5) incubation of hepatocytes isolated from rats fed the 
pellet diet with a defined HDL subfraction (HDL2) had no 
effect on the total synthesis of conjugated cholic, 
chenodeoxycholic and ß- muricholic acids (Chapter 5). 
(6) however, incubation of hepatocyte monolayers with HDL2 
was found to increase the synthesis of total bile salts 
i.e. conjugated cholic + chenodeoxycholic + ß- muricholic 
acids when hepatocytes were prepared from rats previously 
fed cholestyramine (Chapter 5). 
the increase in the synthesis of bile salts by these 
hepatocytes is tentatively ' attributed to the utilization 
(8) 
of HDL2 -esterified cholesterol for the synthesis of bile 
salts (Chapter 6). 
HDL2 did not affect the synthesis of cholesterol or the 
utilization of newly synthesised cholesterol for the 
synthesis of bile salts (Chapter 6). 
The results in this thesis have shown that rat hepatocytes 
maintained in monolayers are suitable for the investigation of 
various aspects of bile salt synthesis. In particular, the system 
has proved to be suitable for the investigation of the degradation 
of lipoprotein cholesterol to bile salts. However, the experiments 
described have certain limitations:- 
1' The possible errors involved in calculating the specific activity 
of HDL2- cholesteryl ester may result in this conclusion being invalid. 
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(a) The detection of the bile salts synthesised by hepatocyte 
monolayers by using specific radioimmunoassays is confined 
to the measurement of conjugated cholic, chenodeoxycholic 
and ß- murichoiic acids. Although these are the major 
primary bile acids synthesised by the rat it is possible 
that other bile salts may be synthesised (Chapter 7.2). 
However, in rat hepatocytes maintained in suspension it 
has been reported that these three bile salts account for 
at least 95% of the total bile salts synthesised (Kempen 
et al., 1982). Current evidence would seem to indicate 
that this is also the case in hepatocytes maintained in 
monolayers (Davis et al., 1983a; R.A. Davis, personal 
communication). 
(b) In those experiments in which degradation of 
HDL2- [4- 14C]cholesterol and HDL2- [4- 14C]cholesteryl oleate 
to bile salts was determined, the method for determination 
of the radioactivity associated with the bile acids had 
certain limitations. To measure the radioactivity 
associated with the bile salts samples were first 
subjected to t.l.c. The solvent system used resulted in 
poor resolution of the individual bile salts and only 
took into account the taurine conjugates. It is of course 
possible that glycine conjugates are also synthesised by 
hepatocytes. In rat hepatocytes maintained in suspension 
the synthesis of both taurine and glycine conjugates of 
bile acids has been reported (Kempen et al., 1982). 
However, in this report addition of taurine to 
the 
incubation medium resulted in the synthesis 
of only taurine 
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conjugated - bile acids, indicating that hepatocytes were 
initially deficient in taurine (Kempen et al., 1982). 
The results, therefore, indicated that taurine conjugates 
were the preferred bile acid conjugates synthesised and 
glycine conjugates were only synthesised when there was a 
deficiency of taurine. Whilst it is possible that in 
this present study glycine conjugated bile acids are 
synthesised it is probably unlikely due to the complex 
culture medium used. This conclusion requires to be 
substantiated. A further disadvantage of the separating 
system used is the poor resolution. This prevents the 
possible investigation of the individual bile acids being 
synthesised from separate substrate pools. (Chapter 1.4.2). 
(c) A further limitation of the experiments with HDL2 is that 
these studies do not indicate the mechanism of HDL2 uptake 
into the hepatocytes. Preliminary studies do however 
suggest that a specific uptake mechanism is required. 
Incubation of hepatocytes with human VLDL, LDL and HDL at 
comparable concentrations to those used with rat HDL2, were 
found not to affect the synthesis of bile salts (results 
not shown). It is now well established that heterologous 
lipoproteins are not recognised by rat hepatocytes with the 
same efficiency as homologous rat lipoproteins (Koelz 
et al., 1982). The finding that the human lipoproteins do 
not affect the synthesis of bile salts by rat hepatocytes 
would seem to indicate that specific receptor- mediated 
uptake of HDL2 is required for degradation of the HDL2 - 
cholesterol to bile salts. However, it is important to 
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note that these human lipoprotein fractions were only 
characterised by their flotation in salt solutions 
following ultracentrifugation. 
7.2 Further experiments 
The results presented in this thesis whilst increasing our 
knowledge of certain aspects of the degradation of cholesterol to 
bile salts, have left a number of questions unanswered. For 
example:- 
(i) do conjugated cholic, chenodeoxycholic and ß- muricholic 
acids actually represent greater than 90% of the bile 
salts synthesised by rat hepatocyte monolayers? 
(ii) What effect does HDL2 have on cholesterol synthesis in 
hepatocytes isolated from rats fed the pellet diet? 
(iii) Is HDL2 used for the synthesis of bile salts by hepatocytes 
isolated from rats fed the pellet diet? 
(iv) Do the individual bile acids arise from separate precursor 
pools? 
(y) Is there any difference in the utilization of cholesterol 
from other lipoprotein classes for the synthesis of bile 
salts. 
There follows some suggestions for ways of obtaining answers 
to these questions. 
The major problem of using radioimmunoassays for the 
detection 
of bile salts is that a profile of the possible 
bile salts synthesised 
cannot be obtained. The use of high performance 
liquid 
chromatography (HPLC) should enable the determination 
of the profile 
of bile salts synthesised by hepatocytes. 
This method has a distinct 
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advantage over methods such as gas -liquid chromatography as lengthy 
extraction procedures and the derivitisation of bile acids are not 
required. HPLC has already been used successfully in obtaining a 
profile of bile salts in the bile of humans and rats (Bloch and 
Watkins, 1978; Shaw et al., 1978; Mingrone & Greco, 1980). The 
use of HPLC should refute or substantiate the assumption that 
greater than 90% of the bile salts synthesised by hepatocyte 
monolayers consists of conjugated cholic, chenodeoxycholic and 
ß- muricholic acids. Further advantages of using HPLC for the 
separation of bile salts include the analysis of the radioactivity 
in individual bile salts that are produced by hepatocytes incubated 
in the presence of radioactive precursors. 
The questions raised with respect to the effects of HDL2 on 
the synthesis of cholesterol and the utilization of HDL2- cholesterol 
for the synthesis of bile salts, in hepatocytes isolated from rats 
fed the pellet diet can be answered by using the methods already 
described with hepatocytes isolated from rats fed cholestyramine. 
However, perhaps the most intriguing question yet to be answered is 
whether a particular lipoprotein class is preferentially utilised 
for the synthesis of bile salts or indeed contributes greater 
amounts of substrate for degradation to bile salts. It 
would be 
of particular interest to determine the effect of the delivery 
to 
the liver of dietary cholesterol in the form of chylomicron 
remnants 
and cholesterol from peripheral tissues by HDL1 
following the plasma 
catabolism of HDL2. Using the protocol already 
described for the HDL2 
studies in this thesis the utilization of cholesterol 
from these 
sources for the synthesis of bile salts could 
be determined. 
There is one final question that has 
not yet been considered. 
In Chapter 1 the complex metabolism of the 
plasma lipoproteins 
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and the importance of certain plasma enzymes was discussed. There 
is considerable evidence to indicate that two of these enzymes, 
LCAT and hepatic lipase are synthesised by the liver from where 
they are secreted into the plasma (Jansen & Hulsmann, 1974; Nordby 
et al., 1976). It is possible that the synthesis of these enzymes 
by hepatocyte monolayers and their subsequent secretion into the 
culture medium could affect the metabolism of added lipoproteins. 
It remains to be seen whether these enzymes are actually synthesised 
and secreted by hepatocyte monolayers in significant quantities 
that would alter the metabolism of lipoproteins by hepatocytes. 
In conclusion, the hepatocyte monolayer system described in 
this thesis is an important addition to the methods available to 
study the catabolism of cholesterol to bile acids. The system 
has the obvious advantage that the contribution of specific 
lipoprotein classes to the delivery of cholesterol to the 
for degradation to bile acids can be studied without the inherent 
disadvantages of the processes of transfer and exchange of 
components between lipoprotein classes that occur in vivo. The 
apparent deficiency of cholesterol available for degradation to 
bile acids in hepatocytes isolated from rats fed cholestyramine 
appears to provide a system where the requirement for exogenous 
cholesterol is at a premium. This system may therefore provide 
a unique means of assessing the utilization of cholesterol for 




Abrams, J.J. and Grundy, S.M. (1981) J. Lipid Res. 22, 323 - 338. 
Andersen, J.M. and Dietschy, J.M. (1977a) J. Biol. Chem. 252, 
3646 - 3651. 
Andersen, J.M. and Dietschy, J.M. (1977b) J. Biol. Chem. 252, 
3652 - 3659. 
Anwer, M.S., Kroker, R. and Hegner, D. (1975) Biochim. Biophys. 
Res. Commun. 64, 603 - 609. 
Anwer, M.S., Kroker, R. and Hegner, D. (1976) Biochim. Biophys. 
Res. Commun. 73, 63 - 71. 
Attie, A.D., Pittman, R.C. and Steinberg, D. (1982) Hepatology 2, 
269 - 281. 
Ayaki, Y., Tsuma - Date, T., Endo, S. and Ogura, M. (1981) Steroids 
38, 495 - 510. 
Balasubramaniam, S., Mitropoulos, K.A. and Myant, N.B. (1973) 
Eur. J. Biochem. 34, 77 - 83. 
Barter, P.J., Hopkins, G.J. and Calvert, G.D. (1982) Biochim. 
Biophys. Acta 713, 136 - 148. 
Barter, P.J. and Lally, J.I. (1978) Biochim. Biophys. Acta 531, 
233 - 236. 
Basu, S.K., Goldstein, J.L., Anderson, R.G.W, and Brown, M.S. 
(1976) Proc. Natl. Acad. Sci. (U.S.A.) 73, 3178 - 
3182. 
Baur, H., Kasperek, S. and Pfaff, E. (1975) Hoppe- Seyler's 
Z. Physiol. Chem. 356, 827 - 838. 
Beckett, G.J., Corrie, J.E,T. and Percy -Robb, I.W. 
(1979) Clin. 
Chim. Acta 93, 145 - 150. 
108 
Beckett, G.J., Hunter, W.M. and Percy -Robb, I.W. (1978) Clin. Chim. 
Acta 88, 257 - 266. 
Beisiegel, U., Kita, T., Anderson, R.G.W., Schneider, W.J., Brown, 
M.S. and Goldstein, J.L. (1981) J. Biol. Chem. 256, 
4071 - 4078. 
Berg, T. and Inversen, J.G. (1976) Acta Physiol. Scand. 97, 
202 - 208. 
Bergmeyer, H.U. and Bernt, E. (1974) in Methods of Enzymatic 
Analysis (Bergmeyer, H.U., ed.) Vol. 2, pp. 574 - 579 
Academic Press, New York. 
Bergstrom, S., Linstredt, S., Samuelsson, B., Corey, E.J. and 
Gregoriou, G.S. (1958) J. Amer. Chem. Soc. 80, 2337 - 2338. 
Bergstrom, S. and Norman, A. (1953) Proc. Soc. Exp. Biol. Med. 
83, 71 - 74. 
Berry, M.N. and Friend, D.S. (1969) J. Cell Biol. 43, 506 - 520. 
Bilheimer, D., Watanabe, Y. and Kita, T. (1982) Proc. Natl. Acad. 
Sci. (U.S.A.) 79, 3305 - 3309. 
Bissel, D.M. and Guzelian, P.S. (1979) Arch. Biochem. Biophys. 
192, 569 - 576. 
Bissel, D.M., Hammaker, L.E. and Meyer, U.A. (1973) J. Cell Biol. 
59, 722 - 734. 
Bjorkhem, I. and Danielsson, H. (1975) Eur. J. Biochem. 53, 
63 - 70. 
Bjorkhem, J. and Lewenhaupt, A. (1979) J. Biol. Chem, 254, 
5252 - 5256. 
Bloch, C.A. and Watkins, J.B. (1978) J. Lipid Res. 19, 510 - 513. 
Boney, R.J. (1974) In Vitro 10, 130 - 142. 
Botham, K.M. (1984) in "Cholesterol 7a- Hydrolase" Ed. R. Fears 
and 
J.R. Sabine, CRC press Boca Raton, Fl., U.S.A. (in 
the press). 
109 
Botham, K.M., Beckett, G.J., Percy -Robb, I.W. and Boyd, G.S. (1980) 
Eur. J. Biochem. 103, 299 - 305 (1980). 
Botham, K.M. and Boyd, G.S. (1979) Eur. J. Biochem. 95, 533 - 542. 
Botham, K.M. and Boyd, G.S. (1983a) Eur. J. Biochem. 134, 191 - 196. 
Botham, K.M. and Boyd, G.S. (1983b) Eur. J. Biochem. 136, 313 - 319. 
Botham, K.M., Boyd, G.S., Williamson, D. and Beckett, G.J. (1983) 
FEBS Lett, 151, 19 - 21. 
Botham, K.M., Suckling, K.E. and Boyd, G.S. (1984) FEBS Lett. 
Boyd, G.S. and Lawson, M.E. (1970) Atherosclerosis, Ed. R.J. Jones, 
Heidelberg, Springer Verlag, p. 286 - 289. 
Boyd, G.S., Mitton, J.R., Simpson, E.R. and Sulimovici, S.L. (1967) 
Ed. V - 2 Proceedings of the 7th Int. Congress on Biochemistry. 
Boyd, G.S. and Percy -Robb, I.W. (1971) Am. J. Med. 51, 580 - 587. 
Boyd, G.S., Scholan, N.A. and Mitton, J.R. (1969) "Proceedings of 
the 3rd Int. Symposium on Drugs Affecting Lipid Metabolism ", 
Milan (Ed. W.L. Holmes, L.A. Carlson, R. Paloetti) N.Y. and 
London, Plenum Press. 
Bradford, M.M. (1976) Anal. Biochem. 72, 248 - 254. 
Breslow, J.L., Lothrop, D.A., Clowes, A.W. and Lux, S.E. (1977) 
J. Biol. Chem. 252, 2726 - 2733. 
Brown, M.S., Dana, S.E. and Goldstein, J.L. (1975) J. Biol. Chem. 
250, 4025 - 4027. 
Brown, M.S., Kovanen, P.T. and Goldstein, J.L. (1981) Science 
212, 
628 - 635. 
Brydon, W.G., Tadesse, K., Eastwood, M,A. and Lawson, 
M.E. (1980) 
Br. J. Nutr. 43, 101 - 106. 
110 
Callandra, S., Pasquali-Ronchetti, I., Gherardi, E., Fornieri, C. 
and Tarugi, P. (1977) Atherosclerosis 28, 369 - 387. 
Carew, T.E., Pittman, R.C. and Steinberg, D. (1982) J. Biol. Chem. 
257, 8001 - 8008. 
Carlson, L.A. and Bottiger, L.E. (1972) Lancet (i) 865 - 868. 
Chao, Y.S., Yamin, T -T and Alberts, A.W. (1982) J. Biol. Chem. 257. 
3623 - 3625. 
Chapman, M.J. (1980) J. Lipid Res. 21, 789 - 853. 
Cole, T.G., Wilcox, H.G. and Heimberg, M. (1982) J. Lipid Res. 
23, 81 - 91 
Cooper, A.D., Erickson, S.K., Nutik, R. and Shrewsbury, M.A. (1982) 
J. Lipid Res. 23, 42 - 52. 
Cornell, N.W., Lund, P. and Krebs, H.A. (1974) Biochem. J. 142, 
327 - 337. 
Craig, I.F., Via, D.P., Sherrill, Sklar, L.A., Mantuling, W.W., 
Gotto, A.M. and Smith, L.C. (1982) J. Biol. Chem. 257, 330 - 335. 
Crisp, D.M. and Pogson, C.I. (1972) Biochem. J. 126, 1009 - 1023. 
Danielsson, H., Einarsson, K. and Johansson, G. (1967) Eur. J. 
Biochem. 2, 44 - 49. 
Danielsson, H. and Sjovall, J. (1975) Ann. Rev. Biochemo 44, 
233 - 253. 
Danielsson, H. and Wikvall, R. (1981) Biochim. Biophys. Res. Commun. 
103, 46 - 51. 
Davis, R.A., Engelhorn, S.C., Pangburn, S.H., Weinstein, D.B. and 
Steinberg, D. J. Biol. Chem. 254, 2010 - 2016 (1979). 
Davis, R.A., Engelhorn, S.C., Weinstein, D.B. and Steinberg, 
D. 
(1980) J. Biol. Chem. 255, 2039 - 2045. 
111 
Davis, R.A., Highsmith, W.E., Malone -McNeal, M., Archambault- 
Schexnayder, J. and Kuan, J -C.W. (1983a) 258, 4079 - 4082. 
Davis, R.A., Hyde, P.M., Kuan, J -C.W., Malone -McNeal, M. and 
Archambault -Schexnayder (1983b) 258, 3661 - 3667. 
Dazord, A., Gallet, D. and Saez, J.M. (1977) Biochim. Biophys. 
Res. Commun, 76, 1238 - 1246. 
Dietschy, J.M. (1968) J. Lipid Res. 9, 297 - 309. 
Dietschy, J.M. and Brown, M.L. (1974) 15, 508 - 516. 
Dietschy, J.M. and McGarry, J.D. (1974) 249, 52 - 58. 
Dolphin, P.J. (1981) J. Lipid Res. 22, 971 - 989. 
Douglas, M. and Butow, R.A. (1976) Proc. Natl. Acad. Sci. (U.S.A.) 
73, 1083 - 1086. 
Drevon, C.A., Berg, T. and Norsum, K.R. (1977) Biochim. Biophys. 
Acta 487, 122 - 136 (1977). 
Drevon, C.A., Weinstein, D.B. and Steinberg, D. (1980) J. Biol. 
Chem. 255, 9128 - 9137. 
Durrington, P.N., Newton, R.S., Weinstein, D.B. and Steinberg, D. 
(1982) J. Clin. Invest. 70, 63 - 73. 
Edwards, P.A. (1975) Biochim. Biophys. Acta 409, 39 - 50. 
Elliott, W.H. and Hyde, P.M. (1971) Am. J. Med. 51, 568 - 
579. 
Erlanger, B.F., Borek, F., Beiser, S.M. and Lieberman, S. 
(1957) 
J. Biol. Chem. 228, 713 - 727. 
Faergeman, 0. and Havel, R.J. (1975) J. Clin. Invest. 
55, 
1210 - 1218. 
Fears, R. and Morgan, B. (1976) Biochem. 
J. 158, 53 - 60. 
Fielding, C.J , Shore, V.G. and Fielding, 
P.E. (1972) Biochim. 
Biophys. Res. Commun. 46, 
1493 - 1498. 
112 
Folch, J., Lees, M. and Sloane -Stanley, G.H. (1957) J. Biol. Chem. 
226, 497 - 510. 
Forte, T.M. (1984) Ann. Rev. Physiol. 46, 403 - 415. 
Gamble, W., Vaughan, M., Kruth, H. and Avigan, J. (1978) J. Lipid 
Res. 19, 1068 - 1070. 
Gardner, B. and Chenouda, M.S. (1978) J. Lipid Res. 19, 985 - 991. 
Ghiselli, G.C., Angelucci, R., Regazzoni, A. and Sitori, C.R. (1981) 
FEBS Lett. 125, 60 - 64. 
Gibbons, G.F. and Pullinger, C.R. (1977) Biochem. J. 162, 321 - 330. 
Glomset, J.A. (1968) 9, 155 - 167. 
Goldstein, J.L. and Brown, M.S. (1974) J. Biol. Chem. 249, 5153 - 5162. 
Goldstein, J.L., Kita, T. and Brown, M.S. (1983) New Eng. J. Med. 309, 
288 - 296. 
Gorban, A. (1980) Ph.D. Thesis, University of Edinburgh. 
Green, P.H.R. and Glickman, R.M. (1981) J. Lipid Res. 22, 1153 - 1173. 
Green, P.H.R., Glickman, R.M., Saudek, C.D., Blum, C.B. and Tall, A.R. 
(1979) J. Clin. Invest. 64, 233 - 242. 
Halloran, L.G., Schwartz, C.C., Vlahcevic, Z.R., Nisman, R.M. and 
Swell, L. (1978) Surgery 84, 1 - 7. 
Hamilton, R.L., Williams, M.C., Fielding, C.J. and Havel, R.J. (1976) 
J. Clin. Invest. 58, 667 - 680. 
Havel, R.J. (1980) Ann. N.Y. Acad. Sci. 348, 16 - 25. 
Havel, R.J., Eder, H.A. and Pragdon, J.H. (1955) J. Clin. 
Invest. 34, 
1345 - 1353. 
Henrikson, T., Evensen, S.A., Blomhoff, J.P., Torsvik. 
H. and 
Carlander, B. (1979) Biochim. Biophys. Acta 
574, 312 - 320. 
113 
Higgins, M., Kawachi, T. and Rudney, H. (1971) Biochim. Biophys. 
Res. Commun. 45, 138 - 144. 
Hoffman, N.E., Iser, J.H. and Smallwood R.A. (1975) Am. J. Physiol. 
229, 298 - 302. 
Hook, M., Rubin, K., Oldberg, A., Obrink, B. and Vaheri, A. (1977) 
Biochim. Biophys. Res. Commun. 79, 726 - 733 (1977). 
Horiuti, Y., Nakamura, T. and Ichihara, A. (1982) J. Biochem. 92, 
1985 - 1994. 
Huff, J.W., Gillfillan, J.L. and Hunt, V.M. (1963) Proc. Soc. Exp. 
Biol. 114, 352 - 355. 
Hui, D.Y., Innerarity, T.L. and Mahley, R.W. (1981) J. Biol. Chem. 
256, 5646 - 5655. 
Hunter, W.M., Nars, P.W. and Rutherford, T. (1975) in 5th Tenovus 
Workshop, Steroid Immunoassays (Cameron, E.H.D. and Griffiths, 
K., eds), pp. 141 - 153, Alpha -Omega -Alpha Press, Caerphilly, 
Wales. 
Iga, T. and Klaassen, C.D. (1982) Biochem. Pharm. 31, 211 - 216. 
Innerarity, T.L., Pitas, R.E. and Mahley, R.W. (1980) J. Biol. 
Chem. 255, 11163 - 11172. 
Jansen, H. (1984) Biochem. Soc. Trans. (in the press). 
Jansen, H. and Hulsmann, W.C. (1974) Biochim. Biophys. Acta 369, 
381 - 396. 
Jansen, H. and Hulsmann, W.C. (1975) Biochim.-Biophys. Acta 398, 
337 - 346. 
Johansson, M.B.N. and Karlsson, B.W. (1976) Comp. Biochem. 
Physiol. 
54B, 495 - 500. 
114 
Johansson, S., Kjellen, L., Hook, M. and Timpl, R. (1981) J. Cell. 
Biol. 90, 260 - 264. 
Kannel, W.B., Castelli, W.P Gordon, T. and McNamara, P.M. (1971) 
Annals of Int. Med. 74, 1 - 12. 
Kempen, H.J., Vos Van Holstein, M -P., M and de Lange, J. (1982) 
J. Lipid Res. 23, 823 - 830. 
Kempen, H.J., Vos Van Holstein, M -P., M and de Lange, J. (1983) 24, 
316 - 323. 
Kita, T., Goldstein, J.L., Brown, M.S., Watanabe, Y., Hornick, C.A. 
and Havel, R.J. (1982) Proc. Natl. Acad. Sci. (U.S.A.) 79, 
3623 - 3627. 
Koelz, H.R., Sherrill, B.C., Turley, S.D. and Dietschy, J.M. (1982) 
J. Biol. Chem. 257, 8061 - 8072 
Krebs, H.A., Hems, R. and Tyler, B. (1976) Biochem. J. 158, 341 - 353. 
Laemmli, U.K. (1970) Nature 227, 680 - 685. 
Laishes, B.A. and Williams, G.M. (1976) In Vitro 12, 521 - 532. 
Lindstedt, S. (1957) Acta Chimica Scand. 11, 417 - 420. 
Long, T.T., Jakoi, L., Stevens, R. and Quarfordt, S. (1978) J. Lipid 
Res. 19, 872 - 878. 
Mahawold, T.A., Matschiner, J.T., Hsia, S.L., Richter, R., Doisy, 
E.A., Elliot, W.H. and Doisy, E.A. (1957) J. Biol. Chem. 
225, 
781 - 793. 
Maslansky, C.J. and Williams, G.M. (1982) In Vitro 18, 
683 - 693. 
Mathe, D., Botham, K.H. and Boyd, G.S. (1984) Biochim. Biophys. 
Acta 793, 435 - 440. 
115 
Matschiner, J.T., Mahawold, T.A., Elliott, W.H., Doisy, E.A., 
Hsia, S.L. and Doisy, E.A. (1957) J. Biol. Chem. 225, 771 - 779. 
Miller, G.J. and Miller, N.E. (1975) Lancet (i) : 16 - 19. 
Miller, L.K., Tiell, M.L., Paul, I., Spaet, T.H. and Rosenfeld, R.S. 
(1982) J. Lipid Res. 23, 335 - 344. 
Mills, G.L. and Taylaur, M. (1971) Comp. Biochem. Physiol. 40B, 489 - 501. 
Millward- Sadler, G.H. and Jezequel, A.M. (1979) in 'Liver and Biliary 
diseases' p. 13 - 43 ed. R. Wright, K.G.M.M. Alberti, S. Karran, 
G.H. Millward- Sadler, W.B. Saunders Co. Ltd. (London). 
Mingrone, G. and Greco, A.V. (1980) J. Chromatography 183, 277 - 286. 
Mitropoulos, K.A., Balasubramanian, S., Gibbons, G.F. and Reeves, 
B.E.A. (1972) FEBS Lett. 27, 203 - 206. 
Mitropoulos, K.A., Myant, N.B., Gibbons, G.F. Balasubramanian, S. and 
Reeves, B.E.A. (1974) J. Biol. Chem. 249, 6052 - 6056. 
Mitropoulos, K.A., Suzuki, M., Myant, N.B. and Danielsson, H. (1968) 
FEBS Lett. 1, 13 - 15. 
Murphy, G.M., Edkins, S.M., Williams, J.W. and Catty, D. (1974) 
Clin. Chim. Acta 54, 81 - 89. 
Nordby, G., Berg, T., Nilsson, M. and Norum, K.R. (1976) Biochim. 
Biophys. Acta 450, 69 - 77. 
. Norman, P.T. and Norum, K.R. (1976) Scand. J. Gastroenterology 11, 
427 - 432. 
Omura, T. and Sato, R. (1964) J. Biol. Chem. 239, 2370 - 2378. 
Oschry, Y. and Eisenberg, S. (1982) J. Lipid Res. 23, 1099 - 1106. 
Ose, L., Ose, T., Norum K.R. and Berg, T. (1980) Biochim. Biophys. 
Acta 620, 120 - 132. 
116 
Paine, A.J. and Hockin, L.J. (1980) Biochem. Pharm. 29, 3215 - 3218. 
Paine, A.J., Hockin, L.J. and Allen, C.M. (1982) Biochem. Pharm. 
31, 1175 - 1178. 
Paine, A.J., Hockin, L.J. and Legg, R.F. (1979) Biochem. J. 184, 
461 - 463. 
Paine, A.J. and Legg, R.F. (1978) Biochim. Biophys. Res. Commun. 
81, 672 - 679. 
Patsch, J.R., Sailer, S., Kostner, G., Sandhofer, F., Holasek, A. 
and Braunsteiner, H. (1974) J. Lipid Res. 15, 356 - 366. 
Pitas, R.E., Innerarity, T.L. and Mahley, R.W. (1980) J. Biol. 
Chem. 255, 5454 - 5460. 
Pittman, R.C., Attie, A.D., Carew, T.E. and Steinberg, D. (1979) 
Proc. Natl. Acad. Sci. (U.S.A.) 76, 5345 - 5349. 
Pittman, R.C., Attie, A.D., Carew, T.E. and Steinberg, D. (1982a) 
Biochim. Biophys. Acta 710, 7 - 14. 
Pittman, R.C., Carew, T.E., Attie, A.D., Witztum, J.L., Watanabe, Y. 
and Steinberg, D. (1982b) J. Biol. Chem. 257, 7994 - 8000. 
Portman, 0.W., Alexander, M. and O'Malley, J.P. (1980) Biochim. 
Biophys. Acta 619, 545 - 558. 
Quistorff, B., Bondesen, S. and Grunnet, N. (1973) Biochim. Biophys. 
Acta 320, 503 - 516. 
Ray, E., Bellini, F., Stoudt, G., Hemperly, S. and Rothblat, 
G. 
(1980) Biochim. Biophys. Acta 617, 318 - 334. 
Redgrave, T.G. (1970) J. Clin. Invest. 49, 465 - 471. 
Redgrave, T.G. and Small, D.M. (1979) J. Clin. Invest. 
64, 162 - 171. 
Risser, T.R., Reaven, G.M. and Reaven, E.P. (1978) 
Am. J. Physiol. 
234, E277 - E281. 
117 
Roheim, P.S., Rachmilewitz, D., Stein, O. and Stein, Y. (1971) Biochim. 
Biophys. Acta 248, 315 - 329. 
Salen, G. and Shefer, S. (1983) Ann. Rev. Physiol. 45, 679 - 685. 
Sanghvi, A,, Grassi, E., Warty, V., Diven, W., Wight, C. and 
Lester, R. (1981) Biochim. Biophys. Res. Commun. 103, 886 - 892, 
Schinike, R.T., Sweeney, E.W. and Berlin, C.M. (1965) J. Biol. Chem. 
240, 322 - 331. 
Scholan, N.A. and Boyd, G.S. (1968) Biochem. J. 108, 27 - 28P. 
Schwartz, C.C,, Vlahcevic, Z.R., Halloran, L.G. and Swell, L. (1981) 
Biochim. Biophys. Acta 663, 143 - 162. 
Seglen, P.O. (1973) Exp. Cell Res. 82, 391 - 398. 
Seglen, P.O. and Fossa, J. (1978) Exp. Cell Res. 116, 199 - 206. 
Shaw, R., Smith, J.A. and Elliott, W.H. (1978) Anal. Biochem. 86, 
450 - 456, 
Shepherd, J., Caine, E.A., Bedford, D.K. and Packard, C.J. (1984) 
The Analyst 109, 347 - 352. 
Shepherd, J., Packard, C.J., Bicker, S., Lawrie, T.D.V. and Morgan 
H.G. (1980) New. Eng. J. Med. 302, 1219 - 1222. 
Sherrill, B.C. and Dietschy, J.M. (1978) J. Biol. Chem. 253, 
1859 - 1867. 
Sherrill, B.C., and Innerarity, T.L. and Mahley, R.W. (1980) J. Biol. 
Chem. 255, 1804 - 1807. 
Sigurdsson, G., Noel, S -P. and Havel, R.J. (1979) J. Lipid Res. 
20, 316 - 324. 
Slater, H.R., Packard, C.J., Bicker, S. and Shepherd, J. (1980) 
J. Biol. Chem. 255, 10210 - 10213. 
Spady, D.K. and Dietschy, J.M. (1983) J. Lipid Res. 24, 303 - 
315. 
118 
Stange, E.F., Spady, D.K. and Dietschy, J.M. (1984) in Proceedings 
of VIII International Bile Acid Meeting, Berne, Switzerland. 
Falk Symposium No. 42 (in the press). 
Staple, E. and Gurin, S. (1954) Biochim. Biophys. Acta 15, 
372 - 376. 
Stein, Y., Dabach, Y., Hollander, G., Halperin, G. and Stein, 0. 
(1983) Biochim. Biophys. Acta 752, 98 - 105. 
Stein, 0., Stein, Y., Goodman, D.S. and Fidge, N.H. (1969) J. Cell. 
Biol. 43, 410 - 431. 
Stein, 0., Vanderhoek, J. and Stein, Y. (1977) Atherosclerosis 26, 
465 - 482. 
Stoudemire, J.B., Haines, H. and Hsia, S.L. (1980) Fed. Proc. 39, 
590. 
Strange, R.C., Beckett, G.J. and Percy -Robb, I.W. (1979) Biochem. 
J. 178, 71 - 78. 
Tall, A.R., Green, P.H.R., Glickman, R.M. and Riley, J.W. (1979) 
J. Clin. Invest. 64, 977 - 989. 
Tall, A.R. and Small, D.M. (1980) Adv. Lipid Res. 17, 1 - 53. 
Tocher, D.R. and Boyd, G.S. (1983) Biochim. Biophys. Acta 754, 
159 - 165. 
Turley, S.D., Andersen, J.M. and Dietschy, J.M. (1981) J. Lipid 
Res. 22, 551 - 569. 
Turley, S.D. and Dietschy, J.M. (1982) in "The Liver : 
Biology 
and Pathobiology ", ed. I. Avias, H. Popper, D. 
Schachter and 
D.A. Shafritz. Raven Press, New York p. 
467 - 492. 
119 
Van Toi, A., Van Gent, T., Van't Hooft, F.M. and Vlaspolder, F. 
(1978) Atherosclerosis 29, 439 - 448. 
Vina, J., Hems, R. and Krebs, H.A. (1978) Biochem. J. 170, 
627 - 630. 
Voight, W., Thomas, F.J. and Hsia, S.L. (1968) J. Biol. Chem. 
243, 3493 - 3499. 
Weisgraber, K.H., Innerarity, T.L. and Mahley, R.W. (1978) J. 
Biol. Chem. 253, 9053 - 9062. 
Williams, G.M., Bermudez, E. and Scaramuzzino, D. (1977) In 
Vitro 13, 809 - 817. 
Windier, E. -E., Kovanen, P.T., Chao, Y -S, Brown, M.S., Havel, R.J. 
and Goldstein, J.L. (1980) J. Biol. Chem. 255, 10464 - 10471. 
Wisher, M.H. and Evans, W.H. (1975) Biochem. J. 146, 375 - 388. 
Yedgar, S., Weinstein, D.B., Patsch, W., Schonfeld, G., Casanda, F. 
and Steinberg, D. (1982) J. Biol. Chem. 257, 2188 - 2192. 
Yousef, I.M., Ho, J. and Jeejeebhoy, K.N. (1978) Can. J. Biochem. 
56, 780 - 783. 
